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Abstract
This thesis concerns the construction of 2,3-dihydro-4//-pyran-4-one and 3(2//)- 
furanone ring systems by mercury(II)-catalysed reactions, or by more conventional 
cyclisations, and the potential of such reactions for the synthesis of natural products.
Chapter one provides a literature survey of reactions permitting the construction of 
2,3-dihydro-4//-pyran-4-one and 3(2//)-furanone ring systems; background literature 
to relevant natural products is also provided, such as polyether antibiotics, 
carbohydrates and antitumer agents.
Chapter two describes the application of mercury(II)-catalysed cyclisations of 
dihydroxylated ynones to give 3(2//)-furanones; this was achieved by the 
dihydroxylation of enynones using Sharpless’s asymmetric dihydroxylation 
conditions followed by treatment with a mecury(II) catalyst. The scope and 
limitations of this method were investigated and shown in several cases to give good 
yields and high enantiomeric excess. In cases where there was an electron-donating 
group on the alkyne functionality, such as an ethoxy group, the cyclisation occurred 
spontaneously during the dihydroxylation step. This methodology was applied for the 
synthesis of a natural product to confirm the selectivity of the cyclisation step.
In chapter three the reactions developed in chapter two formed the basis of a 
proposed route to the natural product (-)-Pestalotin, a gibberellins synergist. Thus, the 
Sharpless asymmetric dihydroxylation method was applied to (3,y-unsaturated ketones 
to give a main intermediate for the synthesis.
Chapter four  details different approaches to NK10958P, a plant growth regulator. 
The synthesis of two main fragments was achieved and the coupling of these 
fragments by syn-selective aldol addition is expected to furnish NK10958 P and its 
methyl analogue, pironetin, which has been reported to have good cytotoxic and 
immunosuppressive activity.
Full experimental details follow chapter 2-4 and reference sections are provided at the 
end of each chapter
Acknowledgement
I have greatly appreciated advice, support and comments from many people and I am 
particularly grateful to my academic supervisor Professor Charles M. Marson, and Dr 
Dave T. Davis my industrial supervisor (GSK), who made helpful suggestions 
throughout the duration of my Ph.D. Also I would like to thank the EPSRC and GSK 
for financial support for this work.
Finally I would like to thank the following people for their kind help and support; Dr 
A. E. Aliev, David Butler and John Hill, as well as the CMM group past and present, 
in particular Dr Stephane Sengmany, and James Morrell.
Abbreviations
AD Asymmetric Dihydroxylation
AIBN Azoisobutyronitrile
BMS Borane-methylsulphide complex
BINAP 2,2 ’ -Bw(diphenylphosphino)-1,1’ -binapthyl
Bn Benzyl
mCPBA meta-Chloroperoxybenzoic acid
DBU l,8-Diazabicyclo[5.4.0]undec-7-ene
DHQD Dihydroquinidine
DIBAL Diisobutylaluminium hydride
DMAP 4-Dimethylaminopyridine
DMF Ar,A-Dimethylformamide
DMP Dess-Martin periodate
DMS Dimethylsulphide
DMSO Dimethylsulphoxide
Im Imidazole
Ipc Isopinocampheyl
KHMDS Potassium bis(trimethylsilyl)amide
K-Selectride Potassium /7 7 -seobutylborohydride
LDA Lithium diisopropylamide
NMM A^-Methylmorpholine
NMO A-Methylmorpholine-A-oxide
PCC Pyridinium chlorochromate
Ph Phenyl
p-TsOH p-Toluenesulphonic acid
Py Pyridine
Red-Al Sodium b «(2-methoxyethoxy) aluminium hydride
TBAF Tetrabutylammonium fluoride
TBS terr-Butyldimethylsilyl
TFA Trifluoroacetic acid
TFAA Trifluoroacetic anhydride
TMS Trimethylsilyl
TMSC1 Trimethylsilyl chloride
iv
Contents
Page
Abstract ii
Acknowledgement iii
Abbreviations iv
Contents v
Chapter 1
Syntheses o f  2,3-Dihydro-4H-pyran-4-ones and 3(2H)-Furanones
1.1 Natural products containing the Dihydropyranone Ring and Related
Systems 1
1.2 The Total Synthesis of Dihydropyranones 2
1.2.1 The Synthesis of Dihydropyranones using Danishefsky’s Diene 3
1.2.2 The Diastereocontrol of the Danishefsky Reaction 4
1.2.3 Enantioselectivity of the Danishefsky Reaction 6
1.2.4 Further Modifications to the Danishefsky Reaction 8
1.2.5 Alternative Methods for the Preparation of 2,3-Dihydropyranones 11
1.2.6 Cyclisation of Hydroxy Alkynones to 2,3-Dihydropyranones 14
1.2.6.1 Baldwin’s Rules for Ring Closure 14
1.2.7 Preparation of Dihydropyranones using p-Hydroxy Alkynes 15
1.2.8 Synthesis of 2, 3-Dihydropyranones using Mercury(II)-Catalysed
Rearrangement of Epoxy Alkynols 17
1.2.9 Preparation of 3(2//)-Furanones from a-Hydroxy Alkynone s 19
1.2.10 Cyclisation of a,p-Dihydroxy Alkynones 21
1.3 Sharpless Asymmetric Dihydroxylation: Background 22
1.3.1 Chiral ligands for Sharpless Asymmetric Dihydroxylation 23
1.3.2 Stoichiometric Co-oxidant 24
1.3.3 The Concentration of Osmium and Ligand 26
1.3.4 Substrates for the Asymmetric Dihydroxylation Reaction 27
1.3.5 Asymmetric Dihydroxylation of Electron-Deficient Olefins 28
1.4 Aim of the Project 29
References 30
Chapter 2
The Enantioselective Synthesis o f  3(2H)-Furanone Ring Systems
2.1 Introduction 34
2.2 Literature Review of 3(2//)-Furanone Syntheses 35
2.3 Results and Discussions 38
2.3.1 Synthesis of 3(2//)-furanones using Mercury(II) Catalysis 38
2.3.2 The Preparation of Enynones 108 39
2.3.3 The Synthesis of 2,3-Dihydroxy Alkynones
2.3.3.1 Synthesis of 3(2//)-Furanones via Asymmetric
42
Dihydroxylation of Weinreb Amides 44
2.3.3.2 Preparation of 4-Ethoxy-Substituted 3(2//)-Furanones 45
2.3.4 Mercury-Catalysed Cyclisations 46
2.3.5 Determination and Optimisation of Enantiomeric Excess (ee) 48
2.3.6 Synthesis of a 3(2//)-Furanone Containing Natural Product 
2.3.6.1 Enantioselective Synthesis of the Natural Product 129
49
Using (N)-Malic Acid
2.3.6.2 An Alternative Approach to the Synthesis of 3(2H)-
49
Furanone 129 using Sharpless Asymmetric Dihydroxylation 51
2.3.7 Palladium(II)-Catalysed Cyclisation Leading to 3(2//)-Furanones 53
2.4 Conclusions 54
Experimental 55
References 97
Chapter 3
Towards the Synthesis o f  (-)-Pestalotin using Sharpless Asymmetric 
Dihydroxylation
3.1 Introduction 101
3.2 Several Syntheses of (6S, 7S)-(-)-Pestalotin Reported in the Literature 102
3.3 Results and Discussion 107
3.3.1 Attempted Preparation of p,y-Unsaturated Alkynone 169 108
3.3.1.1 Preparation of Weinreb amides 109
3.3.1.2 Alkynylation of Weinreb amides 111
3.3.2 Attempted Preparation of Dihydroxy Alkynone 170 112
3.3.2.1 Preparation of Dihydropyranones via Weinreb amides 114
3.3.3 Attempted Synthesis of p-Ketolactone by Base-Catalysed 
Cyclisation 118
3.4 Conclusions 119
Experimental 120
References 136
Chapter 4
Towards the Total Synthesis ofNK10958P
4.1 Introduction 139
4.2 Syntheses of Pironetin Reported in the Literature 140
4.3 Results and Discussions 145
4.3.1 Proposed Synthesis of the a,p-Unsaturated Lactone
250 using a Mercury(II)-Catalysed Cyclisation 145
4.3.1.1 Wittig-Wadsworth-Emmons reaction 146
4.3.2 Proposed Synthesis of the a,p-Unsaturated Lactone 250
Using Evans Asymmetric Aldol Methodology 148
4.3.2.1 Evans Asymmetric Aldol reaction: Introduction 148
4.3.3 Synthesis of the Acyclic Ketone Fragment 249 154
4.4 Conclusions 156
Experimental 157
References 170
Appendix A
X-ray Analysis of 3(2//)-Furanone 24h. 173
vii
Chapter 1
Chapter 1
Syntheses of 2,3-Dihydro-4//-pyran-4-ones and 3(2/J)-Furanones
The dihydropyranone ring system is present in a variety of natural products with 
important therapeutic properties. Dihydropyranones have also been used as key 
intermediates in the synthesis of other ring systems, such as spiroketals and 
substituted tetrahydropyrans.
Tetrahydropyran ring systems are part of the backbone of various carbohydrates and 
are important building blocks in many biologically active natural products such as 
marine toxins and polyether antibiotics.12 Due to the synthetic interest in this ring 
system a number of methods have been developed for the construction of pyran 
rings. These include manipulation of carbohydrates,3 Prins reactions,4,5 hetero Diels- 
Alder cyclisations,6 intramolecular epoxide opening and Michael reactions.7
1.1 Natural Products Containing the Dihydropyranone Ring and Related Systems
The 3-methyltetrahydropyran unit is present in the spiroketal antibiotics oligomycin, 
rutamycin and cytovaricin which are specific inhibitors of mitochondrial ATPase.8 
Other examples of compounds containing a 3-methyltetrahydropyran unit include 
monensin I ,910 a member of the poly ether antibiotics (ionophores), the potent 
antitumour agent spongistatin11,12 and serricomin 2,13 the sex pheromone of the 
cigarette beetle, as well as mycalamides,14 potent antitumour and antiviral agents.
15 16 1718The syntheses of avermectins 3, phyllanthostatins and milbemycins ’ require 
assembly of a spiroketal unit, see Figure 1.1.
1
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HO,
MeO,
HOOC Monensin 1
Me Me
tMe
Me'
OH
Me
R O
OH
Seme omin 2
OH
Stegobiol 4
Avermectin A ia 3 
R = Et, R1 = Me, R2 = L-oleandrosyl-L-oleandrose
Figure 1.1: Tetrahydropyran and spiroketal-containing natural products.
The 2,3-dihydro-4//-pyran-4-one ring is also present in a number of natural products 
including stegobiol 4,19 a component of the sex pheromone produced by females of 
the drugstore beetle, vallartanones A, B20 and various HIV protease inhibitors.21'23
1.2 The Total Synthesis o f Dihydropyranones
Dihydropyranones are important intermediates for the synthesis of a wide range of 
substituted tetrahydropyrans. The synthesis of these systems is usually achieved 
using Lewis-acid catalysed reactions of siloxydienes 5 and aldehydes as developed 
by Danishefsky.24 This reaction has been successfully used for the synthesis of 
polypropionate25 and carbohydrate units, the latter being present in a variety of 
antibiotics26 and antitumour agents.27 The enantioselective syntheses of
28 29dihydropyranones 7 have been reported using chiral aldehydes, ’ chiral 
auxiliaries30,31 attached to the diene and chiral Lewis acids.30'32
2
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OM e
RCHO
5a R* = H;R2 = alkyl 7a
5b R1 = alkyl; R2 = H 
5c R1, R2= alkyl
Scheme 1.1: Dihydropyranone synthesis using the Danishefsky reaction.
1.2.1 The Synthesis o f Dihydropyranones Using Danishefsky’s Diene
Enol silylation provides convenient access to extensively functionalized 1,3- 
butadienes of type 5. It was found that under Lewis-acid catalysis the parent diene 5 
reacts with a number of aldehydes to provide 2-substituted 2,3-dihydro-y-pyrones of 
the general structure 7 (Scheme l .l) .33
In the initial experiments, zinc chloride in tetrahydrofuran or borontrifluoride 
etherate in dichloromethane was used as catalyst. Subsequently dienes of type 5a-c 
were shown to undergo the cyclocondensation reaction. New catalytic systems were 
applied to the transformation, including Eu(fod)3 ,24 TiCl4, and MgBr2 .
The synthesis of the dihydropyranone ring is believed to occur by one of two 
possible pathways, a pericyclic or an aldol-type pathway28 (Scheme 1.2).
3
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r  "Pericyclic" Me3SiO'M e3SiO
Mukaiyama
aldolMe3SiO
R1 = H; Me3Si
Scheme 1.2: Preparation of dihydropyranones using Danishefsky’s diene 5.
The pericyclic mechanistic model proposes a cyclocondensation reaction analogous 
to the catalysed all-carbon hetero Diels-Alder (HDA) reaction and favours a topology 
leading to the cw-2,3-dihydopyran. The alternative mechanism proposed involves 
the formation of an intermediate (k-alkoxy enone 9 by a Mukaiyama variant of the 
aldol condensation reaction followed by ring-closure to give 7. The reaction 
mechanism is greatly affected by the choice of catalyst, solvent system and the 
structure of the aldehyde.
1.2.2 The Diastereocontrol o f the Danishefsky Reaction
The diastereofacial control is dependent on a number of factors such as the substrate, 
solvent and catalyst. It was found that the borontrifluoride etherate catalyst in 
dichloromethane is a trans (threo) selective system (See Table 1.1, method A), while 
the zinc chloride/ tetrahydrofuran system promotes cis (erythro) selectivity (method 
B).34 This enabled some control of the stereochemical outcome of the 
cyclocondensation reaction by simply changing the catalyst/ solvent system.
4
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Table 1.1: Lewis-acid catalysed cyclocondensation reaction.
10 Me 6 11 12 
R Method 11 (Yield %) 12 (Yield %)
a "C5Hn A [(i) BF3-CH2C12, -78 21 69~
°C; (ii) TFA]
B [(i) ZnCl2-THF; (ii) 91 2
NaHC03; (iii) TFA] 
b CeHs A 23 68
B 78 2
c C6H5(CH2 )3  A 17 64
B 83 2
d C6H5CH2OCH2 A 17 68
B 66 24
The formation of the cis products (Scheme 1.3) corresponds to an endo orientation of 
the R group of the aldehyde relative to the diene. This mechanism can be explained 
in terms of the formation of a complex where the Lewis acid (L+) binds to the 
aldehydic oxygen anti to the R group. Thus steric factors might favour positioning 
the Lewis acid in the exo orientation in the pericyclic process, thus resulting in the 
cw-pyranone 13.
MesSiO. R2 q
Rf —• V - O M e  /  Vv
1 \  H /  ^  Ri-'"<
R O —  '' 
H
- °
r'
A (anti) 13
Scheme 1.3: Diastereocontrol of the Danishefsky reaction.
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1.2.3 Enantioselectivity o f the Danishefsky Reaction
Some enantioselectivity was achieved by using chiral aldehydes; however, this 
approach is limited by the availability of the chiral aldehyde and the level of success 
in the transmission of the stereochemical information from the chiral aldehyde to the 
emerging dihydropyran.
With achiral dienes, the commercially available chiral catalyst Eu(hfc)3  
[tris(6,6,7,7,8,8,8-heptafluoro-2,2-dimethyl-3,5-octanedionato)europium] shows only 
modest enantiofacial selectivity (Table 1.2); similarly, modest enantioselectivities 
were observed in the reactions of several chiral dienes and aldehydes in the presence 
of the achiral catalyst Eu(fod)3  (Table 1.3). However, the combination of chiral 
dienes with chiral Eu(hfc)3  catalyst exhibited remarkable interactivities, which led in 
some instances to diastereofacial excesses of 95% (Table 1.4) . 30
Table 1.2: Ratio of L-Dihydropyrone 17/ 7>Dihydropyrone ent-17 for the Reaction 
of Dienes 5 with Benzaldehyde. (Catalyst, (+)-Eu(hfc)3 ; solvent, CDCI3 (R = tert-
butyl).
T B S O
Eu(hfc)3 ] 
CDCl-i
14 15
TB S O
TFA
H Y
Compound
(a)
(b)
(c)
(d)
(e)
X
hT
Me
Me
OAc
OSiMe3
Y
"h
H
Me
H
H
17/ ent-17 
69/31 
70/30 
71/29 
66/32 
71/29
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Table 1.3: Ratios of D-Pyranose 19/ L-Pyranose 20 for the Reaction of /-Menthyloxy 
Dienes 18a-d with Benzaldehyde. (Catalyst, Eu(fod)3 ; solvent, CDCI3)
OMenth
Ox
Me3SiCT H Ph
Y
15
Compound
6 0
(b)
(c)
(d)
Eu(fod)3)
X
H
Me
OAc
Me
OMenth OMenth
Y
h "
H
H
Me
TFA
-*► 17
19/20
33/67
45/55
45/55
49/51
A study of the efficacy of combining the chiral catalyst Eu(hfc)3  with the chiral 
dienes 18 showed that the use of modestly L-selective diene in conjunction with the 
modestly L-selective (+)-Eu(hfc)3  catalyst resulted in poor selectivity for L-pyranone. 
However, the combination of (-)-Eu(hfc)3  with the modestly L-selective diene 
provided substantial diastereotopic preferences for L-pyranose 19/ D-pyranose 20 . 35 
The results are given in Table 1.4.
Table 1.4: Ratios of D- and L-Pyranosides for the Reaction of Menthyloxy Dienes 
18a-d with Bezaldehyde. Catalyst, Eu(hfc)3 ; solvent, CDCI3
OMenth
M©3oiO
Compound
<w
(b)
(c)
(d)
Eu(hfc)3 ^
X
"h
Me
OAc
Me
OMenth OMenth
TFA
17
19/ 20
75/25
92/8
93/7
87/13
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As a result of endo selectivity, only cis pyranones are directly available through this 
methodology. Additionally, this reaction does not allow the direct synthesis of aryl 
or alkyl C-6 substituted dihydropyranones.
Another limitation is for unsubstituted dienes, where X,Y=H (Danishefsky’s Diene) 
which function well in the cycloaddition reaction, but afford poor diastereoselectivity 
even in the presence of different chiral auxiliaries with either of the Eu(hfc)3  
antipodes or in the presence of the achiral Eu(fod)3  as the catalyst.
1.2.4 Further Modifications to the Danishefsky Reaction
Yamamoto and co-workers described the successful application of organoaluminium 
catalysts ((R)-21 / (S)-21) to affect the Danishefsky reaction (Scheme 1.4), leading 
primarily to the c/s-substituted product (cis: tram  77:7) in 84% yield and 95% ee.32 
The enantioselectiviy was established by the presence of bulky aryl groups (R = Ph 
or 3,5-xylyl) on the silyl group of the catalyst.
(l)PhCHO MV ^ V >  Mev ^ " n
cat (R)-13 % 1 Y + T ?
(2) CF3C0 2H O j f ^ P h
Me Me
Me3SiO
11 12
Xl-Me
(R)-21
A1—Me
6S)-21
Scheme 1.4: Enantioselective synthesis of dihydropyranones by the Danishefsky 
reaction using an organoaluminium catalyst (R = Ph or 3,5-xylyl).
The optical purity of the product was independent of the amount of catalyst used (5- 
100 mol%), but it increased gradually by lowering the reaction temperature. The 
choice of the bulky triarylsilyl moiety in 21 is crucial for obtaining the high 
enantiofacial selectivity. The reaction of benzaldehyde with the diene 10 in the
8
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presence of catalyst (R)-21 (Ar = Ph), its tert-butyldimethylsilyl analogue and its 
trimethylsilyl analogue under similar conditions produced 11 and 12 respectively in 
yields of 84% (ratio, 92:8, 95% ee in 11), 91% (69:31, 84% ee), and 72% (53:47, 
64% ee). Since both enantiomers of the catalyst are available both antipodal 
products can be obtained via this route. In the case of benzaldehyde, the 
enantioselective activation of the carbonyl moiety by the catalyst positions the diene 
in an endo alignment relative to the aldehyde phenyl residue, which minimizes steric 
repulsion between the incoming diene and the front triarylsilyl moiety, thereby 
yielding the cis adduct 11, see Scheme 1.4.
Once the hetero-Diels-Alder adduct is formed the aluminium reagent is cleaved and 
the catalyst is available for further use in the catalytic cycle. In contrast, the chiral 
organoaluminium reagents derived from MesAl and (/?)-(+)-3,3 ’ -dialkylbinaphthol 
(alkyl = H, Me, and Ph) was employable only as a stoichiometric reagent and gave 
fewer satisfactory results in reactivity and enantioselectivity of the dihydropyranone 
product.
A solution of the chiral (acyloxy)borane (CAB) catalyst, prepared by the reaction of 
tartaric acid derivative 22 and arylboric acid was reported to affect the hetero Diels- 
Alder reaction.36 The cyclocondensation was carried out with 20 mol% of the CAB 
catalyst at -78 °C. Treatment of the crude product with trifluoroacetic acid in 
dichloromethane afforded the dihydropyranone product. The extent of asymmetric 
induction was largely dependent on the structure of boric acid; where R = Bu or Ph 
the ee of the dihydropyrone was 73% (63% yield), whereas bulky phenylboric acid 
(2,4,6-Me3Ph) resulted in an excellent ee of 95% (47% yield), overly bulky 
substituents, however, led to a loss in reactivity.
CAB catalyst:
COOH COOH 0
, - K A■COOH
Scheme 1.5: CAB catalyst and tartaric acid precursor.
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The catalytic enantioselective aldol reaction was reported by Keck and co-workers, 
using T i(01Pr)4/ BINOL (R- or S- enantiomer) catalyst.37 This reaction was followed 
by trifluoroacetic acid-catalysed cyclisation to furnish the dihydropyranone 7 
(Scheme 1.6). The cyclocondensation reaction between various simple aldehydes 
and l-methoxy-3-[(trimethylsilyl)oxy]-butadiene (Danishefsky5 s diene) was 
investigated and it was reported that this procedure led to high ees (78-97%) and 
moderate yields.
OMe
TMSO OO \ s  Chiral acid i  |j TFA
rA h j k o m s  acid *  R '^ A ^ O M e
6 5 9
Scheme 1.6: The synthesis of dihdropyranones using the aldol reaction followed by 
acid-catalysed cyclisation.
The hetero Diels-Alder reaction reported by the Danishefsky group usually involved 
electron-rich dienes such as l-methoxy-3-(trimethylsilyloxy) butadiene 
(Danishefsky5 s Diene) and/or electron-deficient dienophiles such as glyoxylates 
derivatives. Recently Jacobsen and co-workers reported the asymmetric hetero 
Diels-Alder reaction between less nucleophilic dienes, such as 24 or 26 and 
unactivated carbonyl compounds using the tridentate Schiff base chromium(III) 
complexes 30 (Schemes 1.7 and 1.8).38
9'*2
r  Hv . R4 catalyst
' 3  
+ Yo
R-T ... Rl 0 R424 25
+ Hy R= - cg g f — ^
-iC'
Scheme 1.7: The chromium(III) catalysed cyclisation of electron-deficient
substrates.
10
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The adamantyl-substituted chromium(III) complexes 30 led to high ees (95%) and 
the high endo selectivity of the cyclisation step resulted in the formation of the 
mainly cA-configuration products. This reaction was shown to tolerate a wide range 
of aldehyde starting material and thus led to highly substituted 2,6-cis- 
tetrahydropyran rings.39,40
Scheme 1.8. Reagents and conditions: (a) catalyst 30 (3 mol%), 20°C, 16-40h 
(b) TBAF, AcOH, THF.
1.2.5 Alternative Methods for the Preparation of 2,3-Dihydropyranones
Paterson and co-workers reported the diastereoselective preparation of the syn-aldol 
product 33 (97% de in some cases) using the dienol dibutylborinates 32.41 The 
cyclisation of 33 in the presence of trimethylsilyltriflate generated the cis- 
dihydropyranone product 34 (Scheme 1.9). However, equilibration between the cis- 
dihydropyranone (kinetic product) and the trans-isomer, resulted in lower selectivity 
in some cases (cis.trans 70:30). Enantioselectivity was achieved by using the chiral 
boron reagent (-)-(Ipc)2BOTf for the enolisation step, which in one case resulted in 
the formation of the aldol product in 97% diastereoselectivity and 80% ee.
11
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‘Bu2BOTf Me^SiOTf
1Bu2BO'lPr2NEt
Scheme 1.9: Preparation of dihydropyranones by an aldol-cyclocondensation 
reaction. (R1 = Me, R2 = Alkyl).
For R 1 = Me, the boron-mediated aldol reaction of 31 with a range of aldehydes 
produced the syn adduct 34 in good yield (53-84%) with high syn selectivity (97%) 
via the (Z)-dienol dibutylborinates 32. Selective production of the anti isomer via 
the corresponding (A)-dienol borinates, however, proved unsatisfactory. For R 1 = H, 
the corresponding aldol reaction of the enone 31 also proceeded well.
The cyclisation could not be extended to the situation where R2 is phenyl or alkenyl 
as competitive dehydration occurred. It is believed that the reaction proceeded 
through the trimethylsilyl ether derivatives of 33, which then undergo acid (or 
trimethyl silyl triflate) catalysed cyclisation to the dihydropyrone.
The asymmetric synthesis of dihydropyrones by chiral boron reagents for the initial 
aldol step was investgated. Use of (-)-(Ipc)2BOTf (1.3eq) for the enolisation of 35 
gave the sy?z-aldol product 36 (40%, >97% diastereoselectivity) in 80% ee 
(determined by analysis of the 1HNMR spectra in the presence of Eu(hfc)3), 
cyclisation resulted in the cw-dihydropyrone 37 in 78% yield and 80% ee. Hence no 
detectable racemisation occurred during the cyclisation step. Similarily, the (-)- 
(Ipc)2BCl mediated aldol reaction of 38 with butanal gave 39 in 67% ee which was 
cyclised to give the dihydropyrone 40 (Scheme 1.10).
12
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Scheme 1.10. Reagents and conditions: (a) (i) (-)-(Ipc)2BOTf, 1Pr2NEt, CH2CI2 ; (ii) 
HprCHO; H20 2; (b) Me3SiOTf, iPr2NEt; (c) (i) (-)-(Ipc)2BCl, iPr2NEt, CH2C12; (ii) 
nPrCHO; H20 2.
Clarke and co-workers reported the synthesis of substituted tetrahydropyran-4-ones 
in single diastereoisomers by an aldol reaction between p-ketoesters with aldehydes 
followed by a tandom Knoevengel condensation with a further equivalent of 
aldehyde, and an intramolecular Michael addition (Scheme 1.11).42,43
M eO
41
(a)
aldol
O O OH  
42
(b)
Knoevenagel
O O OH
R r  43
h 3c o 2c ,
Michael
addition
Scheme 1.11. Reagents and conditions: (a) (i) NaH, THF (ii) nBuLi, -78 °C (iii) 
RCHO (b) (i) BF3.OEt2, THF (ii) RiCHO.
A recent publication by Hinterding and co-workers described the preparation of p- 
keto-5-lactone by an intramolecular Claisen-type rearrangement on Evans 
oxazolidinone with an acetate enolate44 (Scheme 1.12); the anti-aldol 45 was initially 
converted to the acetate 46 by treatment with acetic anhydride in the presence of 
triethylamine and DMAP. The exposure of compound 46 to a solution of LiHMDS 
(lithium-bistrimethylsilylamide) led to the clean formation of the lactone product 47 
with the chiral oxazolidinone being generated as the only by-product.
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87%
PhPh
Scheme 1.12. Reagents and conditions', (a) AC2O, NEt3, DMAP, CH2CI2 , 20°C; (b) 
LiHMDS, THF, -  78°C.
1.2.6 Cyclisation of Hydroxy Alkynones to 2,3-Dihydropyranones
1.2.6,1 Baldwin’s Rules for Ring Closure
Baldwin has proposed a set of rules for ring closure;45 the ring-forming reactions are 
designated by a numerical prefix which denotes the ring size, which is then followed 
by either the term exo or endo depending on whether the bond breaking is exocyclic 
or endocyclic to the smallest ring formed, and finally by one of the suffixes tet, trig 
or dig describing the hybridisation of the carbon atom undergoing attack in the 
cyclisation step, referred to as tetrahedral, trigonal and digonal respectively. 
Scheme 1.13 illustrates some of the different possibilities of ring closure for the 
digonal case.
The rules are as follows
Rule 1: Tetrahedral Systems'.
(a) 3 to 1-Exo-Tet are all favoured processes with many reported in the 
literature.
(b) 5 to 6-Endo-Tet are disfavoured.
Rule 2: Trigonal Systems'.
(a) 3 to 1-Exo-Trig are all favoured processes with many literature 
precedents.
(b) 3 to 5-Endo-Trig are disfavoured; 6 to 1-Endo-Trig are favoured.
Rule 3: Digonal Systems'.
(a) 3 to 4-Exo-Dig are disfavoured processes; 5 to 1-Exo-Dig are favoured.
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(b) 3 to 1-Endo-Dig are favoured.
4-Exo-Dig 5-Exo-Dig 5-Endo-Dig 6-Endo-Dig
Scheme 1.13: Digonal cyclisations.
1.2.7  Preparation of Dihydropyranones Using p-Hydroxy Alkynes
A series of molybdenium and tungsten-mediated cycloisomerisation of 
homopropargylic and bis-homopropargylic alcohols to dihydrofurans and 
dihydropyrans has been reported by McDonald and co-workers (Scheme 1.14).46,47 
However, this requires photolysis at elevated temperatures as well as high catalyst 
loading (25%).
V°H .H ""/^ °N
— — — ►  T )
Bn° 48 32% B n O ^ /
Scheme 1.14. Reagents and conditions: (a) (i) (THF)W(CO)5 , THF; (ii) NEt3 , 
Et20/THF.
Simillarily, palladium(II) catalysts have been used to affect the cyclisation of 
propargylic alcohol 50 into the dihydrofuran 51 in excellent yields (Scheme 1.15).48
Scheme 1.15. Reagents and conditions: (a) PdCl2(PhCN)2 , MeCN, 60°C.
The cyclisation of P-hydroxy alkynones 52 to form dihydropyranone 53 in the 
presence of NaH was observed by Dreessen and co-workers.49 The reaction occurs 
by an intramolecular conjugate addition of the hydroxyl group to the ynone.50,51 This
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cyclisation was also effected using a solution of TBAF in THF at 20 °C, and resulted 
in a 43% yield of the dihydropyranone.52
Scheme 1.16: Base-catalysed synthesis of dihydropyranones.
Ziegler and co-workers obtained poor yields of the dihydropyranone 55 (30-49%) by 
using caesium carbonate as a catalyst in acetonitrile. The poor yield was a 
consequence of the formation of the 5-exo-dig product 56 (39-50%),53 (Scheme 
1.17).
,OH (i)
Scheme 1.17: Preparation of dihydropyranone 55 from (T-hydroxy alkynone 54, (i) 
Cs2C 0 3, MeCN, 20 °C, 15-21%.
The cyclisation of 57a-c under basic conditions resulted in a mixture of flavones 
58a-c and aurones 59a-c products via 6-endo-dig and 5-exo-dig modes of cyclisation 
respectively (Scheme 1.18); the product distribution is dependent on the nature of the 
alkyne substituent (R). The cyclisations are presumed to occur via the respective 
vinylic carbanion precursors 60 and 61. The more inductively electron-donating the 
|3-phenyl ring the less stable the carbanion 61, and hence less aurone is seen in the 
product mixture, see Table 1.5.
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57a-c
+
58a-c 59a-c
R
a; R = H
b; R = Me 
c ; R = MeO
R
Scheme 1.18. Base-catalysed cyclisation of l-(2-hydroxyphenyl)-3-arylprop-2-yn-l 
ones. Reagents and conditions: (a) NaOMe (1.1 eq.), MeOH, 20°C, 2 h.
Table 1.5: Product distribution for NaOMe-catalysed cyclisation in MeOH.
Compound Yield (%) Flavone 58 (%) Aurone 59 (%)
57a 86 59 41
57b 91 70 30
57c 95 74 26
The cyclisation was also carried out in the presence of trifluoroacetic acid (TFA), 
under these conditions electron-donating substituents (R) caused the reaction to 
proceed more rapidly and the flavone product was favoured, (i.e. the 6-endo-dig 
cyclisation product); the reaction was performed at 20 °C or at reflux for 24-48 
hours.
1.2.8 Synthesis of 2, 3-Dihydropyranones Using Mercury(Il)-Catalysed 
Rearrangement o f Epoxy Alkynols
Marson and co-workers reported the first examples of 1-alkynyl-2,3-epoxy alcohol 
rearrangement leading to 3-substituted-2,3-dihydro-4//-pyranones (Scheme 1.19).54 
The reaction is believed to occur via a semi-pinacol rearrangement of the epoxide, 
followed by ring-closure. However, the intermediate 64 has not been isolated and so 
an alternative pathway may be operating.
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Epoxidation R-
Scheme 1.19: Stereospecific rearrangement of epoxy alkynols to 2,3-dihydro-4H- 
pyran-4-ones.
It was concluded that the configuration of the alkene (that is epoxidized) exclusively 
determines the configuration of the resulting 2,3-disubstituted dihydropyran; thus a 
trans-(E)-alkene would lead solely to the dihydropyranone 65, with cis 2,3- 
substitution, the (Z)-alkene affords the trans-product. This was explained by the 
suprafacial migration of hydride, with concomitant ring opening of the epoxide, and 
inversion solely at the a-position. Where needed, asymmetric epoxidation can be 
used to provide enantioselective syntheses of dihydopyranones and related natural 
products, such as those discussed in section 1.1.
The 2,3-epoxy alcohols 63 were prepared from enynols 62 using tert-bxxtyX 
hydroperoxide (TBHP)-VO(acac)2  with the subsequent cyclisation being catalysed by 
mercuiy(II) in dilute aqueous sulfuric acid. The configuration of the carbinol carbon 
atom was considered to be unimportant as free rotation will enable both the epimeric 
alcohols to deliver the hydride anti to the C-0 bond of the epoxide undergoing 
cleavage.
The mild reaction conditions enabled the tolerance of alkyl, aryl and hydroxylated 
functionalities at the C6 position of the ring as long as the group is not substantially 
electron-withdrawing. It was also found that placement of an electron-donating 
group, e.g. ethoxy, at C-6 led directly to the 2,3-dihydropyranone 67 from the allylic 
alcohol during the epoxidation step, as no epoxide was isolated the mercury catalyst 
was not required in this case (Scheme 1.20).
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TBHP/ r H 0 -H
Scheme 1.20: Proposed pathway for tandem epoxidation-cyclisation.
As the ethoxy group is a strong electron donor, the movement of electrons shown in 
Scheme 1.20 may result in assisted cleavage of the epoxide ring and perhaps also to 
the ring closure by attack of oxygen on the “ketene oxonium” group leading to the 
pyranone molecule. This is a significant result, not only due to rapid formation of 
the pyranone but as the 6-ethoxy pyranone ring can be converted into a lactone ring 
in the presence of an acid, the lactone ring being common in natural products.
The above epoxidation-cyclisation route can only be applied to the synthesis of 3- 
substituted pyranone rings, as the cyclisation step was unsuccessful for C-3 
unsubstituted epoxides. Thus a different method of synthesis is needed to obtain the 
3-unsubstituted pyranone ring; one proposed method is the synthesis of P-hydroxy 
alkynone 64 (e.g. by Evans auxiliary protocol) followed by the mercury-catalysed 
cyclisation.
1.2.9 Preparation o f 3(2H)-Furanones From a-Hydroxy Alky nones
The 3(2//)-furanone ring system is an important synthetic target, as it is present in a 
number of biologically-active natural products such as bullatenone 69 and the 
antitumour agent geiparvarin. Jackson and Raphael55 reported the synthesis of 
3(2//)-furanone 69 from ynone 68 by heating under reflux in a suspension of 
potassium carbonate in methanol. The acetylenic ketone 68 was obtained by addition 
of lithium phenylacetylide to a-acetoxyisobutyryl chloride in tetrahydrofuran at -  70 
°C.
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Scheme 1.21: Preparation of a 3(2//)-furanone; (i) a-acetoxyisobutyryl chloride, 
THF, - 70 °C, (ii) K2 CO3 , MeOH, 35% overall yield from phenylacetylene.
According to stereoelectronic principles56 the first intermediate of a base-catalysed 
addition to a conjugated acetylenic ketone (ynone) should be an allenic enolate, such 
as 72, followed by protonation leading to the a,(3-unsaturated ketone (enone). Also 
the acid-catalysed Michael-addition mechanism would proceed through an allenic 
enol intermediate. However, this mechanism does not account for the synthesis of 
rings smaller than 8-membered where the allene functionality would result in 
considerable ring strain.
An alternative mechanism was proposed by Brennan and co-workers,57 outlined in 
Scheme 1.22. It was suggested that under acidic conditions the cyclisation of ynones 
70a-c occurred by a rate-limiting protonation of the triple bond; this is followed by 
bending of the vinyl carbenium ion, allowing the overlap of the oxygen lone pair of 
the nucleophile and the vacant sp2 orbital.
FASTSLOW
OH
R70a-c 71a-c X - ;
a; R = H 
b; R = Me 
c; R = MeO
R
R
Scheme 1.22: Ring-closure reaction pathway for 2-hydroxy-2-methyl-5-arylpent-4- 
yn-3-ones.
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1.2.10 Cyclisation of a,P-Dihydroxy Alky nones
The treatment of the diol 73 with Hg(OCOCF3)2 using Schwartz’s conditions58 led in 
a regioselective manner to the dihydropyran-4-one 74 in 71% yield along with 7% of 
the dihydrofuran-3-one 75 (Scheme 1.23).32;59;6°
OH
74
+ 'OH
75
.OH
OH
Scheme 1.23: Dihydropyran-4-one synthesis using mercury(II) trifluoroacetate as the 
catalyst, (i) Hg(OCOCF3)2, Et3N, CH2C12, - 78 °C; then Lil, Et20 , Et3N.
Treatment of acetylenic ketone 76 with methanolic potassium methoxide (0.03 M, 25 
°C, 6 h) produced a mixture of the dihydropyranone 78 in 44% yield and the (E)- 
vinylogous ester 77 (34% yield),61 which proved to be stable to the reaction 
conditions. The penultimate precursor of the dihydropyanone was assumed to be the 
(Z)-isomer of 77. However, acid-catalysed cyclisation {p-TsOH, benzene, 25 °C, 5 
h) of the (^-isom er 77 provided the desired dihydropyranone 78 in 97% conversion 
(total of 76% yield from the acetylenic ketone 76) (Scheme 1.24).
TB SOTBSO
OH
OH OHOH
TBSO
+ OH
Scheme 1.24: Base-catalysed ring closure of 2,3-dihydroxyalkynones. (i) KOMe/ 
MeOH, 25 °C, 6 h.
When conditions (Cs2C 0 3, CH3CN, 45 °C, 9 h) devised by Deslongchamps56 for the 
intramolecular addition of p-keto ester anions to acetylenic ketones were applied to 
the diol 76, exclusive formation of corresponding furanone product was observed.
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1.3 Sharpless Asymmetric Dihydroxylation: Background
Criegee first reported the use of osmium tetroxide for the oxidation of olefins;62 this 
reaction was believed to occur by a concerted [3+2 cycloaddition] mechanism 
(Scheme 1.25).
Scheme 1.25: Proposed [3+2] cycloaddition mechanism for the dihydroxylation of 
alkenes.
A ligand acceleration effect was reported by Criegee, originally using achiral ligands 
such as pyridine. Various co-oxidants were used to regenerate the osmium tetroxide 
catalyst with different levels of success, among those are hydrogen peroxide, N- 
methylmorpholine 7V-oxide (NMO) and potassium ferricyanide (K3 Fe(C N y K2 CO3 ).
Sharpless proposed a stepwise [2+2] model for the formation of the glycol osmate 
ester.63,64 In this mechanism, the olefin first coordinates to the osmium centre and 
this intermediate undergoes a fast and reversible rearrangement to the oxa-osmetane 
intermediate A. Bond migration then leads to the 5-membered ring osmate ester B, 
(Scheme 1.26).65 However, balance of evidence appears to favour the [3+2] 
mechanism over the stepwise [2+2] pathway as the former was more consistent with 
the observed substrate selectivity and enantioselectivity.66
R
[3+2] cycloaddition O^ -1
osmate ester
R
O
[ olefin ]
Scheme 1.26: Proposed [2+2] mechanism for the dihydroxylation of alkene; L 
symbolizes the amine or chiral alkaloid ligands.
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In 1988 Sharpless described the asymmetric dihydroxylation (AD) of olefins; this 
reaction uses osmium-based catalysts,67 such as OsC>4 or the non-volatile osmium 
source K2[Os02(OH)4]. Other reagents involved in this reaction include the 
stoichiometric oxidant K3Fe(CN)6 (3 equivalents) used to regenerate the catalyst, 
K2CO3 (3 equivalents) used to control the pH of the reaction and a chiral 
dihydroquinine (DHQ) or dihydroquinidine (DHQD) ligand that binds to the osmium 
catalyst and induces the enantioselectivity of the reaction.68 A premix of AD 
reagents is commercially available as ADmix-a, (containing (DHQ)2 -PHAL which 
dihydroxylates the a-face of alkenes) and ADmix-p, (containing (DHQD)2-PHAL 
and giving the opposite enantiomer); see Scheme 1.27. Scheme 1.29 describes the 
catalytic cycle involved in the AD reaction.
2 OH delivered from above 
via DHQD-PHAL
"HO OH"
"HO OH"
20H  delivered from below 
via DHQ-PHAL
Scheme 1.27: Sharpless Asymmetric Dihydroxylation.
1.3.1 Chiral ligands for Sharpless Asymmetric Dihydroxylation
Cinchona alkaloids, such as (DHQD^PHAL and (DHQ^PHAL are widely used as 
chiral ligands in the Sharpless AD reaction (Scheme 1.28). A series of other 
Cinchona alkaloid-based ligands with different linkers are applied for specific types 
of alkenes in order to optimise the yield and ee (Table 1.6).67
A D m ix -P HO OH
t-BuOH-H20
( 1:1)
A D m ix -a
R u H 
Rs"J—^vRm 
HO OH
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Dihydroquinine (R = H) 
DHQ
Dihydroquinidine (R = H) 
DHQD
Ph
*AlkO OAlk*
Aik
,0 -A lk
O-Alk
Phthalazine (PHAL) 
ligand
IIN^N 
Ph
diphenylpyrimidine (PYR) 
ligands chlorcarbonyl (CLB) 
ligands
indole (IND)
Scheme 1.28: chiral ligand library (Aik* = DHQD or DHQ).
Table 1.6: Chiral ligands used for Sharpless’ AD reaction
olefin
classes A A
- V
best
ligand
PYR,
PHAL
PHAL IND PHAL PHAL PYR,
PHAL
ee range 30-97% 70-97% 20-80% 90-99.8% 90-99% 20-97%
1.3.2 Stoichiometric Co-oxidant
The stoichiometric co-oxidant used for the Shapless AD is potassium ferricyanide, 
due to its high efficiency of reoxidation of the osmium catalyst and the high ee of the 
resulting product (Scheme 1.29). However, a possible disadvantage is its high 
molecular weight, and as three equivalents are normally required it makes up most of 
the weight of AD-mix reagent used by this reaction (i.e. 1.40 g of AD-mix per mmol 
of the olefin substrate).
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ox. //
)O sv.'/ ''ZHO OH
Organic
Aqueous
2 OH' 2H 20
2Fe(CN)63- 2Fe(CN)64-
2 Fe(III) 2 Fe(II)
Scheme 1.29: The catalytic cycle of the AD reaction with K3Fe(CN) 6  as the co­
oxidant.
Several oxidants such as Af-methylmorpholine N-oxide (NMO), sodium 
peroxodisulfate (Na2 S2 0 g), and iodine have been used in place of ferricyanide, but 
proved to be much less efficient or less practicable.
In the case of NMO, consistently high yields of the diols were obtained but it 
produced lower ees than those obtained using potassium ferricyanide. The lower ees 
observed with NMO were attributed to the presence of a second cycle of “poor 
selectivity”, involving a trioxoglycolate complex (Scheme 1.30).
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HO OH
-  L -  L
NMM
Primary 
cycle 
high %ee
Fast
Secondary 
cycle 
low %ee
Slow
NMO
" L
HO OH
A
Scheme 1.30: Catalytic cycle using NMO as the co-oxidant.
Recently, selenoxides were reported to be efficient stoichiometric co-oxidants in the 
asymmetric dihydroxylation of olefins.69 The reaction used the same chiral catalyst 
((DHQD)2PHAL, 0.016 mol equiv) and oxidant [K20s02(0H)4]; potassium 
carbonate (0.3 equiv) was also used but only one-tenth of the amount present in AD- 
mix.
The dihydroxylation of a-methylstyrene (Scheme 1.31) gave the corresponding diol 
in yield (93%) and ee (97%) similar to those described by Sharpless using the AD- 
mix method.
Ph K20 s02(0H)4, (DHQD^PHAL, ArSe(0)Me Ph,,
K2CO3, aqueous /-BuOH, 20 °C, 3h ** M-" o h  XOH
Scheme 1.31: The application of selenoxide co-oxidants for the Sharpless AD 
reaction.
1.3.3 The Concentration of Osmium and Ligand
The osmium reagent usually used is OsC>4 (0.2 mol%), or as the involatile [K2OSO2 
(OH)4], and 1 mol% of the ligand, i.e. PHAL or PYR. The enantioselectivity of the 
AD reaction has proven quite insensitive to variation in the relative amount of 
osmium and ligand. However, in the case of unreactive olefins the osmium
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concentration may need to be increased to 1 mol% whilst maintaining the ligand 
concentration at the same level.
The olefin concentration is usually 0.1 M. Since the reaction is normally run under 
basic conditions (pH = 12.2 in the aqueous layer), it is possible to buffer the system 
by the addition of 3 equivalents of sodium hydrogen carbonate, which can lead to 
better yields in cases where a base-labile substrate is used or where a base-labile 
product is formed.
1.3.4 Substrates for the Asymmetric Dihydroxylation Reaction
Osmium catalysts are well known to be efficient for asymmetric dihydroxylation of 
alkenes; the reaction conditions tolerate many substituent groups, including alkyl, 
aryl and electron-withdrawing groups, additionally, mono-, di-, tri- and some 
tetrasubstituted alkenes react well. Asymmetric dihydroxylation is one of the 
simplest catalytic asymmetric reactions to perform. The reaction is completely 
insensitive to water and oxygen and can be performed in an open vessel in the range 
of 0-25 °C. The reactivity of the catalyst means that only a small amount is required 
and the reaction generally proceeds in very high yields.
Reports have shown that frvms-alkenes lead to higher enantiomeric exess (70-90 %) 
relative to the cw-alkenes (< 25 %) which react very poorly; this may be attributed to 
steric hindrance of the c/s-alkenes affecting binding of the catalyst. Osmium- 
catalysed AD of various enynes have been reported by Sharpless and co-workers, 70 ’71 
and although it is known that triple bonds can be oxidized to the corresponding a- 
diketones by OSO4 , all reactions showed excellent chemoselectivity, i.e. yne-diol was 
observed as the sole product under the reaction conditions.
The hydrolysis of the intermediate osmate(VI) glycolate product can be accelerated 
by MeS0 2 NH2 ( 1  equivalent is normally added to the reaction mixture); this results 
in higher turnover rates, allowing the reaction to be run at 0 °C instead of 20 °C, 
thereby improving the enantioselectivity of the reaction. However, for terminal 
(monosubstituted and 1 , 1 -disubstitued) alkenes MeSC>2NH2 causes the rate of 
reaction to slow down.
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Sharpless AD has been used in the synthesis of the side chain of taxol (Scheme 1.32),
n0) I'xan essential structural unit for its biological properties. ’ The low cost and ease of 
this reaction allows the large-scale preparation of enantiomerically enriched 
substrates, such as 82 in high yields and excellent ee.
P h
/^ v ^ C O O M e
(c)
74%
(a)
72%
OH
Ph'
NHAc 
81 OH
79  OH
99% ee
(d)
72%
(b)
60%
Br
C O O M e
80 OAc
NHCOPh
ph^ ^ COOH
82 OH
23% overall yield
Scheme 1.32. Reagents and conditions: (a) (i) (DHQ)2PHAL (0.5 mol%), 
K20 s 0 2(0H)4 (0.2 mol%) NMO (1.45 eq.), r-BuOH, (ii) recrystallise from toluene; 
(b) (i) MeC(OMe)3, /7-TsOH, (ii) MeCOBr; (c) (i) NaN3, DMF, 50 °C, 19 h, (ii) H2, 
Pd-C, MeOH; (d) (i) 10% HC1 aq (ii) PhCOCl.
1.3.5 Asymmetric Dihydroxylation of Electron-Deficient Olefins
As O s04 is an electrophilic reagent, the rate of osmylation of electron-deficient 
olefins such as a,p-unsaturated carbonyl compounds can be very slow. The 
dihydroxylation of enones is achieved using fortified ADmix,74 containing 1 mol% 
of [K20 s0 2 (OH)4] (instead of the usual 0.2-0.4 mol%) and 1 mol% of ligand. Also, 
in order to prevent base-induced epimerisation, the reaction should be buffered with 
3 equivalents of sodium hydrogen carbonate.
Unsaturated amides are poor substrates of the AD reaction under normal conditions 
(i.e. 0.2-0.4 mol% O s04 and 1 mol% of ligand). However, the dihydroxylation of 
amides in the presence of 1 mol% of [K20 s 0 2(0H )4], 5 mol% of ligand and 
unsaturated equivalent of M eS02NH2 takes place rapidly and in high enantiomeric 
excesses.75
28
Chapter 1
1.4 Aim of the Project
The 5,6-Dihydropyran-2-one ring is present in the plant growth regulator NK10958P 
83 and the closely related immunosuppressant and cytotoxic agent pironetin 8476 
(which differs from 83 by the presence of a methoxy group in place of the 4’- 
hydroxy group). The relatively simple structure of pironetin 84, together with its 
potent biological activity have made it a synthetic target for different groups77'80 and 
five total syntheses of pironetin have been reported in the past seven years.
I ? (-)-Pestalotin 85
R = H, NK10958P 83 
R = Me, Pironetin 84
Scheme 1.33: 5,6-Dihydropyran-2-one ring-containing natural products.
Another synthetic target is the gibberellin synergist (-)-pestalotin 85, which was 
isolated from Pestaltia cryptomeriaecola by Kimura and has also been obtained from 
an unidentified Penicillium species by Ellestad. Pestalotin has a 5,6-dihydro-4- 
methoxy-2//-pyran-2 -one skeleton with one hydroxy group on the side chain; the 
absolute configuration is 6S, IS. Pestalotin is a biological pesticide and several total 
syntheses have been achieved, both racemic and single enantiomeric forms.
Chapters three and four describe the synthesis of important intermediates which can 
be applied to achieve the total synthesis of the natural products 83 and 85. The main 
reactions used were Sharpless asymmetric dihydroxylation and Evans aldol 
methodology to allow the enantioselective synthesis of these intermediates.
Furthermore, the synthesis of the 3(2/7)-furanone ring system is discussed in chapter 
2 using Sharpless AD reaction followed by a mercury(II) catalysed reaction, which 
gave the dihydrofuranone product in high yields and good enantiomeric excesses.
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Chapter 2
The Enantioselective Synthesis of 3(2//)-Furanone Ring Systems
2.1 Introduction
The 3(2//)-furanone ring system is present in many natural products with varied and 
important biological properties, such as the antitumour agents geiparvarin 861,2 and 
eremantholide 87,35 the antibacterial glycoside spinonin,6 and numerous 
sesquiterpene natural products with anti-inflammatory activity.7,8
Geiparvarin 86 was isolated from the leaves of Geijera parviflora in 1967 and was 
reported to exhibit inhibitory activity against lymphocytic leukaemia.9,10 It has been 
the subject of several synthetic investigations since its isolation.11' 16
In 1975, Le Quesne and co-workers isolated a furanoheliangolide sesquiterpene (+)-
1 n
eremantholide A 87 from the stems of the Brazilian plant Eremanthus elaeagnus, it 
possesses cytotoxic activity against cells derived from human carcinoma of the 
nasopharynx in vitro.18,19 The proposed structure (Figure 2.1) was confirmed by the 
first total synthesis of 87 carried out by Boeckmann and co-workers.3
The 3(2//)-furanone ring system is also present in other antitumour agents, namely 
jatrophone20 and chilenone A,21 it is believed that the ability of the 3(2//)-furanone 
ring to act as an alkylating agent by means of conjugate addition {i.e. as a Michael 
acceptor) is related to the antitumour properties of those compounds.22
5 *OH
(+)-E remantholide A 87
Geiparvarin 86
Figure 2.1: 3(2//)-Furanone-containing natural products
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2.2 Literature Review of 3(2H)-Furanone Syntheses
One of the most efficient routes to the 3(2//)-furanone ring system involves the acid- 
catalysed cyclisation-dehydration of an appropriately substituted a ’-hydroxy-1,3- 
diketone,16 however this route may be limited by the availability of the a 5-hydroxy-
1.3-diketone starting material.
Recently, a new route to substituted 3(2//)-furanones has been reported involving 
isoxazole chemistry (Scheme 2.1).10 The catalytic hydrogenolysis of the isoxazole 
ring in 88 under mild conditions (e.g. H2 , Pt02-Raney-Ni mixture) leads to fission of 
the labile nitrogen-oxygen bond, resulting in the formation of the P-aminoenone 
intermediate 89, which can be considered as a synthetic equivalent of an a ’-hydroxy-
1.3-diketone. Acid-catalysed cyclisation of 89 then furnishes the 3(2//)-furanone. 
This route has been used in the synthesis of the natural product geiparvarin and its 
synthetic analogues.2
Scheme 2.1: Synthesis of 3(2//)-furanones using isoxazoles, (a) PtCVRaney-Ni, (b) 
AcOH: H20  (2:1), 20 °C.
2-Isoxazolines such as 92 may also be converted into 3(2//)-furanones by catalytic 
reduction followed by acid-catalysed cyclisation (reflux in acetic acid with sodium 
acetate), Scheme 2.2.23 Preparation of the 5-acyl-2-isoxazoline 92 was carried out by 
the cycloaddition of the hydroxamic acid chloride 91 with vinyl ketones 
(R2COCH=CH2), see Scheme 2.2.
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Scheme 2.2: The synthesis of 3(2//)-furanones from isoxazolines. (a) (i) H2NOH, 
(ii) Cl2, (b) Et3N, R2COCH=CH2, ( c)  RaNi, EtOH: H20  (1:1), 4 h, (d) AcOH, 
NaOAc (catalyst), 2-3 h, reflux, 55-65%.
A less successful method of dihydrofuranone synthesis uses m-chloroperoxybenzoic 
acid as an oxidising agent to convert furan derivatives into the 3(2//)-furanone 96, 
possibly by an internal Michael addition of the enedicarbonyl intermediate 95, 
(Scheme 2.3). However, over-oxidation to 97 in some examples led to diminished 
yields of the 3(2//)-furanone product (22-39%).24
OH
.2
Scheme 2.3: The synthesis of 3(2//)-furanones using m-chloroperoxybenzoic acid, 
(a) 0.3 M m-CPBA, CHC13, 5 h, -10 °C, 55-75%.
Thomas and co-workers reported the synthesis of 3(2//)-furanones from 1- 
hydroxyalkynyl-2-yn-3-ones 99 using mild acidic conditions.25 The hydroxy ynones 
99 (and regioisomer 99a) was prepared by oxidation of the corresponding acetylenic 
diol 98 using hydrogen peroxide and a tungsten-based catalyst. This method 
generated the 3(2//)-furanone product but as a mixture of regioisomers, 100 and 101, 
which were then separated by column chromatography (Scheme 2.4).
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100 R1 = M e,R2 = nC6H13
101R 1 = n e 6Hi3,R 2 = Me
Scheme 2.4: Preparation of 3(27/)-furanones from l-hydroxyalkynyl-2-yn-3-ones (a) 
30% aq. H20 2, Na2W 04, H3P 0 3, (b) 1% H2S04.
Langer et. a l26 reported that 6-chloro-3,5-dioxoesters 104 cyclise upon treatment 
with base (DBU), to give 3(2//)-furanones in moderate yields. 6-Chloro-3,5- 
dioxoesters 104 were synthesized by a chemo- and regio-selective reaction o f 1,3- 
dianion synthons 102 with a-chlorocarboxylic acid chlorides 103 (Scheme 2.5).
TM SO  OTM S
W Y -
Rt O  
106
Scheme 2.5: Preparation of 3(2//)-furanones using 6-chloro-3,5-dioxoesters, (a) 0.3 
equiv TMSOTf, CH2C12, -78 °C, (b) DBU, THF, 2 h, 65% overall.
The control of the relative and absolute stereochemistry of the 3(2//)-furanone ring is 
essential for the synthesis of a number of natural products such as (+)-eremantholide 
A 87. The following section describes a new route for the enantioselective syntheses 
of 3(2//)-furanones from readily available starting materials.
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2.3 Results and Discussions
2.3.1 Synthesis o f 3(2H)-furanones using Mercury(II) Catalysis
This section discusses the enantioselective synthesis of 3(2//)-furanone ring systems 
of type 110 by the application of Sharpless asymmetric dihydroxylation on a,P- 
unsaturated alkynones 108,27-29 followed by mercury(II)-catalysed cyclisation30 of 
the resulting diol 109 to afford 110 in good yields (50-97%) and high enantiomeric 
excesses (71-97% ee) (Scheme 2.6).
ADmix-a 21/
107 108 109
Hg" Catalyst
110
Scheme 2.6: A mercury® catalysed route to 3(2H)-furanones.
Whilst the asymmetric dihydroxylation (AD) of enones under Sharpless conditions 
have been reported with good yields and excellent enantiomeric excesses (Table 
2.1),31 the asymmetric dihydroxylation of enynones of type 108 has not been 
reported previously.
Different substitution patterns on the enynone 108 were used to establish the scope 
and limitations of the dihydroxylation and cyclisation reactions. The application of 
the mercury(II)-catalysed reaction to achieve the synthesis of a 3(2//)-furanone- 
containing natural product will be investigated. The use of a palladium(II) species in 
the cyclisation of diol 109 was investigated to form an alternative for the mercury(II) 
catalyst.
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Table 2.1: Sharpless asymmetric dihydroxylation of a,p-unsaturated ketones.
Entry Substrate Product Yield %ee
OH
73% 98
OH O
OH
69% 92
OH O 87% 98
Ph
,OH
,OH
'Ph
79% 82
2.3.2, The Preparation of Enynones 108
a,p-Unsaturated ynones 108 were readily prepared using the routes outlined in 
Scheme 2.7; the first synthetic route generates 108 by MnC>2 oxidation of the 
corresponding alcohol 107.32 The second route led to 108 by a displacement reaction 
using the anion of a terminal alkyne and TV-methyl-N-methoxy amide (Weinreb 
amide) 114, itself prepared from the carboxylic acid 112.33 The former route gave 
better yields, and so was used to obtain the allylic alkynones required in this work. 
(Table 2.2)
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OH
(90 %) (84 %)
111
(48 %)
O
OH
(60 %) (60 %)
113112 114
Scheme 2.7: Preparation of enynones (a) pent-1 -ynyl-lithium, THF, 20 °C, 3 h; (b) 
M n02, CH2C12, 20 °C, 24 h; (c) SOCl2, CH2C12, 0 °C, 10 min then 60 °C; (d) 
MeONHMe.HCl, Pyridine, CH2C12, 0-20 °C; (e) pent-1-ynyl-lithium, THF, 20 °C, 3 
h.
a-Alkynyl allylic alcohols of type 107 were prepared by the 1,2-addition of an 
alkyllithium to a,p-unsaturated aldehydes. The alkynyllithium was generated in situ, 
by the deprotonation of the terminal alkyne using H-butyllithium in anhydrous 
tetrahydrofuran under an inert atmosphere. After stirring for a short time (~ 0.5 h), 
the enal in a solution of distilled tetrahydrofuran was added dropwise. After 
completion of the reaction protonation of the resulting lithium enolate was achieved 
by addition of aqueous ammonium chloride (Scheme 2.8). Workup and evaporation 
of the solvents gave the crude material which was purified by flash column 
chromatography. This addition reaction resulted in good yields for all the substrates 
used.
- r 4
R2 R3
R r
*2 ' r 3
OH
r3
107
Scheme 2.8: Synthesis of a-alkynyl allylic alcohols 107.
Table 2.2 summarizes the results for the alkynone synthesis, which were obtained in 
good to excellent yields from the corresponding aldehydes. The oxidation of 107 
using manganese dioxide gave high yields of the enynone 108 and was carried out by 
adding a solution of 107 (1 equiv) in dichloromethane to a stirred suspension of
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manganese dioxide (16 equiv) in dichloromethane under an atmosphere of nitrogen 
and the mixture was stirred at 20 °C until reaction completion (24 h).32
Table 2.2: Synthesis of enynones 108.
“ 2 “ 3
11
R2 R3
107 Ri r 2 R3 R4 Yield (%) 108 Yield (%)
a H H H "Pr 96 a 75
b Me H H "Pr 92 b 80
c H Et H "Pr 90 c 92
d H Et H Ph 95 d 79
e H Me H "Pr 85 e 74
f H Ph H "Pr 99 f 97
g Me Et H "Pr 93 g 95
h Me Et H Ph 94 h 90
i Me Et H OEt 90 i 78
j Me Ph H "Pr 91 j 87
k Me Et H -(CH2)3OH 45a k 84
1 Me Et H -(CH2)4OH 68a 1 90
m Me Et H H 95b m 73
n Me Et H C 02Et 83c n 85
0 H Me Me "Pr 74 0 71
P H Me Me Ph 75 P 74
q (CH2)3 H OEt 66 q 80
a In the cases of 107k and 1071, 2 equivalents of n-butyllithium were used to generate the 
double anion thus making it unnecessary to protect the hydroxyl group and the lower yield 
may be a result of poor selectivity of the two nucleophilic sites. b Alkynyl allylic alcohol 
107m was prepared by the addition of commercially available ethylmagnesium bromide to 
2-methylpent-2-enal, which proceeded in a high yield (95 %) using the procedure reported 
by Spino, and co-workers. 34 c For the synthesis of 107n the procedure reported by Crimmins
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and co-workers was applied, using lithium diisopropylamide (LDA) as the base, instead of 
the usual /i-butyllithium.35,36
2.3.3 Synthesis o f 2,3-Dihydroxy Alkynones
The Shapless asymmetric dihydroxylation (AD) reaction is widely used in natural 
product synthesis because of its convenience and tolerance of a wide range of 
functional groups. The dihydroxylation requires a sub-stoichiometric osmium 
catalyst and the use of an oxidant to regenerate the catalyst, namely K3Fe(CN)6 (3 
equiv). The stereofacial selectivity of the dihydroxylation is determined by the chiral 
ligand used (such as (DHQ)2-PHAL). Another reagent required in this reaction is 
potassium carbonate which acts as a buffer. A premix of the Sharpless AD reagents 
are commercially available as ADmix-a and ADmix-P depending on the chiral ligand 
present. For di- and tri-substituted enynones it was necessary to add one equivalent 
of methane sulphonamide to aid the cleavage of the product from the intermediate 
osmium ester.
Since a,p-unsaturated carbonyl compounds were reported to be poor substrates for 
the original Sharpless asymmetric dihydroxylation reaction,31 modified ADmix was 
used for the dihydroxylation of alkynones 108. This method, described by Sharpless 
and co-workers, involved the addition of higher loadings of the osmium catalyst (to 
increase the total to 1 mol% with respect to the alkynone substrate) also the addition 
of sodium hydrogen carbonate (3 equiv) which is used as a buffer to prevent possible 
side-reactions of the ketone product, such as epimerization of the a-asymmetric 
centre and retro-aldol fragmentation.
The enantiomeric excesses (ee) of the diols 109 (Table 2.3) were not determined at 
this stage as it was expected that the ees of the corresponding 3(2//)-furanone could 
give a good indication of the overall selectivity of this synthetic route.
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Table 2.3: Synthesis of 2,3-dihydroxyalkynones.
R2^*3
108
Modified A D m ix-a
P OH0N p l ^  
R2 ;*OHR3
109
r4
108 Ri r 2 R3 R4 109 Yield (%)
a H H H "Pr a -
b Me H H "Pr b 81
c H Et H "Pr c 50
d H Et H Ph d 47
e H Me H "Pr e 53
f H Ph H "Pr f -
g Me Et H "Pr g 95
h Me Et H Ph h 66
j Me Ph H "Pr j -
k Me Et H -(CH2)3OH k -
1 Me Et H -(CH2)4OH 1 -
m Me Et H H m -
n Me Et H C 0 2Et n -
0 H Me Me "Pr 0 -
P H Me Me Ph P -
Unsubstiuted enynones:
The Sharpless AD was attempted using alkynone 108a, with the conditions described 
above; however, this reaction was unsuccessful and only the starting material was 
isolated.
The 1,1 -disubstituted enynone 108b:
The 1,1-disubstituted alkynone 108b underwent Sharpless asymmetric
dihydroxylation rapidly, giving diol 109b in 81% yield. The crude material was 
sufficiently pure to be used without further purification.
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1.2-Disubstituted enynones:
Addition of more of the chiral ligand (increased to 1.0 mol%), i.e. (DHQ)2 -PHAL for 
ADmix-a or (DHQD)2-PHAL in the case of ADmix-p as well as the osmium catalyst 
( 1 . 0  mol%) was required to allow the reaction to reach completion and to improve 
the yields of 1,1-disubstituted enynones 108c-e. The AD reaction was unsuccessful 
in the case of phenyl-substituted 108f.
1.1.2-Trisubstituted enynones:
The asymmetric dihydroxylation of the ynones 108g and 108h gave high and 
moderate yields of the diols 109g and 109h respectively. However, the AD reaction 
of 108j was unsuccessful and only recovered starting material was obtained. In the 
case of 108k and 1081 a complex mixture was obtained.
Electron-withdrawing groups, such as CCEEt, attached to the alkyne and terminal 
alkynones resulted in no reaction under the Sharpless asymmetric dihydroxylation 
method and only the starting materials 108m and 108n were detected by TLC. This 
poor reactivity could be explained in terms of the electron-deficiency of the double 
bond.
/, 2,2-Trisubstituted enynones:
The dihydroxylation of 1,2,2-trisubstituted ynones 108o and 108p was unsuccessful 
and only starting materials were recovered; this may be due to steric hindrance of the 
alkynone.
2.3.3.1 Synthesis of 3(2/J)-Furanones via Asymmetric Dihydroxylation of 
Weinreb Amides
The enynones derived from einnamaldehyde, such as 108f, were found to be poor 
substrates for the Sharpless AD reaction; therefore an alternative route was devised 
for the preparation of the furanone system (Scheme 2.9). The asymmetric 
dihydroxylation of the corresponding Weinreb amide 116 was reported to give the 
diol 117 in 93% enantiomeric excess (ee) . 37 Then the alkynylation of the acetonide 
118 gave the protected ynone 119 in 87% yield, 33 ’38 which underwent concomitant 
deprotection and cyclisation upon treatment with aqueous acidic mercury(II) to give
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llOf. This route could be applied to obtain the 3(2//)-furanones in cases where the 
dihydroxylation of the enynone was unsuccessful.
Scheme 2.9: An alternative route to 3(2//)-furanones, via the Weinreb amide, (a) (i) 
*BuOCOCl, NMM, CH2C12, 0 °C, 20 min (ii) MeONHMe.HCl, 20 °C, 2 h, (b) 
modified ADmix-P, (DHQ)2-PHAL (5 mol%), 'BuOH: H20  (1:1), 0 °C, 24 h, (c) 2,2- 
dimethoxypropane: DMF (1:1), /?-TsOH.H20  (cat.), 20 °C, 24 h, (d) pent-l-ynyl- 
lithium, THF, 20 °C, 3 h, (e) HgO/ H2 SO4 , acetone, 20 °C, 20 min.
2.3.3.2 Preparation of 4-Ethoxy-Substituted 3(2//)-Furanones
Further investigation of the effect of substitution on the alkyne moiety showed that 
electron-donating groups such as the ethoxy group caused spontaneous cyclisation of 
the dihydroxy ynones after the Sharpless AD reaction, thus allowing the mercury- 
catalysed step to be omitted. The treatement of enynone 108i with the ADmix 
reagents gave the 3(2//)-furanone llOi in 50 % yield (Scheme 2.10).
Scheme 2.10: Preparation of 3(2//)-furanone llOi, (a) ethoxyethynyl-lithium, THF, 
20 °C, 3 h, (b) M n02, CH2C12, 2 0  °C, (c) modified ADmix-a, M eS0 2NH2, NaHC03, 
‘BuOH: H20  (1:1), 0 °C, 24 h.
Similarity, the spiroketone llOq was synthesised from enynone 108q using the 
Sharpless AD reaction, which generated the 3(2//)-furanone product in 62% isolated
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yield after column chromatography (Scheme 2.11). The starting aldehyde 122 was 
obtained from the commercially available cyclohexane-l,2 -diol using the method 
reported by Brown and co-workers.39
Scheme 2.11: Synthesis of spiroketone llOq using Sharpless asymmetric 
dihydroxylation, (a) NalCU, KOH(aq) (b) ethoxyethynyl-lithium, THF, 20 °C, 3 h, (c) 
M n02, CH2C12, 20 °C, (d) modified ADmix-a, M eS02NH2, NaH C03, 'BuOH: H20  
(1:1), 0°C, 24 h.
2.3.4 Mercury(II)-Catalysed Cyclisations
The enantiopure alcohols prepared using the Sharpless asymmetric dihydroxylation 
reaction, as described in section 2.3.3, were treated with the mercury(II) catalyst in 
acidic solution which resulted in the formation of the 3(2//)-furanone products in 
good yields and excellent enantiomeric excesses, the results are summarised in Table 
2.4. The racemic 3(2//)-furanone llOh was used as a reference sample for the ee 
determination of the enantiopure furanones. It was prepared using the osmium-based 
catalyst, A-methylmorpholine A-oxide, and citric acid additive, this procedure, 
described by Sharpless and co-workers, 40 is a modification to the Upjohn procedure 
which permits the dihydroxylation of electron-deficient olefins, the resultant diol was 
cyclised using the mercury(II) oxide catalyst to furnish rac-llOh.
X-ray analysis was performed on the 3(2//)-furanone 11 Oh which supported the fact 
that the product was the 5-membered 3(2//)-furanone and not the 6 -membered 
dihydropyranone ring (See Appendix A for the crystal data and structural 
assignment). This result was in agreement with the 13C NMR of the cyclised 
products, as the 13C peak of the carbonyl group was usually in the region of 206-210 
ppm, whilst for the dihydropyranone ring it is typically in the region of 197-198
0
u  OEt 
H OH llO q
ppm. 30
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Table 2.4\ Synthesis of 3(2//)-furanones
Entry Starting Material 3(2//)-Furanone Yield (%) ee (%)
HO
OTBS
109b
n p r
H O *3
"Pr
109g
HOi
Ph
OH
109h
119
OEt
108i
EtO
TBSO
llOg
HOh
HO
Ph'
HOf
HO
OEt
llOi
HO 9
llOq
93
80
97
50c
50c
62°
OH
EtO.
143
62
9V
92
97
97
95
71{
d.r. 6:4
142
Enantiomeric purity was determined by ‘H NMR analysis of the Mosher’s ester derivative. 
b Enantiomeric purity was determined by HPLC analysis using a chiralcel OJ column (entries
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2 and 3) and chiralcel OD column (entries 4 and 5). c For the terminal ethoxy-substituted 
enynone llOi and llOq, dihydroxylation of the double bond using Sharpless AD conditions 
led to spontaneous cyclisation to the 3(2//)-furanone. d Overall yield for two steps, i.e. 
deprotection of diol and mercury-catalysed cyclisation.
2.3.5 Determination and Optimisation of Enantiomeric Excess (ee)
Enantiomeric excesses of the 3(2//)-furanones were determined either by chiral 
HPLC analysis or by ]H NMR analysis of the Mosher ester derivatives. In both 
cases the racemic 3(2//)-furanone prepared by osmylation of the enynone followed 
by the mercury(II) cyclisation was used as the reference.
The optical purity of llOh was determined by HPLC analysis using a Chiralcel OJ 
column (50:50 ethanol;hexane, X = 210 nM). Racemic llOh gave two separate peaks 
with retension times of 5.32 and 6.84 min. The major enantiomer of the chiral llOh 
eluted after 5.32 min and the optical purity was calculated to be 97% ee using the 
ratio of the estimated peak areas.
The optical purity of 11 Of, 11 Og and llOi was determined using HPLC analysis with 
a Chiralcel OD column (0.46 cm x 5 cm, eluent: 10:90 2-propanol: hexane, flow rate: 
0.7 ml/ min, detection: UV 254 nm).
The Mosher’s ester derivatives41-44 of 110b and llOq were prepared using the 
commercially available a-methoxy-a-trifluoromethylphenyl acetyl chloride, (5)- 
MTPAC1, (DMAP, CH2CI2 , 20 °C) . 41 This allowed the quantitative determination of 
the enantiomeric composition of the chiral 3(2//)-furanone product.
In the case of furanone 110b a poor ee (47%) was obtained when the usual synthetic 
route was applied, i.e. the Sharpless asymmetric dihydroxylation of the enynone 
108b followed by the mercury(II)-catalysed cyclisation. However, an ee of 91% was 
obtained for 110b prepared by the dihydroxylation of the corresponding Weinreb 
amide 124,4 5 ,46 followed by the alkynylation of the mono protected amide 126, and 
finally mercury(II) catalysed ring-closure (Scheme 2.12).
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Scheme 2.12: A highly enantioselective route to 3(2//)-furanone 110b, (a) (i) 
‘BuOCOCl, NMM, CH2C12, 0 °C, 20 min (ii) MeONHMe.HCl, CH2C12, 20 °C, 2 h, 
(b) modified ADmix-a (contains 1 mol% of the osmium catalyst), (DHQ)2-PHAL (5 
mol%), lBuOH: H20  (1:1), 0 °C, 24 h, (c) TBSC1, imidazole, CH2C12, 20 °C, 14 h, 
(d) pent-1-yny 1-lithium, THF, 20 °C, 3 h, (e) HgO/ H2 SO4 , acetone, 20 °C, 20 min, 
(f) HCl(aq), MeOH, 20 °C, 24 h.
2.3.6 Synthesis of a 3(2H)-Furanone-Containing Natural Product
2.3.6.1. Enantioselective Synthesis of the Natural Product 129 using (S)-Malic acid
The 3(2//)-furanone 129 (Scheme 2.13) was recently isolated from Erigeron 
annuus 47 It is a secondary metabolite produced to affect the growth and germination 
of other plant species thereby eliminating competing plants. Such compounds are 
known as allelochemicals and have potential uses as effective and environmentally 
friendly agrochemicals.
The strategy for the synthesis of the plant growth regulator 129 involved the 
cyclisation of the alcohol 130 by treatment with the mercury(II) catalyst in acidic 
solution.
Scheme 2.13: Proposed synthesis of 129 from (5)-malic acid.
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The attempted synthesis of alcohol 130 via deprotection of the acetate 133 with 
potassium carbonate was unsuccessful (Scheme 2.14) as it resulted in degradation of 
the starting material. The convenience of proceeding from (5)-malic acid 131 via its 
anhydride acetate 132 and then ring-opening of the latter to give 133 suggested that 
an alternative and more readily cleavable ester, the TFA ester 134 could succeed 
(Scheme 2.15). It was found that addition of the lithium acetylide to 134 not only led 
to the ynone, but also deacylated the ester functionality, leading in one step to 130, 
the mercury(II) catalysed cyclisation furnished 129.
Scheme 2.14: Attempted preparation of the ynone 130, (a) AcCl, 40 °C, 2 h, (b) hex-
1-ynyl-lithium, 20 °C, THF, 3 h, (c) K2C 0 3, THF, 20 °C.
HO'/,
HO
OH / .  CFjCOO.
(a) (b)
131 75% 134 50%
HO
C.Hq
-►
80%
129
Scheme 2.15: Synthesis of the natural product 129, (a) TFAA, 0 °C, (b) hex-1-yny 1- 
lithium, THF, 20 °C, 3 h, (c) HgO/ H2 S 0 4, acetone, 20 °C, 20 min.
The stereochemistry of the asymmetric centre in the natural product follows from
(S)-malic acid used as the starting material and the enantiomeric purity was 
confirmed by measuring the optical rotation of 129, which was found to be 
comparable to the literature value, (measured [a]o = + 25.0 (c 0.03, MeOH); lit [a]o = 
+ 29.0 (c = 0.07, MeOH) ) . 47
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2.3.6.2 An Alternative Approach to the Synthesis of 3(2H)-Furanone 129 using 
Sharpless Asymmetric Dihydroxylation
The asymmetric synthesis of the 3(2//)-furanone natural product 129 using the 
Sharpless AD reaction. The preparation of enynone 137 by alkynylation of the 
Weinreb amide 136 resulted in a poor yield and very impure material, possibly due to 
poor regioselectivity, as the acetylide anion can also react with the ester functionality 
(Scheme 2.16).48
EtO-
(a)
8 5 %
,OMe
(b) EtO.
3 9 %
Scheme 2.16: Preparation of enynone 137, (a) (i) xBuOCOCl, NMM, CH2CI2 , 0 °C, 
20 min (ii) MeONHMe.HCl, CH2C12, 20 °C, 2 h, (b) hex- 1-ynyl-lithium, THF, -78 
°C, 1 h,
The synthesis of enynone 137 from the corresponding aldehyde 139 gave better 
yields and higher purity of the crude material. The aldehyde was prepared by 
selective reduction of the half-ester 13549,50 (Scheme 2.17), or more conveniently by 
the selective ozonolysis of ethyl sorbate 140 (Scheme 2.18).39,51’52
EtO
OH W
78 % EtO 51 % BO
Scheme 2.17: Synthesis of the aldehyde 139 from the half-ester 135, (a) BH3 .Me2 S, 
THF, 0 °C, (b) M n02, CH2C12, 2 0  °C.
Scheme 2.18 describes the proposed route towards the natural product 129, using the 
aldehyde 139, which was prepared by selective ozonolysis of ethyl sorbate. The 
alkynylation reaction of 139 proceeded rapidly and with greater selectivity (cf. the 
Weinreb amide) and thus resulted in a satisfactory sample of alcohol 141 which was 
oxidised to enynone 137 using manganese dioxide.
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Scheme 2.18: Towards the synthesis of 129. Reagents and conditions: (a) 0 3, 
Me2 S, Sodan-19 indicator, (b) hex-l-ynyl-lithium, THF, - 78 °C, 1 h, (c) MnCX 
CH2CI2 , 20 °C, 24 h, (d) modified ADmix-p, M eS02NH2, NaHCOs, 'BuOH: H20  
(1:1), 0 °C, 24 h, (e) HgO/ H2SO4 , acetone, 20 °C, 20 min, (f) (i) 
Thiocarbonyldiimidazole, THF, 65 °C, 12 h, 57%, (ii) Bu3 SnH, AIBN, toluene, 75 
°C, 90 min, (g) LiOH: H20 , THF, 20 °C.
The furanone 143 was obtained in good yields, however it’s *H NMR showed that it 
underwent epimerisation, possibly prompted by the acidic conditions of the 
cyclisation step (Scheme 2.19). Furthermore, attempts to deoxygenate 143 using
f f
Barton-McCombie conditions were unsuccessful, ' possibly because of the high 
temperatures involved which may have led to degradation of the starting material.
Et'
H<$H 0 V o
H A //
C4 H9
OH OH o
" t 6
143 Ac4H9
Scheme 2.19: Epimerisation of 3(2//)-Furanone 143 at the C2 position.
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2.3.7 Palladium(II)-Catalysed Cyclisation leading to 3(2H)-Furanones
Due to the high toxicity of the Mercury catalyst alternative conditions for the 
cyclisation of a,p-dihydroxy alkynones into the 3(2//)-furanone were sought, such as 
the use of palladium(II)-based catalysts described below.
Palladium(II) chloride (20 mol%) was applied by Saito and co-workers to effect the 
cyclisation of a P-hydroxy alkyne 144 into the dihydrofuran product 145 in 96% 
yield (Scheme 2.20) . 56
HO.
OBn .OTBS
MeO'
OMe
— OTBSOBn O-
MeO'
145OMe
Scheme 2.20: Reagents and conditions', (a) 20 mol% PdCl2, THF, 20 °C, 3.5 h.
Given this precedence, the cyclisation of the diol 109h was attempted using 20 mol 
% ofPdCl2 (THF, 20 °C, 1 h) this gave a 92% yield of the 3(2//)-furanone llOh as 
the sole product. The reaction was also performed using 2 mol% of PdCl2 which 
gave an 83% yield of llOh after 24 h (Scheme 2.21). The high yields, convenience 
and safety of this method make it preferable to the mercury(II)-catalysed reaction. 
However, due to time limitations this reaction was not applied for the other diols.
Scheme 2.21: Palladium(II)-catalysed cyclisation of dihydroxy alkynones. (a) 
PdCl2, THF, 20 °C, 24 h.
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2.4 Conclusions
A novel method for the preparation of 3(2//)-furanone ring systems using the 
Sharpless asymmetric dihydroxylation reaction was described. The cyclisation to the 
3(2//)-furanone ring was achieved by using either a catalytic amount of acidic 
mercury(II) oxide or by using a palladium(II) catalyst. This synthesis used readily 
available starting material and proceeded with good yields and high enantiomeric 
excesses, and so it may be applied for the enantioselective synthesis of furanone- 
containing natural products.
In the case of ethoxy substituted alkynones, such as 108i and 108q, the asymmetric 
dihydroxylation of the enynone under Sharpless’s conditions resulted in 
simultaneous cyclisation to the 3(2//)-furanone product. In all the examples 
investigated the mercury(II)-catalysed cyclisation proceeded cleanly to generate the 
3(2//)-furanone as the sole product with non of the 6 -membered dihydropyranone 
product being formed.
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Experimental
Thin-layer chromatography (TLC) analyses were performed on Merck 0.2 mm 
aluminium-backed silica gel 60 F254 plates and components were visualized by 
illumination with UV light or by staining with aqueous potassium permanganate. 
Flash column chromatography was performed using Merck 0.040 to 0.063 mm, 230 
to 400 mesh silica gel. ]H NMR spectra were recorded on a 300 MHz Bruker AC300 
spectrometer. Chemical shifts are reported in parts per million (ppm) downfield 
from internal tetramethylsilane (TMS), using residual chloroform (7.27 ppm) as an 
integral standard. The following abbreviations are used to describe NMR signals: 8 , 
chemical shift; s, singlet; d, doublet; dd, double doublet; t, triplet; q, quartet; m, 
multiplet; b, broad, coupling constants J  are given in Hertz (Hz). 13C NMR were 
recorded on a 300 (75 MHz) Bruker AC300 spectrometer. Chemical shifts are 
reported in parts per million (ppm) downfield from TMS, using the middle resonance 
of CDCI3 (77.0 ppm) as an integral standard. Infrared (IR) spectra were recorded on 
a Perkin-Elmer PE-983 spectrophotometer: absorption frequencies were recorded in 
wavenumbers (vmax in cm'1). Mass spectra were obtained by using a VG7070H mass 
spectrometer with Finigan Incos II operating in chemical ionization (Cl) and electron 
impact (El) modes, as specified in the text. Molecular ion peaks (M+), base peaks 
and other major peaks are reported.
Starting materials were purchased from Aldrich or Lancaster. Tetrahydrofuran (THF) 
was distilled from sodium/benzophenone prior to use and dichloromethane was 
distilled from calcium hydide. Ether refers to diethyl ether and petroleum ether 
refers to 40-60 °C fractions of petroleum ether. All glassware was oven-dried, 
assembled hot and cooled under a stream of nitrogen gas before use. Reactions with 
air-sensitive materials were carried out by standard syringe techniques. 
Temperatures of -  78 °C were obtained by the addition of dry ice to acetone. 
Evaporation refers to the removal of solvent under reduced pressure.
55
Chapter 2
(JE)-4-Methyldec-3-en-6-yn-5-ol (107g). A solution of pent-l-yne (0.71 g, 1.0 mL,
10.4 mmol) in dry tetrahydrofuran (26 mL) was treated dropwise at 25 °C with a 
solution of «-butyllithium in hexanes (4.5 mL, 11.4 mmol, 2.5 M). The mixture was 
stirred at 25 °C for 30 min, then treated dropwise with a solution of (E)-2- 
methylpent-2-enal (0.93 g, 1.08 mL, 9.8 mmol) in dry tetrahydrofuran (13 mL). The 
mixture was stirred for a further 3 h, and then poured into saturated aqueous 
ammonium carbonate (11.5 mL). The aqueous layer was extracted with ether (3 x 10 
mL) and the combined organic extracts were dried (MgS04), filtered and evaporated. 
The residue was purified by column chromatography on silica gel (5:95 ethyl acetate: 
petroleum ether) to give 107g (1.19 g, 76%) as a pale yellow oil; IR vmax (cm'1) 3362 
(OH), 2206 (alkyne group), 1626 (C=C); *H NMR 8 H 5.60 (1H, t, J  = 7.1, C=CH), 
4.74 (1H, s, C//OH), 2.21 (2H, m, CH2), 2.06 (2H, pentet, J=  7.5, CH2), 1.74 (3H, s, 
CH3), 1.58 (2H, sextet, J  = 7.5, CH2), 0.98 (6 H, t, J  -  7.5, CH3); 13C NMR 6 C 134.6 
(C H C C H 3), 129.9 (C//=CCH3), 8 6 . 6  (C=CCO), 80.3 (C=CCO), 68.5 (COH), 22.4 
(CH2), 21.3 (2 x CH2), 14.4 (CH3) 14.3 (CH3) 13.7 (CH3); LRMS m/z (%)+EI 166 
(M+, 20%), 151 (10), 137 (100), 109 (10), 95 (30), 91 (15), 69 (23), 56 (25), 43 (57), 
32 (15); HRMS calcd for CnHigO 166.1358, found 166.1355.
(Zs)-2-MethyI-pent-2-eiioyl chloride (113). To a solution of (£')-2-methyl-2- 
pentenoic acid (2.0 g, 14.1 mmol) in dichloromethane (100 mL) cooled in an ice-bath 
under nitrogen, thionyl chloride (3.2 g, 4 mL, 33.6 mmol) was added dropwise with 
stirring. The mixture was then heated under reflux at 60 °C (under nitrogen). After 
the reaction was complete, indicated by TLC analysis, the solvent and excess thionyl 
chloride were evaporated under reduced pressure at 40 °C to give 113 (-2.0 g) as a 
dark brown oil, which was used directly in the next step; IR Vmax (cm 1) 1800 (COC1)
(£)-2-Methylpent-2-enoic acid A-methoxy-A-methyl amide (114). To a solution 
of (£’)-2-methylpent-2-enoyl chloride (2.58 g, 16.4 mmol) in dichloromethane (50 
mL) at 0 °C was added N, Odimethylhydroxylamine hydrochloride (1.88 g, 19.3 
mmol) followed by pyridine (3.05 g, 2.9 mL, 38.5 mmol). The mixture was stirred at 
20 °C and progress of the reaction was monitored by TLC. On completion, the 
reaction was acidified using aqueous hydrochloric acid (20 mL, 2 M), and the 
aqueous layer was extracted with dichloromethane (2 x 20 mL). The combined
56
Chapter 2
organic layers were washed with saturated aqueous sodium hydrogen carbonate ( 2  x 
60 mL) followed by brine (60 mL). The solution was dried over MgSCL, filtered and 
evaporated. The residue was purified by column chromatography (30:70 ether: 
petroleum ether) to give 114 (1.3 g, 60%) as a pale yellow oil; ER vmax (cm'1) 1740 
(C=0), 1621 (C=C); NMR (300 MHz, CDC13) 5H 5.80 (1H, t, J  = 7.0, C.H=C), 
3.61 (3H, s, OCH3), 3.20 (3H, s, NCH3), 2.12 (2H, q,J =  7.5, CH2CH=), 1.84 (3H, s, 
CH3), 1.05 (3H, t, J  = 7.5, CH2CH3); 13C NMR (75 MHz, CDC13) 5 149.9 (C O ),
135.6 (CH=C), 130.5 (CH=C), 60.9 (OCH3), 33.8 (NCH3), 21.1 (CH2), 13.8 (CH3)
13.3 (CH3); LRMS m/z (%)+CI 158 (M+H, 3%), 111 (2), 97 (100), 82 (2), 74 (2), 69 
(60), 61 (3), 56 (18); HRMS calcd for C8H 150 2N 158.11808 (M+H), found 
158.11783.
(2i)-4-Methyldec-3-en-6-yn-5-one (108g). Method A: A solution of 4-methyldec-3- 
en-6-yn-5-ol (0.60 g, 3.6 mmol) in dichloromethane (5 mL) was added in one portion 
to a stirred suspension of manganese dioxide (6.36 g, 74.1 mmol, 16 eq.) in 
dichloromethane (60 mL) under an atmosphere of nitrogen. Stirring was continued at 
20 °C for 24 h. Then the mixture was filtered through celite, and the celite 
thoroughly washed with dichloromethane (4 x 20 mL). The combined organic 
filtrates were evaporated and the residue was purified by flash column 
chromatography (10:90, ethyl acetate: hexanes) to give 108g (0.50 g, 83%) as a 
colourless oil; IR vmax (cm'1) 2201 (alkyne group), 1694 (C=0); !H NMR (300 MHz, 
CDC13) 5h 7.32 (1H, t, J  = 7.5, CH=C), 2.61 (2H, t, J  = 7.0, C=CCH2\  2.54 (2H, 
pentet, J  = 7.5, CH2CH=C), 2.02 (3H, s, C=CCH3\  1.89 (2H, sextet, J  = 7.0, 
CH2CH2CH3), 1.34 (3H, t, J  = 7.5, C=CUCH2CH3\  1.27 (3H, t, J  = 7.0, 
CH2CH2C/A); 13C NMR (75 MHz, CDC13) 5C 180.8 (O O ), 151.1 (CH=C), 137.9 
(CH=C), 94.1 (C=CCO), 79.0 (C=CCO), 22.6 (CH2C=C), 21.4 (C C C H 2CH2), 21.0 
(C=CH2CH2), 13.5 (CH3), 12.9 (CH2CH3), 10.4 (CH2CH3); LRMS m/z (%)+CI 165 
(M+, 100 %), 153 (7 ), 137 (12), 123 (5), 113 (22), 95 (20), 85 (6 ), 69 (10) and 59 
(25); HRMS calcd for CnHieO (M+H) 165.1279, found 165.1277.
Method B: To a stirred solution of 1-pentynyllithium (prepared by the dropwise 
addition of «-butyllithium (3.8 mL, 9.5 mmol, 2.5 M) to a solution of pent-l-yne (1.4 
mL, 13.9 mmol) in dry tetrahydrofuran (10 mL) at -  78 ° C; and allowing it to stir for
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30 min) a solution of (is)-2 -methylpent-2 -enoic acid A-methoxy-A-methyl amide ( 1 . 0  
g, 6.3 mmol) in anhydrous tetrahydrofuran (5.0 mL) was added dropwise and the 
resultant mixture was warmed to -  3 °C over 2 h, then cooled to -78 °C and treated 
with glacial acetic acid (0.25 mL), then warmed to -  5 °C and poured into a mixture 
of ether (80 mL) and brine (80 mL). The organic layer was separated and the 
aqueous layer was extracted with ether (3 x 80 mL). The combined organic extracts 
were washed with brine (2 x 80 mL), dried over anhydrous MgSCL, filtred and 
evaporated and the residue was purified by column chromatography (10:90 ethyl 
acetate: petroleum ether) to give 108g (0.50 g, 50%) as a pale yellow oil. The full 
spectroscopic data are given above.
Oct-l-en-4-yn-3-ol (107a).57 A solution of pent-l-yne (4.38 g, 64.3 mmol) in dry
tetrahydrofuran (60 mL) was treated dropwise at 25 °C with a solution of n-
butyllithium in hexanes (26.8 mL, 67 mmol, 2.5 M). The mixture was stirred at 25
°C for 30 min, then treated dropwise with a solution of acrolein (3.0 g, 53.6 mmol) in
dry tetrahydrofuran (20 mL). The mixture was stirred for 24 h, and then worked up
as for 107g. The oily residue was purified by column chromatography (10:90 ethyl
i
acetate: petroleum ether) to give 107a (6.4 g, 96%) as a pale yellow oil; H NMR 
(300 MHz, CDC13) 5h 5.97 (1H, m, CH= CH2), 5.47 (1H, d, J=  17.0, CH=CH2\  5.21 
(1H, d9J  = 10.1, CH=CH2\  4.86 (1H, bs, CHOU), 2.22 (2H, t, J =  7.0, CH2), 1.86 
(1H, bs, CH OH), 1.58 (2H, sextet, J  = 7.0, CH2), 0.98 (3H, t, J  = 7.0, CH3)\ °C 
NMR (75 Mz, CDCI3) 5C 137.6 (Ci/=CH2), 116.0 (CH=CH2\  %1.2 (O CCO H ), 79.1 
(C=CCOH), 63.4 (CAOH), 22.0 (CH2), 20.7 (CH2), 13.5 (CH3).
2-Methyloct-l-en-4-yn-3-oI (107b). A solution of pent-l-yne (3.50 g, 51.4 mmol) 
in dry tetrahydrofuran (50 mL) was treated dropwise at 25 °C with a solution of n- 
butyllithium in hexanes (21.4 mL, 53.6 mmol, 2.5 M). The mixture was stirred at 25 
°C for 30 min, then treated dropwise with a solution of 2-methylpropenal (3.0 g, 43 
mmol) in dry tetrahydrofuran (15 mL). The mixture was stirred for 3 h and then 
poured into saturated aqueous ammonium chloride (11.5 mL). The aqueous layer was 
extracted with ether (3 x 10 mL) and the combined organic extracts were dried 
(MgSCL), filtered and evaporated. The residue was purified by column 
chromatography (5:95 ethyl acetate: petroleum ether) to give 107b (5.5 g, 92%) as a
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pale yellow oil; IR vmax (cm'1) 3416 (OH), 2209 (alkyne group), 1626 (C=C); 'u  
NMR (300 MHz, CDC13) 5H 5.08 (1H, s, C C //H ), 4.81 (1H, s, C//OH), 4.72 (1H, s, 
C=CHH), 2.42 (1H, bs, OH), 2.12 (2H, m, CH2), 1.78 (3H, s, CH3), 1.48 (2H, m ,J  =
7.0, CH2CH3), 0.92 (3H, t, J  = 7.0, CH3); 13C NMR (75 MHz, CDC13) 5C 143.8 
(C=CH2), 111.3 (C=CH2\  85.7 (C=CCOH), 78.5 (C=CCOH), 65.7 (CHOH), 20.4 
(CH2), 20.2 (CH2), 18.1 (CH3), 12.2 (CH3); LRMS m/z (%)+CI 138 (M+, 10 %), 123 
(95), 111 (90), 95 (60), 81 (50), 67 (100), 55 (50), 53 (30); HRMS calcd for C9H 140  
138.1039, found 138.1039.
(2s)-Dec-3-en-6-yn-5-ol (107c). A solution of pent-l-yne (2.9 g, 43 mmol) in dry 
tetrahydrofuran (50 mL) was treated dropwise at 25 °C with a solution of n- 
butyllithium in hexanes (17.8 mL, 44.6 mmol, 2.5 M). The mixture was stirred at 25 
°C for 30 min, then treated dropwise with a solution of (£’)-pent-2-enal (3.0 g, 36 
mmol) in dry tetrahydrofuran (5.7 mL). The mixture was stirred for 3 h, and then 
worked up as for 107g. The residue was purified by column chromatography (10:90 
ethyl acetate: petroleum ether) to afford 107c (4.0 g, 90%) as a pale yellow oil; IR
vmax (cm'1) 3335 (OH), 2201 (alkyne group), 1620 (C=C); H NMR (300 MHz, 
CDC13) 5h 5.91 (1H, m, CH=CHCOH), 5.62 (1H, dd, J =  15.3, 3.7, CH=C//COH),
4.83 (1H, m, CHOH), 2.22 (2H, t, J  = 7.0, CH2), 2.06 (2H, quintet, J  = 7.0, CH2), 
1.53 (2H, sextet, J  = 7.0, CH2), 1.01 (6 H, t, J  = 7.0, 2CH3); °C  NMR (75 MHz, 
CDC13) 5c 135.1 (CH=OTCOH), 128.6 (C//=CHCOH), 86.7 (OCCO H ), 79.8 
(CCCO H ), 63.3 {CHOW), 24.9 (CH2), 22.0 (CH2), 20.8 (CH2), 13.5 (CH3), 13.1 
(CH3); LRMS m/z (%)+CI 153 (M+H, 5 %), 151 (32), 135 (25), 123 (25), 85 (100), 
69 (32), 67 (30), 57 (45), 55 (35); HRMS calcd for Ci0H16O 153.12739 (M+H), 
found 153.12724.
(2s)-l-Phenylhept-4-en-l-yii-3-oI (107d). A solution of phenylacetylene (4.37 g, 43 
mmol) in dry tetrahydrofuran (50 mL) was treated dropwise at 25 °C with a solution 
of «-butyllithium in hexanes (17.8 mL, 45 mmol, 2.5 M). The mixture was stirred at 
25 °C for 30 min, then treated dropwise with a solution of (£)-pent-2-enal (3.0 g, 36 
mmol) in dry tetrahydrofuran (15 mL). The mixture was stirred for 3 h, and then 
worked up as for 107g. The residue was purified by column chromatography (10:90 
ethyl acetate: petroleum ether) to afford 107d (5.6 g, 85%) as a pale yellow oil; IR
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Vmax (cm'1) 3347 (OH), 2204 (alkyne group), 1615 (C=C); 'h  NMR (300 MHz, 
CDC13) 8 h 7.44 (2H, m, Ph), 7.32 (3H, m, Ph), 6.00 (1H, dt, J  = 16.5, 7.5, 
0/=CHCOH), 5.71 (1H, dd, J  = 16.5, 6.0, CH=C7/COH), 5.08 (1H, d, J  = 6.0 Hz,
C7/0H), 2.09 (2H, quintet, J  = 7.5 Hz, CH2), 1.04 (3H, t, J  = 7.5 Hz, CH3); ” c  NMR 
(75 MHz, CDCI3 ) 8 c  135.8 (CH=C//COH), 132.1 O/Mo-phenyl), 131.7 (phenyl),
128.8 (para-phenyl), 128.5 (phenyl), 127.9 (C7/=CHCOH), 88.5 (C=CCOH), 85.9 
(O CCO H), 63.5 (C//OH), 25.0 (CH2), 13.1 (CH3); LRMS m/z (%)+CI 187 (M+H, 
20 %), 185 (45), 169 (85), 103 (100), 91 (25), 85 (90), 57 (45); HRMS calcd for 
C 13H 14O 187.11174 (M+H), found 187.11199.
(£)-Non-2-en-5-yn-4-ol (107e). A solution of pent-l-yne (3.88 g, 57.0 mmol) in 
dry tetrahydrofuran (100 mL) was treated dropwise at 25 °C with a solution of n- 
butyllithium in hexanes (24 mL, 60.0 mmol, 2.5 M in hexanes). The mixture was 
stirred at 25 °C for 30 min, then treated dropwise with a solution of (£')-but-2-enal 
(3.0 g, 42.8 mmol) in dry tetrahydrofuran (5.7 mL). The mixture was stirred for 1 h, 
and then worked up as for 107g. The residue was purified by column 
chromatography (10:90 ethyl acetate: petroleum ether) to afford 107e (5.0 g, 85%) 
as a colourless oil; *H NMR (300 MHz, CDC13) 6 h 5.91 (1H, dq, J  = 9.0 and 6.5, 
C7/CHOH), 5.63 (1H, dd, J=  9.0 and 6.0, C=C//COH), 4.80 (1H, bs, CHOH), 2.18 
(2H, t, J =  7.0 Hz, CH2), 1.84 (1H, bs, OH), 1.73 (3H, d, J=  6.5 Hz, CUrCHCffs),
1.55 (2H, sextet, J  = 7.0 Hz, CH2), 0.97 (3H, t, J  = 7.0 Hz, CH3); 13C NMR (75 MHz, 
CDCI3) 6 c 130.9 (CH=O/C0H), 128.4 (CtfCHCO H ), 86.7 (O CCO H ), 79.8 
(CCCO H ), 63.2 (CH-OH), 22.0 (CH2), 20.7 (CH2), 17.5 (CH3), 13.5 (CH3). The 
spectroscopic data are identical to those reported in the literature. 58
(£)-l-Phenyloct-l-en-4-yn-3-ol (107f)- A solution of pent-l-yne (1.72 g, 25.2 
mmol) in dry tetrahydrofuran (50 mL) was treated dropwise at 25 °C with a solution 
of «-butyllithium in hexanes (11 mL, 27.5 mmol, 2.5 M). The mixture was stirred at 
25 °C for 30 min, then treated dropwise with a solution of (£)-3-phenyl-propenal 
(3.0 g, 22.7 mmol) in dry tetrahydrofuran (5.7 mL). The mixture was stirred for 3 h, 
and then worked up as for 107g. The residue was purified by column 
chromatography (10:90 ethyl acetate: petroleum ether) to afford 107f (4.0 g, 8 8 %) as
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a pale yellow oil; ER vmax (cm'1) 3342 (OH), 2210 (alkyne group), 1632 (C=C); 
NMR (300 MHz, CDC13) 6 H 7.42 (2H, m, phenyl), 7.38 (3H, m, phenyl), 6.78 (1H, d, 
J  = 15.6 Hz, C//=CHCOH), 6.31 (1H, dd, J  = 15.6 and 5.9 Hz, CH=C//COH), 5.04 
(1H, m, C//OH), 2.24 (2H, t, J  = 7.0, CH2), 1.58 (2H, sextet, J -  7.0 Hz, CH2), 1.03 
(3H, t, J  = 7.0, CH3); °C  NMR (75 MHz, CDC13) 5C 136.3 (z/wo-phenyl), 131.5 
(CH=C//COH), 128.9 (C//CHCOH), 128.6 (phenyl), 128.0 (phenyl), 127.1 
(phenyl), 87.3 (OCCOH), 79.3 (OCCOH), 63.2 (CHOH), 22.0 (CH2), 20.8 (CH2),
13.5 (CH3); LRMS m/z (%)+CI 201 (M+H, 15%), 199 (12), 183 (90), 133 (100), 105 
(12), 91 (10); HRMS calcd for Ci4Hi60  201.12739 (M+H), found 201.12726.
(£)-4-Methyl-l-phenylhept-4-en-l-yn-3-ol (107h). A solution of phenylacetylene 
(3.73 g, 36.5 mmol) in dry tetrahydrofuran (50 mL) was treated dropwise at 25 °C 
with a solution of «-butyllithium in hexanes (15.3 mL, 38.3 mmol, 2.5 M). The 
mixture was stirred at 25 °C for 30 min, then treated dropwise with a solution of (£)- 
2-methylpent-2-enal (3.0 g, 30.6 mmol) in dry tetrahydrofuran (20 mL). The mixture 
was stirred for 3 h, and then worked up as for 107g. The residue was purified by 
column chromatography (5:95 ethyl acetate: petroleum ether) to give 107h (5.80 g, 
94%) as a pale yellow oil; IR Vmax (cm 1) 3390 (OH), 2202 (alkyne group), 1626 
(C=C); ]H NMR 6 H 7.45 (2H, m, phenyl), 7.30 (3H, m, phenyl), 5.67 (1H, t, 7.5 
Hz, CH=C\ 4.97 (1H, s, CffOH), 2.09 (2H, pentet, J=  7.5 Hz, C //2CH3), 1.60 (3H, 
s, C //3), 0.90 (3H, t, J  = 7.5 Hz, CH2C //5); 13C NMR 6 C 133.3 (z/?jo-phenyl), 131.7 
(phenyl), 130.2 (phenyl), 128.4 (phenyl), 128.6 (CH=CCOH), 123.0 (C,H=CCOH),
8 8 . 6  (C^CCOH), 85.9 (C=CCOH), 6 8 . 6  (CHOH), 21.1 (CH2), 13.8 (CH3), 14.5 
(CH3); LRMS m/z (%)+EI 200 (M+, 30%), 183 (15), 171 (90), 129 (100), 115 (30), 
105 (65), 91 (22), 77 (46), 45 (45); HRMS calcd for Ci4Hi60  200.1201, found 
200.1216.
(£)-l-Ethoxy-4-methylhept-4-eii-l-yn-3-ol (107i).30 A solution of ethoxy ethyne 
(2.0 g, 28.5 mmol, 40% w/v in hexanes) in dry tetrahydrofuran (50 mL) was treated 
dropwise at 25 °C with a solution of «-butyllithium in hexanes (12.0 mL, 30.0 mmol,
2.5 M). The mixture was stirred at 25 °C for 30 min, then treated dropwise with a 
solution of (£’)-2-methylpent-2-enal (2.1 g, 2.4 mL, 21.4 mmol) in dry 
tetrahydrofuran (15 mL). The mixture was stirred for 3 h, and then worked up as for
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107g The residue was purified by column chromatography (10:90 ethyl acetate: 
petroleum ether) to give 107i (3.23 g, 90%) as a yellow oil; *H NMR (300 MHz, 
CDCf) 5h 5.42 (1H, t , J  = 7.3, CH=C), 4.64 (1H, bs, CHOH), 4.00 (2H, q, J  = 7.0, 
OCH2), 1.93 (2H, pentet, J=  7.3, CH2CH=C), 1.61 (3H, s, CH3), 1.25 (3H, t, J=  7.0, 
CH3), 0.86 (3H, t , J =  7.3, CH*); UC NMR 5C (75 MHz, CDC13), 135.1 (C=CH),
129.3 (CH=C), 95.1 (C=CO), 75.0 (C=CO), 68.4 (COH), 38.6 (CH20), 21.3 
(CH2C=C), 14.7 (CH3), 14.1 (CH3), 12.3 (CH3).
(2s)-2-Methyl-l-phenyloct-l-en-4-yn-3-ol (107j). A solution of pent-l-yne (1.68 g,
24.6 mmol) in dry tetrahydrofuran (50 mL) was treated dropwise at 25 °C with a 
solution of «-butyllithium in hexanes (10.3 mL, 25.6 mmol, 2.5 M). The mixture 
was stirred at 25 °C for 30 min, then treated dropwise with a solution of (E)-2- 
methyl-3-phenylpropenal (3.0 g, 20.5 mmol) in dry tetrahydrofuran (5.7 mL). The 
mixture was stirred at 25 °C for 3 h, and then worked up as for 107g. The residue 
was purified by column chromatography (10:90 ethyl acetate: petroleum ether) to 
give 107j (4.0 g, 91%) as a pale yellow oil; IR vmax(crn"1) 3347 (OH), 2204 (alkyne
group), 1618 (C=C); H NMR (300 MHz, CDC13) 8 H 7.31 (5H, m, Ph), 6.67 (1H, s, 
CH= C), 4.91 (1H, s, CHOH), 2.23 (2H, t, J=  7.0 Hz, CH2), 1.99 (3H, s, CH3), 1.56 
(2H, sextet, J  =7.0 Hz, CH2), 1.01 (3H, t, J  = 7.0 Hz, CH3); °C  NMR (75 MHz, 
CDC13) 5c 137.9 (C=CH), 137.7 (/>so-phenyl), 129.0 (phenyl), 128.2 (phenyl), 126.3 
(C//=C), 87.5 (O CCO H ), 79.9 (CCCO H ), 68.3 {CHOH), 22.5 (CH2), 21.4 (CH2),
14.5 (CH3), 13.9 (CH3); LRMS m/z (%)+CI 215 (M+H, 30 %), 213 (35), 198 (60), 
197 (100), 148 (75), 147 (99), 129 (80), 119 (85), 91 (87); HRMS calcd for Ci5H 180  
215.14304 (M+H), found 215.14356.
(£)-7-Methyldec-7-en-4-yne-l,6-diol (107k). A solution of 4-pentyn-l-ol (3.34 g,
39.8 mmol) in dry tetrahydrofuran (300 mL) was treated dropwise at 25 °C with a 
solution of w-butyllithium in hexanes (29.5 mL, 73.8 mmol, 2.5 M). The mixture 
was stirred at 25 °C for 30 min, then treated dropwise with a solution of (E)-2- 
methylpent-2-enal (3.0 g, 30.6 mmol) in dry tetrahydrofuran (5.0 mL). The mixture 
was stirred at 25 °C for 20 h, and then poured into saturated aqueous ammonium 
carbonate (300 mL). The layers were separated and the aqueous layer was extracted
62
Chapter 2
with ether (3 x 90 mL). The combined organic extracts were dried (MgS04), filtered 
and evaporated. The residue was purified by column chromatography (1:1 ethyl 
acetate: petroleum ether) to afford 107k (2.5 g, 45%) as a pale yellow oil; IR Vmax
(cm'1) 3450 (OH), 2205 (alkyne group), 1617 (C=C); H NMR (300 MHz, CDC13) 
5h 5.57 (1H, t, J  = 7.0 Hz, CH=C), 4.73 (1H, bs, CHOH), 3.76 (2H, t, J  = 6.0 Hz, 
CH2 0), 2.37 (2H, t, J  = 7.0 Hz, CH2), 2.06 (2H, m, CH2), 1.81 (2H, quintet, J  = 7.0 
Hz, CH2), 1.74 (3H, s, CH3), 0.98 (3H, t, J=  7.0, CH3); 13C NMR (75 MHz, CDC13) 
6 c 134.4 (CH=CCOH), 130.2 (C//=CCOH), 86.1 (OCCOH), 80.6 (O CCOH ), 68.7 
(CHOH), 62.1 (CH20), 31.6 (CH2), 21.4 (CH2), 15.8 (CH2), 14.2 (CH3), 12.4 (CH3); 
LRMS m/z(%)+CI 182 (M+, 10 %), 164 (20), 153 (35), 135 (30), 121 (25), 111 (30), 
97 (60), 91 (50), 83 (20), 79 (40), 69 (80), 55 (40); HRMS calcd for C n H 180 2 
182.13067, found 182.13023.
(2s)-Methylundec-8-en-5-yiie-l,7-diol (1071). A solution of 5-hexyn-l-ol (3.9 g,
39.8 mmol) in dry tetrahydrofuran (300 mL) was treated dropwise at 25 °C with a 
solution of butyllithium in hexanes (29.5 mL, 73.8 mmol, 2.5 M). The mixture was 
stirred at 25 °C for 30 min. then treated dropwise with a solution of (E)-2- 
methylpent-2-enal (3.0 g, 30.6 mmol) in dry tetrahydrofuran (5.0 mL). The mixture 
was stirred at 25 °C for 18 h, and then poured into saturated aqueous ammonium 
carbonate (300 mL). The layers were separated and the aqueous layer was extracted 
with ether (3 x 90 mL). The combined organic extracts were dried (MgS04), filtered 
and evaporated. The residue was purified by column chromatography (1:1 ethyl 
acetate: petroleum ether) to afford 1071 (4.1 g, 6 8 %) as a pale yellow oil; IR vmax
(cm 1) 3450 (OH), 2205 (alkyne group), 1622 (C=C); H NMR (300 MHz, CDC13) 
5h 5.57 (1H, t, J  = 7.0 Hz, CH=C)9 4.73 (1H, s, CHOH), 3.68 (2H, t, J  = 6.0 Hz, 
OCH2), 2.29 (2H, t, J  = 7.0 Hz, CH2), 2.06 (2H, m, CH2), 1.74 (3H, s, CH3), 1.68 
(4H, m, CH2), 0.98 (3H, t, J  = 7.5 Hz, CH3); °C  NMR (75 MHz, CDC13) 6 C 134.4 
(CH=C), 130.1 (CH=C), 8 6 . 6  (C-CCOH), 80.4 (C=CCOH), 68.7 (CHOH), 62.7 
(CH20), 32.2 (CH2), 25.2 (CH2), 21.4 (CH2), 19.0 (CH2), 14.2 (CH3), 12.4 (CH3); 
LRMS m/z (%)+CI 195 (10 %), 179 (15), 177 (20), 99 (100), 97 (65), 95 (30), 85 
(27), 81 (75), 71 (40), 69 (35), 67 (15), 59 (20), 57 (43), 55 (40); HRMS calcd for 
Ci2H2 0O2 197.15361 (M+H), found 197.15353.
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(£)-4-Methyl-hept-4-en-l-yn-3-ol (107m).34,39 (£)-2-Methylpent-2-enal (3.0 g,
30.6 mmol) was added to a solution of ethynylmagnesium bromide in THF (61.2 mL,
30.6 mmol, 0.5 M) at -  78 °C. After stirring for 2 h, the mixture was poured into a 
solution of saturated aqueous ammonium chloride (30 mL) and extracted with ether 
(2 x 30 mL). The combined organic layers were washed with water (30 mL), 
followed by brine (30 mL) and then dried over MgSCL, and filtered. Evaporation 
gave 107m (3.6 g, 95%) as a pale yellow oil; H NMR (300 MHz, CDC13) 5H 5.61 
(1H, X, J -  7.0, C H -C), 4.74 (1H, s, CHOH), 2.53 (1H, s, C=CH), 2.03 (2H, pentet, J  
-  7.0 Hz, CH2), 1.75 (3H, s, CH3), 1.00 (3H, t , J  = 7.0 Hz, CH3); °C  NMR (75 MHz, 
CDC13) 5 c  133.1 (CH=C), 130.5 (CH-C ) ,  83.2 (O C H ), 74.0 (C=CH), 67.9 (CHOH),
21.0 (CH2), 13.7 (CH3), 12.0 (CH3).
(£)-4-Hydroxy-5-methyloct-5-en-2-ynoic acid ethyl ester (107n). To a solution 
of diisopropylamine (48.0 g, 47.1 mmol) in tetrahydrofuran (100 mL), cooled to -78 
°C, was added «-butyllithim (18.8 mL, 2.5 M solution in hexanes). After stirring for 
10 min, a solution of ethyl propiolate (4.65 g, 47.1 mmol) in tetrahydrofuran (10 mL) 
was added over 30 min. After a further 20 min, a solution of (is)-2-methylpent-2- 
enal (3.0 g, 30.6 mmol) in tetrahydrofuran (10 mL) was added dropwise. After 
stirring for 2 0  min, the mixture was quenched by the addition of saturated aqueous 
ammonium chloride (30 mL), extracted with ether (3 x 30 mL) and the combined 
organic extracts were dried over MgSC>4 , filtered and evaporated. Purification by 
flash column chromatography (1:3, ethyl acetate:petroleum ether) gave 107n as an 
orange oil (5.0 g, 83%); IR vmax(cm'1) 3362 (OH), 2201 (alkyne group), 1617 (C=C); 
H NMR (300 MHz, CDC13) 5H 5.61 (1H, t, J  = 7.0 Hz, CH=C), 4.85 (1H, s, 
C//OH), 4.22 (2H, q, J  = 6.5 Hz, OCH2), 2.29 (1H, bs, OH), 2.08 (2H, quintet, J  =
7.0 Hz, CH2), 1.74 (3H, s, CH3), 1.26 (3H, t, J  = 6.5 Hz, CH3), 0.97 (3H, t, J  = 7.0
Hz, CH3); 13C NMR (75 MHz, CDC13) 5c 171.2 (0=0), 153.6 (C=CH), 113.8 
(C=CH), 86.0 (O CC O H ), 77.0 (O CCO H), 67.8 (C//OH), 62.2 (CH2 0), 21.1 
(CH2), 14.0 (CH3), 13.6 (CH3), 12.2 (CH3); LRMS m/z (%)+CI 196 (M+, 50 %), 179 
(82), 169 (92), 151 (40), 139 (100), 121 (65), 105 (48), 91 (70), 69 (55), 53 (60); 
HRMS calcd for ChH ,603 196.1099, found 196.1095.
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2-Methylnon-2-en-5-yn-4-ol (107o). A solution of pent-l-yne (2.90 g, 42.8 mmol) 
in dry tetrahydrofuran (75 mL) was treated dropwise at 25 °C with a solution of n- 
butyllithium in hexanes (17.8 mL, 44.6 mmol, 2.5 M). The mixture was stirred at 25 
°C for 30 min, then treated dropwise with a solution of 3-methylbutenal (3.0 g, 35.7 
mmol) in dry tetrahydrofuran (30 mL). The mixture was stirred at 25 °C for 3 h, and 
then worked up as for 107g. The residue was purified by column chromatography 
(10:90 ethyl acetate: petroleum ether) to give 107o (4.0 g, 74%) as a pale yellow oil; 
IR vmax (cm'1) 3336 (OH), 2202 (alkyne group), 1622 (C=C); H NMR (300 MHz, 
CDCI3) 5h 5.35 (1H, m, CH=C\ 5.03 (1H, m, CHOH), 2.24 (2H, t, J  = 7.0, 
CH2C=C), 1.70 (6 H, d, J=  6.5, CH3\  1.52 (2H, m, CH2\  0.97 (3H, t, J=  7.0, CH3); 
13C NMR (75 MHz, CDCI3) 5C 136.5 (C=CH), 125.9 (C=CH), 85.4 (CCC O H ), 81.4 
(C=CCOH), 59.6 (C//OH), 22.4 {CH2\  21.1 (C,H2), 18.4 (1CH3\  13.8 (CH3)\ LRMS 
m/z (%)+CI 153 (M+H, 10%), 151 (15), 135 (75), 107 (25), 93 (65), 85 (100), 69 
(27), 57 (30), 55 (35); HRMS calcd for Ci0Hi6O 153.1274 (M+H), found 153.1277.
5-Methyl-l-phenylhex-4-en-l-yn-3-ol (107p). A solution of phenylacetylene (4.40 
g, 42.8 mmol) in dry tetrahydrofuran (75 mL) was treated dropwise at 25 °C with a 
solution of «-butyllithium in hexanes (17.8 mL, 44.6 mmol, 2.5 M). The mixture 
was stirred at 25 °C for 30 min, then treated dropwise with a solution of 3- 
methylbutenal (3.0 g, 35.7 mmol) in dry tetrahydrofuran (30 mL). The mixture was 
stirred at 25 °C for 3 h, and then worked up as for 107g. The residue was purified by 
column chromatography (10:90 ethyl acetate: petroleum ether) to give 107p (5.0 g, 
75%) as a pale yellow oil; IR vmax (cm'1) 3341 (OH), 2203 (alkyne group), 1630
(C=C); H NMR (300 MHz, CDCI3) 6 H 7.43 (2H, m, phenyl), 7.30 (3H, m, phenyl),
5.47 (1H, d, J  = 6.5, C//=C), 5.26 (1H, d, J  = 6.5, C//OH), 1.78 (6 H, s, CH3); 13C 
NMR (75 MHz, CDC13) 6 C 137.6 (C=CH), 132.1 (phenyl), 128.7 (C=CH), 128.6 
(phenyl), 125.1 (phenyl), 123.0 (phenyl), 90.0 (OCCOH), 84.9 (OCCO H ), 60.0 
(CHOH), 26.0 (CH3), 18.6 (CH3); LRMS m/z (%)+CI 187 (M+H, 5 %), 185 (15), 
171 (10), 169 (20), 151 (18), 103 (62), 85 (100), 83 (10); HRMS calcd for C 13H 14O 
187.11174 (M+H), found 187.11149.
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l-Cyclopent-l-enyl-3-ethoxyprop-2-yn-l-ol (107q). A solution of ethoxy ethyne 
(2.5 g, 6.3 mL, 36.3 mmol, 40% wt. solution in hexanes) in dry tetrahydrofuran (100 
mL) was treated dropwise at 25 °C with a solution of w-butyllithium in hexanes (15.3 
mL, 38.2 mmol, 2.5 M). The mixture was stirred at 25 °C for 30 min, then treated 
dropwise with a solution of cyclopent-l-enecarboxaldehyde (3.0 g, 27.3 mmol) in 
dry tetrahydrofuran (15 mL). The mixture was stirred for 3 h, and then worked up as 
described above. The residue was purified by column chromatography (10:90 ethyl 
acetate: petroleum ether) to give 107q (2 . 1  g, 6 6 %) as a pale orange oil; IR Vmax (cm'
l) 3376 (OH), 2208 (alkyne group), 1632 (C=C); H NMR (300 MHz, CDCfi) 5H
5.84 (1H, m, CH=C\ 4.98 (1H, s, C//OH), 4.07 (2H, q, J=  7.0, OCH2), 2.34 (4H, m, 
CH2C=CHCH2\  1.93 (2H, m, CH2C//2CH2), 1.35 (3H, t, J  = 7.0, CH3); 13C NMR 
(75 MHz, CDC13) 5C 144.7 (C=CH), 126.6 (C=CH), 94.1 (C O O ), 74.6 (C//OH), 
61.4 (OC//2CH3), 38.1 (C O O ), 32.2 (CH2), 31.4 (CH2), 23.4 (CH2), 14.3 (CH3); 
LRMS m/z (%)+CI 166 (M+, 20 %), 137 (70), 110 (50), 95 (90), 79 (60), 67 (90), 53 
(50); HRMS calcd for Ci0Hi4O2 166.0994, found 166.0993.
Oct-l-en-4-yn-3-one (108a). A solution of the oct-1 -en-4-yn-3-ol (3.5 g, 28.2 
mmol) in dichloromethane (5 mL) was added in one portion to a stirred suspension 
of manganese dioxide (39.2 g, 0.45mol) in dichloromethane (250 mL) under an 
atmosphere of nitrogen. Stirring was continued at 20 °C for 24 h. Then the mixture 
was filtered through celite, and the celite thoroughly washed with dichloromethane 
(4 x 20 mL). The combined organic filtrates were evaporated and the residue was 
purified by flash column chromatography (10:90, ethyl acetate: hexanes) to give 
108a (2.2 g, 63%) as a yellow oil; IR Vmaxfcm'1) 2210 (alkyne group), 1685 (C O ),
1621 (C O ); H NMR (300 MHz, CDC13) 5H 6.57 (1H, d, J  = 17.3 Hz, C H O //H ),
6.42 (1H, dd, J=  10.0 and 17.3 Hz, C H O H //), 6.16 (1H, d, J=  10.0 Hz, CH=CH2),
2.42 (2H, t, J=  7.0 Hz, CH2\  1.65 (2H, sextet, J=  7.0 Hz, CH2), 1.06 (3H, t, 7 = 7.0
Hz, CH3)- 13C NMR (75 MHz, CDC13) 5C 179.2 (C O ), 138.1 (CH2=CH), 133.3 
(CH2=CH), 95.5 ( C O C O ) ,  78.7 (C O C O ) , 21.3 (CH2), 20.9 (CH2), 13.5 (CH3); 
LRMS m/z (%)+CI 123 (M+H, 100 %), 111 (10), 95 (20), 71 (10), 56.9 (10), 54.9
(14); HRMS calcd for C gH O  123.0804 (M+H), found 123.0799.
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2-Methyloct-l-en-4-yn-3-one (108b). A solution of the 2-methyloct-l-en-4-yn-3-ol 
(3.0 g, 21.7 mmol) in dichloromethane (5 mL) was added in one portion to a stirred 
suspension of manganese dioxide (30.2 g, 0.35 mol, 16 eq.) in dichloromethane (250 
mL) under an atmosphere of nitrogen. Stirring was continued at 20 °C for 24 h. 
Then the mixture was filtered through celite, and the celite thoroughly washed with 
dichloromethane (4 x 20 mL). The combined organic filtrates were evaporated and 
the residue was purified by flash column chromatography (10:90, ethyl acetate: 
hexanes) to give 108b (2.4 g, 80%) as a yellow oil; IR vmax (cm'1) 2206 (alkyne 
group), 1683 (C=0), 1624 (C=C); H NMR (300 MHz, CDC13) 5H 6.43 (1H, s, 
C=C7/H), 6.00 (1H, s, C=CHB), 2.39 (2H, t, J  = 7.0, CH2), 1.90 (3H, s, CH3), 1.62 
(2H, m, CH2CH3), 1.04 (3H, t, J  = 7.0, CH3); 13C NMR (75 MHz, CDC13) 6 C 180.5 
(0 =0 ), 145.5 (C=CH2), 130.6 (C=CH2\  97.4 (O CC=O ), 79.2 (O C C = 0), 21.9 
(CH2), 21.5 (CH2), 13.8 (CH3), 13.5 (CH3); ); LRMS m/z (%)+CI 137 (M+H, 100 
%), 111 (15), 109 (10), 97 (12), 95 (13), 71 (10), 69 (15); HRMS calcd for C9H 120  
137.0961 (M+H), found 138.0965.
(£)-Dec-3-en-6-yn-5-one (108c). A solution of the (ZT)-dec-3-en-6-yn-5-ol (2.5 g, 
16 mmol) in dichloromethane (5 mL) was added in one portion to a stirred 
suspension of manganese dioxide (12.0 g, 0.139 mol, 16 eq.) in dichloromethane 
(200 mL) under an atmosphere of nitrogen. Stirring was continued at 20 °C for 24 h. 
Then the mixture was filtered through celite, and the celite thoroughly washed with 
dichloromethane (4 x 20 mL). The combined organic filtrates were evaporated and 
the residue was purified by flash column chromatography (10:90, ethyl acetate: 
hexanes) to give 108c (2.3 g, 92%) as an orange oil; ER vmax (cm'1) 2203 (alkyne
group), 1685 (O O ), 1622 (C=C); H NMR (300 MHz, CDC13) 6 H 7.24 (1H, dt, J  =
15.7 and 6.5 Hz, C//=CHC=€>), 6.16 (1H, d, J  = 15.7 Hz, CH=C//C=0), 2.39 (4H, 
m, 2CH2), 1.66 (2H, sextet, J  = 7.0 Hz, CH2CH3) 1.11 (6 H, t, / =  7.0 Hz, 2CH3); 13C 
NMR (75 MHz, CDC13) 5C 179.1 (0=0), 155.2 (CH=C//C=0), 131.5
(07=€H C =0), 94.4 (O C C = 0), 79.2 (O C C = 0), 25.6 (CH2), 21.4 (CH2), 21.0 
(CH2), 13.6 (CH3), 12.1 (CH3); LRMS m/z (%)+CI 151 (M+H, 10 %), 150 (100), 
149 (10), 95 (30), 83 (15), 59 (7), 57 (6 ); HRMS calcd for Ci0Hi4O 151.1117 
(M+H), found 151.1119.
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(£)-l-Phenylhept-4-en-l-yii-3-one (108d). A solution of (Zs)-l-phenylhept-4-en- 
l-yn-3-ol (3.4 g, 18.2 mmol) in dichloromethane (5 mL) was added in one portion to 
a stirred suspension of manganese dioxide (14.5 g, 0.17 mol) in dichloromethane 
(200 mL) under an atmosphere of nitrogen. Stirring was continued at 20 °C for 24 h. 
Then the mixture was filtered through celite, and the celite thoroughly washed with 
dichloromethane (4 x 20 mL). The combined organic filtrates were evaporated and 
the residue was purified by flash column chromatography (10:90, ethyl acetate: 
hexanes) to give 108d (2.7 g, 79%) as a red oil; IR vmax (cm'1) 2214 (alkyne group), 
1693 (0=0), 1615 (C=C); H NMR (300 MHz, CDC13) 5H 7.59 (2H, m, phenyl),
7.36 (4H, m, phenyl, and C//=CHC=0), 6.22 (1H, d, J  = 15.8 Hz, C H = C //0 0 ) ,
2.36 (2H, quintet, J  = 7.0 Hz, CH2), 1.14 (3H, t, J  = 7.0 Hz, CH3); °C  NMR (75 
MHz, CDC13) 5c 178.7 (C=0), 155.6 (C H =C M >0), 132.9 (i/»o-phenyl), 132.1 
(phenyl), 131.5 (C tfC H O O ), 130.5 (phenyl), 128.6 (phenyl), 91.1 (O C C O ),
86.3 (C=CC=0), 25.8 (CH2), 12.1 (CH3); LRMS m/z (%)+CI 185 (M+H, 100 %), 
167 (5), 145 (5), 129 (12), 103 (10); HRMS calcd for Ci3H120  185.0961 (M+H), 
found 185.0958.
Non-2-en-5-yn-4-one (108e). A solution of (£)-non-2-en-5-yn-4-ol (2.0 g, 14.5 
mmol) in dichloromethane (3 mL) was added in one portion to a stirred suspension 
of manganese dioxide (20.2 g, 0.23 mol) in dichloromethane (200 mL) under an 
atmosphere of nitrogen. Stirring was continued at 20 °C for 24 h. Then the mixture 
was filtered through celite, and the celite thoroughly washed with dichloromethane 
(4 x 20 mL). The combined organic filtrates were evaporated and the residue was 
purified by flash column chromatography (5:95, ethyl acetate: hexanes) to give 108e 
(1.45 g, 74 %) as a pale yellow oil; IR Vmaxfcm'1) 2212 (alkyne group), 1691 (C=0),
1620 (C=C); H NMR (300 MHz, CDC13) 5H 7.14 (1H, m, CH=CHC=0), 6.18 (1H, 
d, J  = 15.6 Hz, CH =07C =0), 2.37 (2H, 19J=  7.0 Hz, CH2), 1.98 (3H, d, J  = 7.0 Hz, 
CH3), 1.67 (2H, sextet, J  = 7.0 Hz, CH2), 1.05 (3H, t,J =  7.0 Hz, CH3); 13C NMR (75 
MHz, CDC13) 5c 178.8 (C=0), 149.1 (CH=CtfC=0), 134.0 (CH=CHC=0), 94.4 
(<>CC=0), 79.1 (O C C = 0), 21.4 (CH2), 20.9 (CH2), 18.4 (CH3), 13.6 (CH3); 
LRMS m/z (%)+CI 137 (M+H, 25 %), 121 (30), 108 (60), 95 (100), 77 (55), 69 (70); 
HRMS calcd for C9Hi20  137.0966 (M+H), found 137.0973.
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(jE)-l-Phenyloct-l-en-4-yn-3-one (108f). A solution of (£)-l-phenyloct-l-en-4-yn-
3-ol (1.35 g, 9.0 mmol) in dichloromethane (5 mL) was added in one portion to a 
stirred suspension of manganese dioxide (11.4 g, 0.144 mol, 16 eq.) in 
dichloromethane (150 mL) under an atmosphere of nitrogen. Stirring was continued 
at 20 °C for 24 h. Then the mixture was filtered through celite, and the celite 
thoroughly washed with dichloromethane (4 x 20 mL). The combined organic 
filtrates were evaporated and the residue was purified by flash column 
chromatography (10:90, ethyl acetate: hexanes) to give 108f (1.3 g, 97%) as a 
colourless oil; H NMR (300 MHz, CDCI3) 5H 7.84 (1H, d, J  = 16.1 Hz, 
C //O H C O ), 7.56 (2H, m, phenyl), 7.42 (3H, m, phenyl), 6.80 (1H, d, J=  16.1 Hz, 
C H O //C O ), 2.45 (2H, t ,J = 7 .0  Hz, CH2), 1.72 (2H, sextet, J=  7.0 Hz, CH2), 1.09 
(3H, t, J  = 7.0 Hz, CH3); 13C NMR (75 MHz, CDC13) 5C 180.7 (C O ), 149.4 
(C H O //C O ), 135.5 (//wo-phenyl), 132.3 (CH=CH C O ), 130.4 (phenyl), 130.0 
(phenyl), 129.9 (phenyl), 96.3 (C O C O ) , 81.8 (C O C O ) , 22.8 (CH2), 22.4 (CH2),
14.9 (CH3). The spectroscopic data are identical to those reported in the literature. 60
(2s)-4-MethyI-l-phenylhept-4-en-l-yn-3-one (108h). A solution of (£)-4-methyl- 
l-phenylhept-4-en-l-yn-3-ol (4.0 g, 19.9 mmol) in dichloromethane (5 mL) was 
added in one portion to a stirred suspension of manganese dioxide (27.7 g, 0.32 mol) 
in dichloromethane (100 mL) under an atmosphere of nitrogen. Stirring was 
continued at 20 °C for 24 h. The mixture was worked up and purified as described 
for 108g to give 108h (3.35 g, 90%) as an orange oil; IR vmax (cm'1) 2202 (alkyne
group), 1675 (C=0), 1624 (C=C); H NMR (300 MHz, CDC13) 5H 7.60 (2H, m, 
phenyl), 7.40 (3H, m, phenyl), 7.24 (1H, t, J  = 7.0, CH=C\ 2.36 (2H, quintet, J  =
7.0, CH2), 1.86 (3H, s, CH3), 1.15 (3H, t, J =  7.0, CH3); °C  NMR (75 MHz, CDC13) 
6c 180.5 (C O ), 151.8 (C/ZO ), 138.0 (C H O ), 132.7 (z/wo-phenyl), 130.3 (phenyl), 
128.8 (phenyl), 120.6 (phenyl), 91.0 (C O C O ) , 86.1 (C O C O ) , 22.8 (CH2), 12.9 
(CH3), 1 0 . 5  (CH3); LRMS m/z (%)+CI 199 (M+, 100 %), 197 (20 ), 129 (22), 113
(15), 105 (23), 103 (15); HRMS calcd for C 14H 14O (M+H) 199.1117, found 
199.1115.
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(£)-l-Ethoxy-4-methylhept-4-eii-l-yn-3-one (108i). A solution of (£)-l-ethoxy-4- 
methylhept-4-en-l-yn-3-ol (1.60 g, 11.9 mmol) in dichloromethane (5 mL) was added 
in one portion to a stirred suspension of manganese dioxide (12.0 g, 0.19 mol) in 
dichloromethane (180 mL) under an atmosphere of nitrogen. Stirring was continued at 
20 °C for 24 h. The mixture was worked up and purified as described for 108g to give 
108i (1.25 g, 78%) as an orange oil; IR vmax (cm'1) 2215 (alkyne group), 1684 (C=0), 
1627 (C=C); H NMR (300 MHz, CDC13) 5H 6 . 8 6  (1H, t, J=  7.5, CH=C), 4.25 (2H, q, 
J  = 7.0, OCH2), 2.20 (2H, pentet, J=  7.5, CH2CH=C), 1.72 (3H, s, CH3), 1.40 (3H, t, 
J =  7.0, OCH2 C//3), 1.12 (3H, t, J  = 7.5, CH3); 13C NMR (75 MHz, CDC13) 5C 181.2 
(C=0), 149.4 (CH=C), 138.0 (CH=C), 102.4 (C=CCO), 77.1 (OCH2), 42.3 (CsCCO),
22.9 {CH2C=C), 14.8 (CH3), 13.3 (CH3), 10.9 (CH3).
(£)-2-Methyl-l-phenyloct-l-en-4-yn-3-one (108j). To solution of (iT)-2-methyl-l- 
phenyloct-l-en-4-yn-3-ol (3.0 g, 14.0 mmol) in dichloromethane (5 mL) was added 
in one portion to a stirred suspension of manganese dioxide (19.5 g, 0.22 mol, 16 eq.) 
in dichloromethane (200 mL) under an atmosphere of nitrogen. Stirring was 
continued at 20 °C for 24 h. Then the mixture was filtered through celite, and the 
celite thoroughly washed with dichloromethane (4 x 20 mL). The combined organic 
filtrates were evaporated and the residue was purified by flash column 
chromatography (10:90, ethyl acetate: hexanes) to give 108j (2.6 g, 87%) as a brown 
oil; IR vmax (cm"1) 2209 (alkyne group), 1686 (C=0), 1625 (C=C); H NMR (300 
MHz, CDC13) 5h 8.01 (1H, s, CH= C), 7.44 (5H, m, Ph), 2.44 (2H, t, J  = 7.0 Hz, 
CH2), 2.11 (3H, s, CH3), 1.71 (2H, sextet, J=  7.0 Hz, CH2), 1.08 (3H, t, J=  7.0 Hz, 
CH3); l3C NMR (75 MHz, CDC13) 8 C 181.4 (C=0), 145.5 (C.H=C), 138.5 (C=CH),
136.0 (1/ 7 5 0 -phenyl), 130.0 (phenyl), 129.5 (para-phenyl), 128.4 (phenyl), 95.6 
(O C C =0), 79.4 (C^CC=O), 21.5 (CH2), 21.2 (CH2), 14.0 (CH3), 12.6 (CH3); 
LRMS m/z (%)+CI 214 (M+H, 60 %), 213 (100), 212 (15), 183 (15), 145 (50), 95 
(47); HRMS calcd for C]5Hi60  213.1274 (M+H), found 213.1272.
(£)-10-Hydroxy-4-methyldec-3-en-6-yn-5-one (108k). A solution of (E)-l- 
methyldec-7-en-4-yne-l,6-diol (3.0 g, 16.5 mmol) in dichloromethane (5 mL) was 
added in one portion to a stirred suspension of manganese dioxide (22.9 g, 0.263 
mol, 16 eq.) in dichloromethane (250 mL) under an atmosphere of nitrogen. Stirring
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was continued at 20 °C for 24 h. Then the mixture was filtered through celite, and 
the celite thoroughly washed with dichloromethane (4 x 20 mL). The combined 
organic filtrates were evaporated and the residue was purified by flash column 
chromatography (1:1 ethyl acetate: hexanes) to give 108k (2.4 g, 84%) as a 
colourless oil; IR vmax (cm'1) 3495 (OH), 2205 (alkyne group), 1678 (C=0), 1620 
(C=C); HNM R (300 MHz, CDC13) 6 H 7.08 (1H, t, J  = 7.0, CH=C\ 3.77 (2H, t, J  =
6.0, OCH2), 2.54 (2H, t, J =  7.0, CH2), 2.28 (2H, m, CH2), 1.89 (2H, m, CH2), 1.78 
(3H, s, CH3), 0.85 (3H, t, J  -  7.0, CH3); 13C NMR (75 MHz, CDC13) 6 C 181.1 (C=0),
151.9 (CH=C\ 138.1 (CH=C), 93.8 (C C C O ), 84.2 (C=CCO), 61.6 (OCH2), 34.5 
(CH2), 22.4 (CH2), 21.4 (CH2), 16.0 (CH3), 15.4 (CH3); LRMS m/z (%)+CI 181 
(M+H, 100 %), 179 (25), 167 (15), 163 (23), 151 (15), 113 (20), 111 (22), 99 (15), 
97 (40), 87 (15), 84.9 (25), 83 (10); HRMS calcd for C nH 160 2 181.1223 (M+H), 
found 181.1220
(£)-ll-Hydroxy-4-methylundec-3-en-6-yn-5-one (1081). A solution of (E)- 
methylundec-8-en-5-yne-l,7-diol (2.0 g, 10.2 mmol) in dichloromethane (5 mL) was 
added in one portion to a stirred suspension of manganese dioxide (14.2 g, 0.163 
mol, 16 eq.) in dichloromethane (180 mL) under an atmosphere of nitrogen. Stirring 
was continued at 20 °C for 24 h. Then the mixture was filtered through celite, and 
the celite thoroughly washed with dichloromethane (4 x 20 mL). The combined 
organic filtrates were evaporated and the residue was purified by flash column 
chromatography (1:1, ethyl acetate: hexanes) to give 1081 (1.8 g, 90%) as a 
colourless oil; IR vmax (cm 1) 3510 (OH), 2208 (alkyne group), 1680 (C O ), 1618 
(C=C); H NMR (300 MHz, CDCI3) 5H 7.10 (1H, t, J  = 7.0 Hz, CH=C), 3.65 (2H, t, 
J  = 6.0 Hz, OCH2), 2.97 (1H, bs, OH), 2.46 (2H, t, J  = 7.0 Hz, CH2), 2.28 (2H, 
quintet, J  = 7.0 Hz CH2), 1.78 (3H, s, CH, h 1 .73 (4H, m, CH2), 1.11 (3H, t , J =  7.0 
Hz, CH3); 13C NMR (75 MHz, CDClj) 8 C 181.2 (C O ), 152.1 (CH=C), 138.0 
(CH=Q, 94.6 ( C O C O ) , 79.2 (C O C O ) , 61.8 (CH20), 32.0 (CH2), 24.8 (CH2),
23.0 (CH2), 18.5 (CH2), 13.1 (CH,), 10.9 (CH,); LRMS m/z (%)+CI 195 (M+H, 100 
%), 177 (15), 165 (5), 149 (6 ), 125 (6 ), 109 (8 ), 97 (72), 69 (5); HRMS calcd for 
Ci2Hi80 2 195.1380 (M+H), found 195.1373.
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(2s)-4-Methylhept-4-en-l-yn-3-one (108m). A solution of (£’)-4-methyl-hept-4-en-
l-yn-3-ol (3.0 g, 24.2 mmol) in dichloromethane (3 mL) was added in one portion to 
a stirred suspension of manganese dioxide (33.6 g, 0.39 mol, 16 eq.) in
dichloromethane (250 mL) under an atmosphere of nitrogen. Stirring was continued 
at 20 °C for 24 h. Then the mixture was filtered through celite, and the celite 
thoroughly washed with dichloromethane (4 x 20 mL). The combined organic
filtrates were evaporated and the residue was purified by flash column
chromatography (silica gel, 10:90, ethyl acetate: hexanes) to give 108m (2.2 g, 73%)
as an orange oil; IR Vma^cm'1) 2213 (alkyne group), 1696 (C O ), 1612 (C O ); *14 
NMR (300 MHz, CDC13) 6 H 7.18 (1H, t, J  = 7.0 Hz, CH=C), 3.14 (1H, s, C O //) , 
2.30 (2H, quintet, J  = 7.0 Hz, CH2), 1.79 (3H, s, CH3), 1.12 (3H, t, J=  7.0 Hz, CH3); 
13C NMR (75 MHz, CDC13) 8 C 179.7 (C O ), 153.2 (CH=C), 137.6 (C H C ), 79.7 
(O C H ), 79.0 (C=CH), 22.8 (CH2), 12.8 (CH3), 10.2 (CH3); LRMS m/z (%)+CI 121 
(M+, 20 %), 107 (15), 97 (42), 77 (20), 69 (36), 53 (25); HRMS calcd for C8Hi0O 
122.0732, found 122.0728.
(ls)-5-Methyl-4-oxo-oct-5-en-2-ynoic acid ethyl ester (108n). A solution of (E)-4- 
hydroxy-5-methyloct-5-en-2-ynoic acid ethyl ester (4.0 g, 20.4 mmol) in 
dichloromethane (5 mL) was added in one portion to a stirred suspension of 
manganese dioxide (28.0 g, 0.326 mol, 16 eq.) in dichloromethane (300 mL) under 
an atmosphere of nitrogen. Stirring was continued at 20 °C for 24 h. Then the 
mixture was filtered through celite, and the celite thoroughly washed with 
dichloromethane (4 x 20 mL). The combined organic filtrates were evaporated and 
the residue was purified by flash column chromatography (10:90, ethyl acetate: 
hexanes) to give 108n as an orange oil (3.35 g, 85%); IR v^x (cm 1) 2209 (alkyne 
group), 1690 (C=0), 1621 (C=C); H NMR (300 MHz, CDC13) 5H 7.13 (1H, t, J  =
7.5 Hz, CH=C\ 4.29 (2H, q, J=  7.0 Hz, OCH2), 2.35 (2H, quintet, J=  7.5 Hz, CH2), 
1.81 (3H, s, CH3), 1.34 (3H, t, J =  7.0 Hz, CH3), 1.13 (3H, t, J =  7.5 Hz, CH3); l3C 
NMR (75 MHz, CDC13) 5C 178.3 (C=0), 154.8 (CH=C), 152.5 (C=0), 137.7 
(CH=C), 79.7 (C=CC=0), 79.5 (C=CC=0), 62.8 (OCH2), 23.0 (CH2), 14.0 (CH3),
12.7 (CH3), 10.2 (CH3); LRMS m/z (%)+CI 195 (M+, 45 %), 165 (30), 149 (80), 120 
(70), 107 (40), 97 (75), 91 (62), 79 (32), 69 (100), 57 (28); HRMS calcd for 
ChHi4 0 3 194.0943, found 194.0950.
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2-Methylnon-2-en-5-yn-4-one (108o). A solution of 2-methylnon-2-en-5-yn-4-ol 
(3.0 g, 19.7 mmol) in dichloromethane (5 mL) was added in one portion to a stirred 
suspension of manganese dioxide (27.4 g, 0.315 mol) in dichloromethane (200 mL) 
under an atmosphere of nitrogen. Stirring was continued at 20 °C for 24 h. Then the 
mixture was filtered through celite, and the celite thoroughly washed with 
dichloromethane (4 x 20 mL). The combined organic filtrates were evaporated and 
the residue was purified by flash column chromatography (10:90, ethyl acetate: 
hexanes) to give IO80 (2.1 g, 71%) as a colourless oil; IR vmax (cm'1) 2205 (alkyne 
group), 1672 (C O ), 1626 (C=C); H NMR (300 MHz, CDCI3 ) 5H 6.14 (1H, s, 
CH=C), 2.35 (2H, t, J  = 6.5, CH2\  2.21 (3H, s, CH3\  1.92 (3H, s, CH3), 1.62 (2H, 
m, CH2I  1.02 (3H, t, J =  7.5, CH3); °C  NMR (75 MHz, CDCI3) 6 C 177.3 (C O ),
157.6 (C O H ), 126.6 (C O //) , 92.9 (C O C O ), 83.8 (C O C O ), 28.1 (2 x CH3), 21.4 
(CH2), 21.4 (CH2), 13.9 (CH3); LRMS m/z (%)+CI 151 (M+H, 100 %), 135 (5), 111
(6 ), 95 (20), 83 (17), 57 (10); HRMS calcd for Ci0H,4O 151.1117 (M+H), found 
151.1114.
5-Methyl-l-phenylhex-4-en-l-yn-3-one (108p). A solution of 5-methyl-1- 
phenylhex-4-en-l-yn-3-ol (3.0 g, 16.1 mmol) in dichloromethane (5 mL) was added in 
one portion to a stirred suspension of manganese dioxide (22.4 g, 0.26 mol) in 
dichloromethane (200 mL) under an atmosphere of nitrogen. Stirring was continued at 
20 °C for 24 h. Then the mixture was filtered through celite, and the celite thoroughly 
washed with dichloromethane (4 x 20 mL). The combined organic filtrates were 
evaporated and the residue was purified by flash column chromatography (silica gel, 
10:90, ethyl acetate: hexanes) to give 108p (2.2 g, 74%) as a colourless oil; *H NMR 
(300 MHz, CDCI3) 5h 7.56-7.30 (5H, m, Ph), 6.30 (1H, s, C,H=C), 2.42 (3H, s, CH3), 
1.97 (3H, s, CH3); °C  NMR (75 MHz, CDC13) 8 C 176.9 (C=0), 158.5 (C O H ), 133.6 
(phenyl), 130.7 (C=C//), 128.7 (phenyl), 126.6 (phenyl), 120.9 (phenyl), 90.7 
(CO C O ), 89.5 (C O C O ), 28.3 (CH3), 21.6, (CH3). The spectroscopic data are 
identical to those reported in the literature.61
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l-Cyclopent-l-enyl-3-ethoxy-propynone (108q). A solution of 1-cyclopent-l-enyl- 
3-ethoxyprop-2-yn-l-ol (2.0 g, 12.0 mmol) in dichloromethane (2 mL) was added in 
one portion to a stirred suspension of manganese dioxide (30.0 g, 0.345 mol) in 
dichloromethane (250 mL) under an atmosphere of nitrogen. Stirring was continued 
at 20 °C for 24 h. The mixture was worked up and purified as described for 108g to 
give 108q (1.60 g, 80%) as an orange oil; IR vmax (cm'1) 2216 (alkyne group), 1680 
(C=0), 1624 (C=C); H NMR (300 MHz, CDCI3) SH 7.01 (1H, s, CH=C\ 4.28 (2H, 
q, J  = 7.5, OCH2), 2.56 (4H, t, J  = 7.5, CH2CH2CH2), 1.94 (2H, pentet, J  = 7.5, 
CH2C //2CH2), 1.45 (3H, t, J  = 7.5, CH3); 13C NMR (75 MHz, CDC13) 6C 176.2 
(0=0), 147.4 (CH=CCO), 125.2 (CH= CCO), 101.3 (O C C O ), 71.3 (CH20), 33.7 
(CH2), 42.9 (C=CCO), 30.8 (CH2), 23.2 (CH2), 14.4 (CH3); LRMS m/z (%)+CI 165 
(M+, 60 %), 153 (68), 137 (100), 111 (32), 95 (80), 85 (42), 71 (25), 55 (15); HRMS 
calcd for Ci0Hi2O2 (M+H) 165.0915, found 165.0913.
(l?)-l,2-Dihydroxy-2-methyloct-4-yn-3-one (109b). To a stirred solution of 
modified ADmix-a (6.2 g, containing an additional 16.0 mg of potassium osmate) in 
1:1 tert-buty\ alcohol-water (35 mL) was added sodium hydrogen carbonate (1.11 g,
13.2 mmol) at 0 °C. A solution of 2-methyloct-l-en-4-yn-3-one (0.60 g, 4.41 mmol) 
in toluene (3 mL) was added and the mixture was stirred until the reaction was 
complete as determined by TLC (~ 24 h). Ethyl acetate (20 mL) was added followed 
by sodium metabisulfite (6.6 g) and the solution was allowed to warm to 20 °C with 
stirring. The separated aqueous layer was extracted with ethyl acetate (4 x 20 mL) 
and the combined organic layers were washed with aqueous sodium hydroxide (2 x 
15 mL, 1 M) then dried (Na2S 04), filtered and evaporated. The residue was purified 
by flash column chromatography (30:70 ethyl acetate: petroleum ether) to give 109b 
(0.60 g, 81%) as an orange oil; [(x] d =  + 80.8 (c 0.08, CHC13); IR vmax (cm'1) 3446 
(OH), 2212 (alkyne group), 1695 (C=0); H NMR (300 MHz, CDC13) 5H 3.95 (1H, 
d, J  = 11.5, C/m OH), 3.60 (1H, d, J =  11.5, CHtfOH), 2.36 (2H, t, J  = 7.0, CH2), 
1.62 (2H, m, CH2CH3), 1.35 (3H, s, CH3), 0.97 (3H, t, J  = 7.5, CH3); UC NMR (75 
MHz, CDC13) 5c 190.5 (C=0), 101.3 (C=CC=0), 80.8 (C=CC=O), 67.8 (CH2OH), 
21.4 (CH2), 21.2 (CH2), 21.1 (CH3), 13.5 (CH3); LRMS m/z (%)+CI 171 (M+, 25 %), 
153 (30), 141 (100), 137 (50), 123 (55), 111 (30), 99 (40), 97 (45), 95 (45), 85 (30), 
71 (35), 37 (25); HRMS calcd for C9Hi40 3 (M+H) 171.1016, found 171.1015.
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(35,^i2)-3,4-Dihydroxy-dec-6-yn-5-one (109c). To a stirred solution of modified 
ADmix-a (3.5 g, containing an additional 9.0 mg of potassium osmate) in 1:1 tert- 
butyl alcohol-water (24 mL) was added sodium hydrogen carbonate (0.63 g, 7.5 
mmol) and methanesulfonamide (0.24 g, 2.5 mmol) at 0 °C. A solution of (£)-dec-3- 
en-6-yn-5-one (0.40 g, 2.5 mmol) in toluene (3 mL) was added and the mixture was 
stirred until the reaction was complete as determined by TLC (~ 24 h). Ethyl acetate 
(20 mL) was added followed by sodium metabisulfite (6.5 g) and the solution was 
allowed to warm to 20 °C with stirring. The separated aqueous layer was extracted 
with ethyl acetate (2 x 20 mL) and the combined organic layers were washed with 
aqueous sodium hydroxide (2 x 35 mL, 1M) then dried (Na2S04), filtered and 
evaporated. Flash column chromatography (30:70 ethyl acetate: petroleum ether) 
gave 109c (0.12 g, 50%) as an orange oil; IR vmax (cm'1) 3512 (OH), 2217 (alkyne 
group), 1697 (C=0); H NMR (300 MHz, CDC13) 6H 4.17 (1H, s, CHOU), 4.12 (1H, 
t , J  = 4.0, CHOU), 2.43 (2H, t, J=  7.0, C=CCH2), 1.66 (4H, m, CH2), 1.04 (6H, t, J  =
7.0, CH3); 13C NMR (75 MHz, CDC13) 5C 187.9 (C O ), 103.9 (CO C O ), 80.1 
(CHOH), 78.0 (CO CO ), 73.4 (CHOH), 27.5 (CH2), 21.2 (2CH2), 13.5 (CH3), 10.3 
0CHs).
(^i?,55)-4,5-dihydroxy-l-phenyl-hept-l-yii-3-one (109d). To a stirred solution of 
modified ADmix-a (2.8 g, containing an additional 8.1 mg of potassium osmate) in 
1:1 ter/-butyl alcohol-water (20 mL) was added sodium hydrogen carbonate (0.55 g,
6.5 mmol) and methanesulfonamide (0.21 g, 2.17 mmol) at 0 °C. A solution of (E)- 
l-phenylhept-4-en-l-yn-3-one (0.40 g, 2.17 mmol) in toluene (3 mL) was added and 
the mixture was stirred until the reaction was complete as determined by TLC (~ 24 
h). Ethyl acetate (20 mL) was added followed by sodium metabisulfite (1.5 g) and 
the solution was allowed to warm to 20 °C with stirring. The separated aqueous 
layer was extracted with ethyl acetate (2 x 20 mL) and the combined organic layers 
were washed with aqueous sodium hydroxide (2 x 35 mL, 1 M) then dried (Na2S04), 
filtered and evaporated. Flash column chromatography (30:70 ethyl acetate: 
petroleum ether) gave 109d (0.22 g, 47%) as a pale yellow oil; IR vmax (cm'1) 3502 
(OH), 2209 (alkyne group), 1695 (C=0); H NMR (300 MHz, CDC13) 5H 7.60 (2H, 
m, phenyl), 7.40 (3H, m, phenyl), 4.32 (1H, m, CHOW), 4.22 (1H, t, J  = 6.0 Hz, 
CHOW), 1.76 (2H, quintet, J  = 7.5 Hz, CH2), 1.08 (3H, t,J =  7.5 Hz, CH3); ‘3C NMR
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(75 MHz, CDCI3) 5c 187.7 (C=0), 133.2 ( / /7 5 0 - p h e n y l ) ,  131.4 ( p h e n y l ) ,  128.8 
( p h e n y l ) ,  119.3 ( p h e n y l ) ,  96.9 (C=CC=0), 85.0 (C=CC=0), 80.2 (O CO TO H), 73.5 
(CZ/OH), 27.5 (CH2), 10.3 (CH3).
(25,i/?)-2,3-Dihydroxy-non-5-yn-4-one (109e). To a stirred solution of modified 
ADmix-a (6.20 g, containing an additional 16.0 mg of potassium osmate and also an 
additional 0.71 g of the chiral ligand, (DHQ)2-PHAL)) in 1:1 tert-butyl alcohol-water 
(40 mL) at 0 °C was added sodium hydrogen carbonate (1.11 g, 13.2 mmol) and 
methanesulfonamide (0.42 g, 4.40 mmol). A solution of the non-2-en-5-yn-4-one 
(0.60 g, 4.40 mmol) in toluene (2 mL) was added and the mixture was stirred until it 
was complete as determined by TLC (~ 24 h). Ethyl acetate (20 mL) was added 
followed by sodium metabisulfite (6 . 6  g) and the solution was allowed to warm to 2 0  
°C with stirring. The separated aqueous layer was extracted with ethyl acetate (3 x 
20 mL) and the combined organic layers were washed with aqueous sodium 
hydroxide (2 x 35 mL, 1M) then dried (Na2 S0 4 ), filtered and evaporated. Flash 
column chromatography (60:40 ethyl acetate: petroleum ether) gave 109e (0.40 g, 
53%) as an orange oil; IR vmax(crn'1) 3430 (OH), 2203 (alkyne group), 1693 (C=0);
H NMR (300 MHz, CDCI3) 5H 4.10 (1H, quintet, J  = 6.0, CHOH), 3.93 (1H, m, 
CHOH), 2.38 (2H, t, J  = 7.0, CH2), 1.62 (2H, m, CH2), 1.23 (3H, d, J  = 6.0, CH3),
1.03 (3H, t, J  = 7.0, CH3); BC NMR (75 MHz, CDC13) 5C 179.5 (C=0), 94.9 
(O CCO ), 79.2 (O CC O ), 67.9 (CHOH), 67.2 (CHOH), 34.0 (CH2), 27.5 (CH2),
21.0 (CH3), 13.6 (CH3); LRMS m/z (%)+CI 171 (M+H, 50 %), 163 (30), 153 (100), 
127 (95), 109 (40), 93 (98), 81 (40), 71 (20); HRMS calcd for C9H 14O3 171.1021 
(M+H), found 171.1024.
(35',4J?)-3,4-Dihydroxy-4-methyl-dec-6-yn-5-one (109g). To a stirred solution of 
modified ADmix-a (6.1 g, containing an additional 22.0 mg of potassium osmate) in 
1:1 tert-butyl alcohol-water (60 mL) was added sodium hydrogen carbonate (1.54 g,
18.3 mmol) and methanesulfonamide (0.58 g, 6.1 mmol) at 0 °C. A solution of (E)-4- 
methyldec-3-en-6-yn-5-one (1.0 g, 6.1 mmol) in toluene (2 mL) was added and the 
mixture was stirred until the reaction was complete as determined by TLC (~ 24 h). 
Ethyl acetate (30 mL) was added followed by sodium metabisulfite (12 g) and the
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solution was allowed to warm to 20 °C with stirring. The separated aqueous layer 
was extracted with ethyl acetate (2 x 30 mL) and the combined organic layers were 
washed with aqueous sodium hydroxide (2 x 30 mL, 1 M) then dried (Na2 S0 4 ), 
filtered and evaporated. Flash column chromatography (1:5 ethyl acetate: petroleum 
ether) gave 109g (1.14 g, 95%) as an orange oil; [a]o= + 90.7 (c 0.03 in CHCI3); IR
vmax (cm'1) 3394 (OH), 2212 (alkyne group), 1690 (C=0); H NMR (300 MHz, 
CDCI3) 5h 3.95 (1H, dt, J =  10.0, 2.5, C//OH), 2.50 (2H, t, J =  7.0, C=CCH2\  1.74 
(4H, m, 2 C //2CH3), 1.43 (3H, s, CH3), 1.15 (3H, t, J  = 7.5, CH3), 1.14 (3H, t, J = 7.5, 
CH3); 13C NMR (75 MHz, CDCI3) 8 C 191.6 (C O ). 101.3 (C O C O ) , 82.6 
(C O C O ), 78.1 (0=CCOH), 76.5 (COH), 24.0 (CH2), 21.7 (CH2), 21.6 (CH2), 21.5 
(CH3), 13.8 (CH3), 10.7 (CH3); LRMS m/z (%)+FAB 199 (M+, 60), 181 (10), 154 
(32), 141 (100), 107 (15), 95 (40), 69 (17), 57 (30), 43 (55); HRMS calcd for 
ChHi80 3 (M+H) 199.1334, found 199.1330.
(4/?,5S)-4,5-Dihydroxy-4-methyl-l-phenylhept-l-yn-3-one (109h). To a stirred 
solution of modified ADmix-a (5.0 g, containing an additional 18.0 mg of potassium 
osmate) in 1:1 tert-butyl alcohol-water (50 mL) was added sodium hydrogen 
carbonate (1.28 g, 15.2 mmol) and methanesulfonamide (0.48 g, 5.05 mmol) at 0 °C. 
A solution of (iT)-4-methyl-l-phenylhept-4-en-l-yn-3-one (1.0 g, 5.05 mmol) in 
toluene (3 mL) was added and the mixture was stirred until the reaction was 
complete as determined by TLC (~ 24 h). Ethyl acetate (20 mL) was added followed 
by sodium metabisulfite (6.5 g) and the solution was allowed to warm to 20 °C with 
stirring. The separated aqueous layer was extracted with ethyl acetate (2 x 20 mL) 
and the combined organic layers were washed with aqueous sodium hydroxide ( 2  x 
35 mL, 1 M) then dried (Na2 S 04), filtered and evaporated. Flash column 
chromatography (30:70 ethyl acetate: petroleum ether) gave 109h (0.77 g, 6 6 %); as 
an orange oil; [a]D = + 1.69 (c 0.59, CHCI3); IR vmax(cm'1) 3429 (OH), 2202 (alkyne 
group), 1685 (C=0); H NMR (300 MHz, CDCI3) 5H 7.60 (2H, m, phenyl), 7.42 (3H, 
m, phenyl), 3.96 (2H, bs, 20H), 2.34 (1H, bs, C//OH), 1.74-1.53 (2H, m, CH2), 1.43 
(3H, s, CH3), 1.06 (3H, t ,J =  7.5, CH3); *3C NMR (75 MHz, CDC13) 5C 192.9 (C O ),
133.1 (zpso-phenyl), 131.2 (phenyl), 129.4 (phenyl), 119.8 (phenyl), 97.3 
( C O C O ) , 84.8 (C O C O ) , 82.6 (COH), 77.7 (C7/OH), 24.1 (CH2), 21.9 (CH3),
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10.8 (CH3); LRMS m/z (%)+CI 233 (M+H, 56%), 203 (47), 173 (85), 147 (66), (90), 
120 (63), 103 (100), 91 (39); HRMS calcd for Ci4H160 3 232.1099, found 232.1103.
4,5-Dihydroxy-4-methyl-l-phenylhept-l-yii-3-oiie (rac-109h). (F)-4-methyl-l -
phenylhept-4-en-l-yn-3-one (lc) (1.0 g, 5.05 mmol) and citric acid (0.79 g, 3.77 
mmol) were dissolved in a 1:1 mixture of tert-butyl alcohol-water (5 mL) in a 25 mL 
Erlenmeyer flask. Potassium osmate (1.85 mg, 5.02 x 10° mol) was then added 
followed by 4-methylmorpholine 7V-oxide (0.75 g, 5.53 mmol). The bright green 
mixture was stirred at 20 °C for 24 h, by which time it had become nearly colourless. 
The tert-butyl alcohol was removed on a rotary evaporator, and the aqueous residue 
was acidified with hydrochloric acid (lmL, 1M) and extracted with ethyl acetate (3 x 
5 mL). The combined organic extracts were dried (MgS04) and evaporated to give 
racemic 109h (0.59 g, 50%) as an orange oil. Spectroscopic data were identical to 
those given for enantiopure 109h prepared above.
./V-Methoxy-/V-methyI-3-pheiiylacrylamide (116).62 Isobutyl chloroformate (5.54 
g, 40.5 mmol) was added to a solution of cinnamic acid (6.0 g, 40.5 mmol) and 4- 
methylmorpholine (8.20 g, 81.1 mmol) in anhydrous dichloromethane (200 mL) at 0 
°C. After stirring for 20 min, N,O-dimethylhydroxylamine hydrochloride (3.95 g,
40.5 mmol) was added and the resulting solution was stirred at 0 °C for 20 min and at 
20 °C for 2 h. The mixture was partitioned between water (100 mL) and 
dichloromethane (2 x 100 mL) and the combined organic layers were dried (MgS04), 
filtered and evaporated. The residue was purified by column chromatography (silica 
gel, 30:70, ethyl acetate: petroleum ether) to give 116 (5.0 g, 64%) as a pale yellow 
oil; HNMR (300 MHz, CDC13) 8H7.82 (1H, d, J=  16.0, C/OCHCO), 7.56 (2H, m, 
phenyl), 7.40 (3H, m, phenyl), 7.06 (1H, d9 J  = 16.0, C H C //C O ), 3.76 (3H, s, 
OCH3), 3.31 (3H, s, NCH3); °C  NMR (75 MHz, CDC13) 5C 167.0 (0=0), 143.5 
(CH=CHCO), 135.2 (//wo-phenyl), 129.9 (phenyl), 128.8 (phenyl), 128.1 (phenyl),
115.8 (CH=C7/CO), 61.9 (OCH3), 32.5 (NCH3).
(2S,3/?)-2,3-Dihydroxy-/V-methoxy-/V-methyl-3-phenylpropionamide (117). 37 To
a stirred solution of modified ADmix-p (14.7 g, containing an additional 38.2 mg of 
potassium osmate, plus an additional 0.41 g of the chiral ligand (DHQD)2PHAL) in
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1:1 tert-butyl alcohol-water (60 mL) at 0 °C was added iV-methoxy-A-methyl-3- 
phenylacrylamide (2.0 g, 10.5 mmol) and the mixture was stirred until the reaction 
was complete as determined by TLC (~ 24 h). Ethyl acetate (30 mL) was added 
followed by sodium metabisulfite (21.0 g) and the solution was allowed to warm to 
20 °C with stirring. The separated aqueous layer was extracted with ethyl acetate (3 x 
50 mL) and the combined organic layers were dried (Na2S04), filtered and 
evaporated Flash column chromatography (100% ethyl acetate) gave 117 (1.5 g,
63%) as a white solid; H NMR (300 MHz, CDC13) 5H 7.37 (5H, m, phenyl), 4.97 
(1H, s, CHOH), 4.60 (1H, s, CHOH), 3.64 (3H, s, OCH3), 3.26 (3H, s, NCH3), 3.03 
(1H, bs, OH), 1.60 (1H, bs, OH); °C  NMR (75 MHz, CDC13) 5C 168.5 (0=0), 137.2 
(//wo-phenyl), 28.4 (phenyl), 127.9 (phenyl), 126.1 (phenyl), 74.8 (COH), 72.3 
(COH), 61.2 (OCH3), 32.5 (NCH3).
(^5',5/2)-2,2-Dimethyl-5-phenyl-[ly3]dioxolane-4-carboxylic acid A-methoxy-TV- 
methyl amide (118). A solution of (2R, 3S)-2,3-dihydroxy-A-methoxy-A-methyl-S- 
phenylpropionamide (1.50 g, 6.67 mmol) in a 1:1 mixture of N,N- 
dimethylformamide: 2,2-dimethoxypropane (89 mL) at 20 °C was treated with p- 
toluenesulfonic acid monohydrate (0.30 g). After 24 h saturated aqueous sodium 
hydrogen carbonate (25 mL), water (25 mL) and diethyl ether (25 mL) were added to 
the mixture, and the aqueous layer was separated and extracted with diethyl ether (3 
x 25 mL). The combined organic layers were washed with water (25 mL) and brine 
(25 mL) and then dried (MgS04). Filtration and evaporation gave a residue that was 
purified by flash column chromatography (20:80, ethyl acetate: petroleum ether) to 
afford 118 (1.0 g, 79%) as a pale yellow oil; [a]D= + 47.8 (c 0.03, CHC13); IR (cm 1) 
vmax 1715 (C O ); *H NMR (300 MHz, CDC13) 5H 7.44 (2H, m, phenyl), 7.35 (3H, m, 
phenyl), 5.39 (1H, d, J  = 7.5, OCHCO), 4.68 (1H, d, J  = 7.5, OCH), 3.48 (3H, s, 
OCH3), 3.18 (3H, s, NCH3), 1.61 (3H, s, C //3CCH3), 1.57 (3H, s, CH3CC//5); 13C 
NMR (75 MHz, CDC13) 8C 170.0 (C O ), 137.7 {ipso-phenyl), 128.5 (phenyl), 128.4 
(phenyl), 126.8 (phenyl), 111.1 (C(CH3)2), 80.3 (OCH), 78.8 (OCH), 61.5 (OCH3),
32.4 (NCH3), 27.1 (CH3), 26.2 (CH3).
l-((4S,5/?)-2,2-Dimethyl-5-phenyI-[l,3]dioxolan-4-yl)-hex-2-yn-l-one (119). A
solution of pent-l-yne (0.42 g, 6.2 mmol) in dry tetrahydrofuran (25 mL) was treated
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dropwise at 20 °C with a solution of w-butyllithium in hexanes (2.0 mL, 4.9 mmol,
2.5 M). The mixture was stirred at 20 °C for 30 min and then added slowly to a 
stirred solution of 2,2-dimethyl-5-phenyl-[l,3]dioxolane-4-carboxylic acid N- 
methoxy-/V- methyl amide (0.80 g, 3.1 mmol) in tetrahydrofuran (20 mL). This 
mixture was stirred at 20 °C for 1 h and then poured into saturated aqueous 
ammonium carbonate (100 mL). The layers were separated and the aqueous layer 
was extracted with diethyl ether (3 x 50 mL). The combined organic extracts were 
dried (MgS04), filtered and evaporated. The residue was purified by column 
chromatography on silica gel (10:90 ethyl acetate: petroleum ether) to give 119 (0.90 
g, 85%) as a pale yellow oil; [a]o = + 53.7 (c 0.24 in CHCf); IR (cm'1) 2206
(alkyne group), 1703 (C=0); H NMR (300 MHz, CDCI3) 6 H 7.35 (5H, m, phenyl), 
5.14 (1H, d, J  = 7.6, OCH), 4.38 (1H, d, J  = 7.6, OCH), 2.33 (2H, t, J  = 7.0, 
C //2CH2CH3), 1.62 (3H, s, OCC//5 CH3), 1.56 (3H, s, OCCH3C //3), 1.55 (2H, m,
C //2CH3) 0.96 (3H, t, J  = 7.5, CH3); 13C NMR (75 MHz, CDC13) 5C 185.2 (C O ),
137.6 (/pso-phenyl), 128.6 (phenyl), 126.8 (phenyl), 111.8 (C(CH3)2), 88.0 
(OCHCOl 87.5 (CO CO ), 80.3 (OCH), 79.3 (C O C O ), 27.1 (CH2), 26.1 (CH2),
21.1 (CH3), 21.0 (CH3), 13.5 (CH3); LRMS m/z (%)+FAB 295 (M+, 30 %), 218 (5), 
198 (20), 176 (100), 172 (27); HRMS calcd for Ci7H2 0O3 (M+Na) 295.1310, found 
295.1328.
(S)-2-((/?)-Hydroxyl-phenyl-methyl)-5-propyl-furan-3-one (llOf). To a stirred 
solution of l-((4^,5S)-2,2-dimethyl-5-phenyl-[l,3]dioxolan-4-yl)-hex-2-yn-l-one 
(0.50 g, 1.75 mmol) in acetone (30 mL, HPLC grade) at 20 °C was added acidified 
mercury(II) sulfate solution (0.30 mL, 0.1 M obtained by dissolving yellow 
mercury(II) oxide in aqueous 2.5% H2 S 0 4). The mixture was stirred for 30 min then 
neutralized by the addition of powdered sodium hydrogen carbonate. The mixture 
was stirred for a further 1.5 h, filtered and the filtrate evaporated. The residue was 
taken up in ether (20 mL) and the solution was washed with water (20 mL). The 
aqueous layer was extracted with ether (2 x 20 mL), and the combined extracts 
washed with saturated aqueous sodium hydrogen carbonate (30 mL) then brine (30 
mL), and dried over Na2 S 04, filtered and evaporated. The residue was purified by 
flash column chromatography (30:70 ethyl acetate: petroleum ether) to give 11 Of 
(0.20 g, 50%) as a yellow oil; [ oi] d  = + 90.7 (c 0.08, CHCI3 ); IR vmax (cm'1) 3405
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(OH), 1684 (C=0), 1647 (C=C); 'h  NMR (300 MHz, CDC13) SH 7.35 (5H, m, 
phenyl), 5.42 (1H, s, CH=C), 4.67 (2H, d, J =  3.5, C//OH), 3.04 (1H, bs, CHO//), 
2.44 (2H, t, J  = 6.0, CH2), 1.60 (2H, m, C/f-CH,), 0.95 (3H, t, J  = 7.4, CH,); ' c  
NMR (75 MHz, CDC1,) 5C 203.5 (C=0), 195.7 (C=CCO), 139.0 Opso-phenyl ), 128.9 
(phenyl), 128.3 (phenyl), 126.5 (phenyl), 104.8 (C H O ), 86.6 (OCH), 72.8 (CHOH),
32.7 (CH2), 19.5 (CH2), 13.6 (CH3); LRMS m/z (%)+CI 233 (M+, 70 %), 215 (72), 
187 (20), 167 (25), 155 (60), 141 (20), 127 (100); HRMS calcd for C,4H160 3 (M+H) 
233.1178, found 233.1179.
Enantiomeric excess of 11 Of was determined by HPLC analysis using a 
Chiralcel OD column (10:90 isopropanol: «-hexane, A,=210 nM), the major 
enantiomer eluting after 15.76 min and the minor enantiomer after 14.21 min, (flow 
rate of 0.7 mL/min)
(/?)-5-Ethoxy-2-((S)-l-hydroxypropyl)-2-inethylfuran-3-one (HOi). To a stirred 
solution of modified ADmix-a (6.63 g, containing an additional 22.0 mg of 
potassium osmate) in 1:1 ter/-butyl alcohol-water (50 mL) was added sodium 
hydrogen carbonate (1.52 g, 18.1 mmol) and methanesulfonamide (0.57 g, 6.0 mmol) 
at 0 °C. A solution of (£)-l-ethoxy-4-methylhept-4-en-l-yn-3-one (1.0 g, 6.0 mmol) 
in toluene (3 mL) was added and the mixture was stirred until it was complete as 
determined by TLC (~ 24 h). Ethyl acetate (20 mL) was added followed by sodium 
metabisulfite (6.5 g) and the solution was allowed to warm to 20 °C with stirring. 
The separated aqueous layer was extracted with ethyl acetate (2 x 20 mL) and the 
combined organic layers were washed with aqueous sodium hydroxide (2 x 35 mL, 1 
M) then dried (Na2S04), filtered and evaporated. The residue was purified by flash 
column chromatography (50:50 ethyl acetate: petroleum ether) to give llOi (0.59 g, 
50%) as an orange oil; [a]o = + 60.0 (c 0.05 in CHCft); IR v^x (cm'1) 3426 (OH), 
1695 (C O ), 1644 (C=C); H NMR (300 MHz, CDCI3) 6H 4.74 (1H, s, CH=C), 4.24 
(2H, q, J  = 7.0, OCH2), 3.69 (1H, dt, J  = 5.3 and 2.6, C//OH), 1.70 (1H, m, 
C/mCHOH), 1.46 (3H, t, J  = 7.0, OCH2CH3\  1.43 (3H, s, CCH3), 1.37 (1H, m, 
CH//CHOH), 1.06 (3H, t, J  = 7.0, CH2CH3)\ 13C NMR (75 MHz, CDC13) 5C 202.2 
(C O ), 184.3 (CO H CO ), 93.7 (CH3CO), 80.1 (C H O ), 75.4 (CHOH), 68.2 (CH20),
23.9 (CH2CH3), 19.1 (CH3), 14.5 (CH3), 10.8 (CH3); LRMS m/z (% )O I 201 (M+,
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15 %), 143 (100), 115 (70), 59 (75); HRMS calcd for C i0H16O4 (M+H) 201.1121, 
found 201.1121.
Enantiomeric excess of llOi was determined by HPLC analysis using a 
Chiralcel OD column (10:90 isopropanol: «-hexane, >.=210 nM), the major 
enantiomer eluting after 16.02 min and the minor enantiomer after 14.42 min (flow 
rate of 0.7 mL/min).
Cyclopent-l-enecarboxaldehyde (122).39 A solution of sodium metaperiodate 
(13.6 g, 6.63 mmol) in water (165 mL) was treated with />*<ms-cyclohexane-l,2-diol 
(6.0 g, 51.7 mmol). The mixture was stirred for 30 min and then treated with 20% 
aqueous potassium hydroxide (19 mL) and ether (22 mL). The resulting mixture was 
stirred vigorously for 10 min; the organic layer was separated and the aqueous layer
was extracted with ether (4 x 55 mL). The combined organic extracts were dried
i
(MgS04), filtered and evaporated to give 122 (3.8 g, 67%) as a pale yellow oil; H 
NMR (300 MHz, CDC13) 5H 9.75 (1H, s, C H O ), 6.83 (1H, m, C H O ), 2.55 (2H, m, 
CH2), 2.51 (2H, m, CH2), 1.96 (2H, t, J  = 7.5, CH2CO H ); °C  NMR (75 MHz, 
CDCft) 5c 189.8 (C H O ), 152.9 (C/ZO ), 147.9 (C H O ), 33.6 (CH2) 28.3 (CH2),
22.9 (CH2).
(5/f,6S)-2-Ethoxy-6-hydroxy-l-oxaspiro[4.4]non-2-en-4-one (HOq). To a stirred 
solution of modified ADmix-a (4.2 g, containing an additional 11.0 mg of potassium 
osmate) in 1:1 tert-butyl alcohol-water (32 mL) was added sodium hydrogen 
carbonate (0.76 g, 9.0 mmol) and methanesulfonamide (0.29 g, 3.0 mmol) at 0 °C. A 
solution of 1-cyclopent-l-enyl-3-ethoxypropynone (0.50 g, 3.0 mmol) in toluene (3 
mL) was added and the mixture was stirred until the reaction was complete as 
determined by TLC (~ 24 h). Ethyl acetate (16 mL) was added followed by sodium 
metabisulflte (4.5 g) and the solution was allowed to warm to 20 °C with stirring. 
The aqueous layer was separated and extracted with ethyl acetate (4 x 20 mL); the 
combined organic layers were washed with aqueous sodium hydroxide (10 mL, 1M), 
dried (Na2S 04) and then filtered. Evaporation gave a residue that was purified by 
flash column chromatography (30:70 ethyl acetate: petroleum ether) to give llOq 
(0.37 g, 62%) as an orange oil; [a]o = + 30.2 (c 0.04 in CHCI3); IR (cm'1) 3408
(OH), 1693 (C=0), 1645 (C=C); H NMR (300 MHz, CDC13) 5H 4.76 (1H, s,
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Ctf=C), 4.25 (3H, m, CHOH and OCH2), 2.13 (2H, m, CH2), 1.91-1.71 (4H, m, 
2CH2), 1.42 (3H, t, J =  7.0, CH3); 13C NMR (75 MHz, CDC13) 8C 199.6 (C=0),
183.7 (O C H ), 98.4 (OCCO), 80.7 (O C H ), 76.8 (CHOH), 68.0 (OCH2), 32.1 
(CH2), 31.8 (CH2), 19.2 (CH2), 14.2 (CH3); LRMS m/z (%)+CI 198 (M+, 30 %), 184 
(100), 168 (20), 150 (20), 126 (10), 96 (10); HRMS calcd for C i0H14O4 (M+H) 
198.0898, found 198.0883.
Enantiomeric excess of HOq was determined by 1HNMR analysis of 
the Mosher’s ester derivative. General procedure for the preparation of MTPA 
ester: To a solution of furanone 210q (10 mg, 5 x 10'5 mol) and DMAP (12.4 mg, 
0.10 mmol) in dry dichloromethane (3.0 mL) was added (S)-MTPAC1 (15.0 pL, 8.3 x 
10 5 mol) and the mixture was stirred at 20 °C for 1 h. The mixture was quenched by 
the addition of water (1.0 mL) and ether (3.0 mL) and stirred for 15 min. The 
mixture was washed with aqueous hydrochloric acid (4.0 mL, 1.0 M), aqueous 
sodium hydroxide (4.0 mL, 1.0 M), and brine (4.0 mL) and then dried over M gS04. 
Filtration and evaporation gave the corresponding MTPA ester, which was 
characterised by H NMR without further purification (75%). The vinyl peak for the 
major enantiomer was at 4.70 ppm and for the minor enantiomer at 4.61 ppm; H 
NMR (300 MHz, CDCI3) 5H 7.42 (2H, m, phenyl), 7.37 (3H, m, phenyl), 5.30 (1H, t, 
J  = 7.0 Hz, CHOH), 4.70 (1H, s, CH=C major enantiomer), 4.61 (1H, s, CH=C 
minor enantiomer), 4.13 (2H, q, J  = 7.2 Hz, OCH2), 3.49 (3H, s, OCH3), 2.40 (1H, 
m, CH//), 2.22 (1H, m, C//H), 2.00 (2H, m, CH2\  1.87 (2H, m, CH2) 1.35 (3H, t , J  =
7.2 Hz, CHS).
(/?)-2-Hydroxymethyl-2-methyl-5-propylfuran-3-one (110b). To a stirred 
solution of l,2-dihydroxy-2-methyloct-4-yn-3-one (0.30 g, 1.76 mmol) in acetone 
(30 mL, HPLC grade) at 20 °C was added acidified mercury oxide solution (0.45 mL, 
0.1 M HgO in 2.5% H2S 04). The mixture was stirred for 30 min then neutralized by 
the addition of powdered sodium hydrogen carbonate. The mixture was stirred for a 
further 1.5 h, filtered and the filtrate evaporated. The residue was dissolved in ether 
(15 mL) and the solution was washed with water (25 mL). The aqueous layer was 
extracted with ether (2 x 15 mL) and the combined extracts were washed with 
saturated aqueous sodium hydrogen carbonate (30 mL), then brine (30 mL), dried 
over Na2SQ4 and filtered. Evaporation gave a residue which was purified by flash
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column chromatography on silica gel (30:70 ethyl acetate: petroleum ether) to give 
110b as an orange oil (0.28 g, 93%); IR vmax (cm 1) 3485 (OH), 1682 (0=0), 1650 
(C=C); ‘h  NMR (300 MHz, CDClj) SH 5.35 (1H, s, CH=C), 3.76 (1H, d, J = 11.5, 
CH//OH), 3.62 (1H, d, J = 11.5, C//HOH), 2.44 (2H, t, J  = 7.0, CH2), 1.64 (2H, m, 
C/CCH,), 1.32 (3H, s, CH3), 0.96 (3H, t, .1=1.5, CH3); ' ’c  NMR (75 MHz, CDC13) 
6c 206.2 (C O ), 193.7 (OC=CH), 102.8 ( O /C ) ,  90.8 (CH3CO), 65.4 (CH2OH),
32.7 (CH2), 19.5 (CH2), 18.1 (CH3), 13.6 (CH3); LRMS m/z (%)+CI 171 (M+, 55 
%), 169 (15), 155 (11), 141 (100), 137 (15), 113 (15); HRMS calcd for C9H140 3 
(M+H) 171.1016, found 171.1013.
Enantiomeric excess of 110b was determined by HPLC analysis using 
a Chiralcel OD column (10:90 isopropanol: «-hexane, >1=254 nM).
(i?)-2-((S)-l-Hydroxypropyl)-2-methyl-5-propylfuran-3-one (110g). {3R,4S)-?>,4- 
dihydroxy-4-methyl-dec-6-yn-5-one (0.30 g, 1.5 mmol) in acetone (30 mL, HPLC 
grade) at 20 °C was added acidified mercury(II) sulfate solution (0.1 M obtained by 
dissolving yellow mercury(II) oxide in aqueous 2.5% H2SO4). The mixture was 
stirred for 30 min then neutralized by the addition of powdered sodium hydrogen 
carbonate. The mixture was stirred for a further 1.5 h, filtered and the filtrate 
evaporated. The residue was worked up as described for 110b and then purified by 
column chromatography on silica gel (1:9 ethyl acetate: petroleum ether) to give 
HOg (0.24 g, 80%) as a pale yellow oil; [< x ]d =  + 75.4 (c 0.13 in CHCI3); IR Vmax (cm* 
') 3436 (OH), 1683 (C=0), 1653 (C=C); ‘h  NMR (300 MHz, CDC13) SH 5.43 (1H, s, 
C=CH), 3.66 (1H, t, J  = 7.5, C//OH), 2.69 (1H, bs, CHO//), 2.53 (2H, t, J  = 7.5, 
C =CCH2\  1.71 (3H, m, C//HCH3, C //2CH3), 1.44 (3H, s, CCHS), 1.37 (1H, m,
CH//CH3), 1.07 (6H, t, J  = 7.5, 2CH3); ’3C NMR (75 MHz, CDC13) 5C 207.5 (C=0),
193.8 (C O H ), 103.4 (C=CH), 91.9 (O C C O ), 76.1 (CHOH), 33.1 (CH2C=C), 24.0 
(CH2CH3), 19.0 (CH2), 19.1 (CH3), 14.5 (CH3), 10.8 (CH3); LRMS m/z (%)+FAB 
199 (100), 181 (5), 141 (75), 111 (7), 83 (5), 69 (10), 43 (15); HRMS calcd for 
C ,iH is03 (M+H) 199.1334, found 199.1333.
Enantiomeric excess of llOg was determined by HPLC analysis using a 
Chiralcel OD column (10:90 isopropanol: «-hexane, X=254 nM).
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(R)-2-((S)-l-Hydroxypropyl)-2-methyl-5-pheiiylfuraii-3-one (1 lOh). 4,5- 
dihydroxy-4-methyl-l-phenylhept-l-yn-3-one (0.30 g, 1.14 mmol) was reacted as for 
110b to give a residue which was purified by flash column chromatography on silica 
gel (30:70 ethyl acetate: petroleum ether) to give llOh (0.29 g, 97%) as white 
needles; m.p. 114-116 “C; [u]D = + 120.4 (c 0.04, CHCI,); IR vm ,(cm '') 3406 (OH), 
1678 (C=0), 1647 (C=C); H NMR (300 MHz, CDC13) SH 7.85 (2H, m, Ph), 7.55 
(3H, m, Ph), 6.02 ( 1 H, s, C H C ) ,  3.73 (1H, t, J  = 8.0, CHOH), 1.75-1.38 (2H, m, 
CH2), 1.55 (3H, s, CH3), 1.03 (3H, t, J  = 7.5, CH3); ‘3C NMR (75 MHz, CDC13) 8 C
210.3 (0=0), 185.0 (CH=CO), 132.9 Opvo-phenyl), 128.9 (phenyl), 128.8 (phenyl),
127.2 (phenyl), 100.6 {CH=C), 91.7 (CH3 CO), 76.2 (CHOH), 30.1 (CH2), 23.9 
(CH3), 1.8 (CH3); LRMS m/z (%)+CI 233 (M+H, 40 %), 231 (15), 229 (14), 227 
(2 0 ), 225 (10), 215 (7), 203 (20), 176 (20), 175 (100), 174 (10); HRMS calcd for 
Ci4H,6 0 3 233.1172 (M+H), found 233.1173; found C, 71.77; H, 6.92 (Ci4 Hi60 3 
requires C, 73.15; H, 7.37).
Enantiomeric excess of llOh was determined by HPLC analysis using a 
Chiralcel OJ column (50:50 ethanol: rc-hexane, >1 = 2 1 0  nM), the major enantiomer 
eluting after 5.32 min and the minor enantiomer after 6.84 min.
./V-Methoxy-./V-methyl-2-dimethylacrylamide (124). Isobutyl chloroformate (7.94 
g, 58.1 mmol) was added to a solution of methacrylic acid (5.0 g, 58.1 mmol) and 4- 
methylmorpholine (11.8 g, 0.12 mol) in anhydrous dichloromethane (200 mL) at 0 
°C. After stirring for 20 min, N,O-dimethylhydroxylamine hydrochloride (5.70 g,
58.1 mmol) was added and the resulting solution was stirred at 0 °C for 2 0  min, then 
at 20 °C for 2 h. The mixture was partitioned between water (100 mL) and 
dichloromethane (2 x 100 mL) and the combined organic layers were dried (MgSCL),
filtered and evaporated to give 124 (4.80 g, 64%) as a pale yellow oil; H NMR (300 
MHz, CDCfi) 8 h 5.29 and 5.22 (2H, m, C/Z^C), 3.64 (3H, s, CH3O), 3.22 (3H, s, 
CH3N), 1.97 (3H, s, CH3); 13C NMR (75 MHz, CDC13) 5C 171.6 (C=0), 140.2 
(C=CH2), 117.4 (C=CZZ2), 61.2 (OCH3), 33.3 (NCH3), 19.9 (CH3). The 
spectroscopic data are identical to those reported in the literature. 45
(/?)-2^-Dihydroxy-7V-Methoxy-2,7V-dimethylpropionamide (125).46 To a stirred 
solution of modified ADmix-a (16.0 g, containing an additional 42.0 mg of
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potassium osmate plus an additional 0.45 g of the chiral ligand (DHQD)2PHAL) in 
1:1 tert-butyl alcohol-water (60 mL) at 0 °C was added the Ar-methoxy-2,A^- 
dimethylacrylamide (1.50 g, 11.6 mmol). The mixture was stirred until the reaction 
was complete, as determined by TLC (~ 24 h). Ethyl acetate (50 mL) was added 
followed by sodium metabisulfite (22.0 g) and the solution was allowed to warm to 
20 °C with stirring. The separated aqueous layer was extracted with ethyl acetate (3 x 
50 mL) and the combined organic layers were dried (Na2S04), filtered and 
evaporated. Flash column chromatography (100% ethyl acetate) gave 125 (1.50 g, 
55%) as a yellow oil; H NMR (300 MHz, CDC13) 5H 4.57 (1H, bs, OH), 3.91 (1H, d, 
J  = 11.0, C=CHH), 3.61 (1H, d,J =  11.0, C=CH//), 3.74 (3H, s, OCH3), 3.28 (3H, s, 
NCH3), 2.66 (1H, bs, OH), 1.36 (3H, s, CH3); °C  NMR (75 MHz, CDC13) 6C 174.5 
(C=0), 76.0 (COH), 67.8 (CH2OH), 61.0 (OCH3), 33.6 (NCH3), 21.5 (CH3).
(i?)-3-(fe/t-Butyldimethylsilanyloxy)-2-hydroxy-Ar-methoxy-2^V-dimethylpropio- 
namide (126). Imidazole (3.34 g, 49.1 mmol) and /er/-butyldimethylsilyl chloride 
(4.40 g, 29.4 mmol) were added to a stirred solution of 2,3-dihydroxy-jV-methoxy- 
^Wdimethylpropionamide (2.0 g, 12.3 mmol) in dry dichloromethane (100 mL) at 0 
°C. The cloudy mixture was stirred at 20 °C for 14 h. Water (50 mL) was added and 
the resulting mixture was extracted with dichloromethane (3 x 50 mL); the combined 
organic layers were washed with brine (50 mL) and then dried (M gS04), filtered and 
evaporated. Purification by flash column chromatography (20:80 ethyl acetate: 
hexane) gave 126 (1.60 g, 60%) as a colourless oil; [a]o= + 10.9 (c 0.05, CHC13); IR
Vmax (cm 1) 3520 (OH), 1695 (C O ); H NMR (300 MHz, CDC13) 8H 4.03 (1H, d, J  =
10.0, C//HOTBS), 3.73 (3H, s, OCH3), 3.60 (1H, d, J  = 10.0, CH//OTBS), 3.27 (3H,
s, NCH3), 1.34 (3H, s, CH3), 0.85 (9H, s, SiC(Ctf3)3), 0.03 (6H, s, Si(C//3)2); ' 3C 
NMR (75 MHz, CDC13) 5C 174.7 (C O ), 76.4 (COH), 69.0 (OCH2), 60.8 (OCH3),
33.8 (NCH3), 25.8 (SiC(CH3)3), 21.2 (CH3), 18.2 (SiC(CH3)3), -3.6 (Si(CT/3)2); 
LRMS m/z (%)+CI 278 (M+, 10 %), 264 (20), 220 (10), 195 (35), 173 (30), 137 (65), 
120 (70), 89 (50); HRMS calcd for C ^ y N O aS i (M+H) 278.1787, found 278.1779.
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(l?)-l-(te/f-Butyldimethylsilanyloxy)-2-hydroxy-2-methyloct-4-yii-3-one (127). A
solution of pent-l-yne (1.50 g, 22.0 mmol) in dry tetrahydrofuran (25 mL) was 
treated dropwise at 20 °C with a solution of w-butyllithium (5.0 mL, 12.5 mmol, 2.5 
M in hexanes). The mixture was stirred at 20 °C for 30 min and then added slowly to 
a stirred solution of 3-(/er/-butyldimethylsilanyloxy)-2-hydroxy-Ar-methoxy-2,A- 
dimethylpropionamide (1.60 g, 5.86 mmol) in tetrahydrofuran (25 mL). The mixture 
was stirred at 20 °C for 20 min and then poured into saturated aqueous ammonium 
carbonate (100 mL). The layers were separated and the aqueous layer was extracted 
with diethyl ether (3 x 50 mL). The combined organic extracts were dried (MgSCL), 
filtered and evaporated. The residue was purified by column chromatography on 
silica gel (5:95 ethyl acetate: petroleum ether) to give 127 (1.30 g, 78%) as a pale 
yellow oil; [a]D = + 24.4 (c 0.04 in CHC13); IR v »  (cm 1) 3502 (OH), 2208 (alkyne 
group), 1692 (C=0); H NMR (300 MHz, CDClj) 5H 4.03 (1H, d, J  = 10.0, 
C//HOTBS), 3.56 (1H, d , ./ - 10.0, CH//OTBS), 2.39 (2H, t, J  = 7.0, O C C H 2), 
1.64 (2H, sextet, J  = 7.0, CH2), 1.33 (3H, s, CH3), 1.02 (3H, t, J  = 7.0, CH3), 0.85 
(9H, s, SiC(0 / 3)3), 0.04 (6 H, s, Si( 0 / 3 ) 2 ) ;  ‘3C NMR (75 MHz, CDC13) 6 C 191.0 
(C=0), 99.2 (O C C O ), 80.4 (COH), 78.4 (O C C O ), 69.0 (OCH2), 25.7 (SiCfC///),),
21.1 (CH2), 20.6 (CH2), 18.2 (CH3), 13.5 (CH2CH3), -3.6 Si(C//i)2; LRMS m/z 
(%)+CI 285 (M+, 85 %), 267 (90), 227 (35), 173 (8 ), 131 (5); HRMS calcd for 
C,5H2 8 0 3 Si (M+H) 285.1886, found 285.1878.
(l?)-2-(tert-Butyldimethylsilaiiyoxymethyl)-2-methyl-5-propylfuran-3-one (128).
To a stirred solution of l-(tert-butyldimethylsilanyloxy)-2-hydroxy-2-methyloct-4- 
yn-3-one (0.50 g, 1.76 mmol) in acetone (30 mL, HPLC grade) at 20 °C was added 
acidified mercury(II) sulfate solution (0.45 mL, 0.1 M obtained by dissolving yellow 
mercury(II) oxide in aqueous 2.5% H2 SO4). The mixture was stirred for 30 min then 
neutralized by the addition of powdered sodium hydrogen carbonate. The mixture 
was stirred for a further 1.5 h, filtered and the filtrate evaporated. The residue was 
dissolved in diethyl ether (20 mL) and the solution we washed with water (20 mL). 
The aqueous layer was extracted with diethyl ether (2 x 20 mL), and the combined 
extracts were washed with saturated aqueous sodium hydrogen carbonate (30 mL), 
then brine (30 mL), and dried over Na2 SC>4 , filtered and evaporated. The residue was 
purified by flash column chromatography on silica gel (10:90 ethyl acetate:
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petroleum ether) to give 128 (0.46 g, 92%) as a yellow oil; [a]o = -  112.9 (c 0.05, 
CHC13); IR (KBr, cm'1) v „  1687 (C=0), 1645 (C=C); H NMR (300 MHz, CDCI,) 
SH 5.38 (1H, s, CH=C), 3.76 (1H, d, J  = 11.0, C//HOTBS), 3.70 (1H, d, /  = 11.0, 
CH//OTBS), 2.47 (2H, t, J  = 7.5, CH2), 1.68 (2H, sextet, J  = 7.5, CH2), 1.28 (3H, s, 
CH3), 0.99 (3H, t, ./=  7.5, CH3), 0.83 (9H, s, SiC(CH3)2), 0.01 (6H, s, Si(CH3)2); ’’c  
NMR (75 MHz, CDCI,) 8C 205.5 (C=0), 193.1 (C=CHCO), 102.8 (C=CHCO), 91.2 
(OCH), 66.1 (C/72OTBS), 32.7 (CH2), 25.7 (SiC(CH3h), 19.6 (CH2), 18.2 
(SiC(CH3)3), 17.8 (CH2), 13.7 (CH3), -3.6 (Si(C'//3)2); LRMS m/z (%)+CI 285 (M+, 
100 %), 269 (40), 227 (70), 199 (5); HRMS calcd for Ci5H280 3Si (M+H) 285.1886, 
found 285.1891.
(.tf)-2-Hydroxymethyl-2-methyI-5-propyIfuran-3-one (110b). To a stirred solution 
of 2-(ter/-butyldimethylsilanyoxymethyl)-2-methyl-5-propylfuran-3-one (0.40 g,
1.41 mmol) in methanol (17 mL) at 20 °C was added hydrochloric acid (2.8 mL, 1.0 
M). After 24 h, the methanol was evaporated and the aqueous residue was extracted 
with ether ( 3 x 5  mL). The organic layers were then washed with 5% aqueous 
sodium carbonate ( 2 x 5  mL) followed by brine (5 mL), and then dried over M gS04, 
filtered and evaporated. Flash column chromatography (30:70 ethyl acetate: 
petroleum ether) gave 110b (0.20 g, 83%) as an orange oil; [a]o = + 67.1 (c 0.07, 
CHCI3). The spectroscopic data was identical to that of 110b stated earlier.
Enantiomeric excess of 110b was determined by 1HNMR analysis of 
the Moshers ester derivative, prepared by the general procedure described for HOq. 
The vinyl peak for the major enantiomer was at 5.36 ppm and for the minor 
enantiomer at 5.43 ppm; H NMR (300 MHz, CDCI3) 8h 7.46 (2H, m, phenyl), 7.40 
(3H, m, phenyl), 5.43 (1H, s, CH=C minor enantiomer), 5.36 (1H, s, CH=C major 
enantiomer), 4.47 (2H, m, CH2O), 3.50 (3H, s, OCH3), 2.33 (2H, t, J  = 7.6 Hz, 
CHjC=CK)9 1.53 (2H, m, CH2), 1.38 (3H, s, CH3), 0.92 (3H, t, J=  7.6 Hz, CH3).
(5')-(-)-2-Acetoxysuccinic anhydride (132).63 A mixture of (5)-malic acid (3.2 g,
23.9 mmol) and acetyl chloride (26.5 g, 0.34 mol) was heated to 40 °C with stirring 
for 2 h. The excess acetyl chloride and acetic acid/anhydride were removed in 
vacuo. The white residue (3.6 g, 95%) of 132 was used in the next step without
further purification; H NMR (300 MHz, CDC13) 8H 5.72 (1H, dd, J  = 9.0 and 6.0
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Hz, OCH), 3.37 (1H, dd, J  = 19.0 and 9.0 Hz, C//HCO), 3.01 (1H, dd, J  = 19.0 and
6.0 Hz, CH//CO), 2.19 (3H, s, CH3C=0); 1?C NMR (75 MHz, CDC13) 5C 169.6 
(CH3 O O ), 167.1 (C=0), 166.1 (C=0), 67.5 (OCH), 35.1 (CH20), 20.2 (CH3).
(S)-3-Acetoxy-4-oxodec-5-ynoic acid (133). To a stirred solution of (S)-(-)-2- 
acetoxysuccinic anhydride (2.0 g, 12.7 mmol) in tetrahydrofuran (10 mL) at -  78 °C 
was added dropwise during 25 min a freshly prepared solution 1-lithio hexyne 
(prepared by treating a solution of «-hexyne (0.93, 11.4 mmol) in tetrahydrofuran ( 8  
mL) with a n-butyllithium (4.6 mL, 11.4 mmol, 2.5 M in hexanes) at -  78 °C, 
followed by stirring for 30 min). After addition, the mixture was stirred for 10 min, 
then quenched by addition to saturated aqueous ammonium chloride (20 mL). The 
aqueous layer was extracted with ether (3 x 20 mL) and the combined organic layers 
were dried over MgSCL, filtered and evaporated to give crude 133 (2.3 g, 76%) as a 
red oil; [a]D = -  24.5 (c 0.14, CHC13); IR vmax (cm 1) 3510 (C 0 2H), 2214 (alkyne
group), 1680 (C O ); H NMR (300 MHz, CDC13) 5H 8.94 (1H, bs, C 0 2H), 5.48 (1H, 
t, J=  4.0 Hz, OCH), 3.05 (1H, dd, J  = 17.0 and 4.0 Hz, CH //C 0 2H), 2.86 (1H, dd, J  
= 17.0 and 8.0 Hz, C //H C 0 2H),), 2.40 (2H, t, J  = 7.0 Hz, CH2C=C\ 2.16 (3H, s, 
CH3C O ), 1.57 (2H, m, CH2), 1.44 (2H, m, CH2CH3), 0.92 (3H, t ,J = 7 .0  Hz, CH3); 
13C NMR (75 MHz, CDC13) 5C 182.1 (C O ), 174.9 (COOH), 169.7 (CH3C O ), 99.7 
(CO CO ), 78.0 (C O C O ), 74.4 (OCH), 35.1 (CH2), 29.5 (CH2), 21.9 (CH2), 20.5 
(CH3), 18.8 (CH2), 13.4 (CH3); LRMS m/z (%)+CI 241 (M+H, 52 %), 223 (40), 199 
(15), 181 (100), 163 (70), 137 (20), 109 (55), 81 (9), 61 (12); HRMS calcd for 
Ci2H160 5 241.1076 (M+H), found 241.1078.
(5)-2-Trifluoroacetoxyl succinic anhydride (134).64 (S)-Malic acid (1.90 g, 14.9 
mmol) was placed in a 20 mL round-bottomed flask and cooled to 0 °C. 
Trifluoroacetic anhydride (4 mL, 32.8 mmol) was added and the suspension was 
stirred, within 15 min the solution became homogenous. After 2 h at 0 °C, the 
trifluoroacetic acid formed and excess trifluoroacetic anhydride were removed by
vacuum distillation to give 134 (2.25 g, 75%) as a white solid; H NMR (300 MHz, 
CDC13) 5h 5.90 (1H, dd, J =  9.5 and 7.5 Hz, C//OH), 3.54 (1H, dd, J=  19.0 and 9.5 
Hz, C //H C O ), 3.22 (1H, dd, J=  19.0 and 7.5 Hz, C H //C O ); '3C NMR (75 MHz,
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CDCI3) 5c 170.5 (C=0), 168.3 (O O ), 167.6 (C=0), 123.6 (CF3), 69.5 (OCH), 30.7 
0CH2CO).
(5)-3-Hydroxy-4-oxodec-5-ynoic acid (130). To a stirred solution of (S)-(-)-2- 
trifluoroacetoxysuccinic anhydride (2.0 g, 9.43 mmol) in tetrahydrofuran (10 mL) at 
-  78 °C was added dropwise during 25 min a freshly prepared solution of lithiated 
hex-l-yne (prepared by treating a solution of «-hexyne (0.70 g, 8.5 mmol) in 
tetrahydrofuran (8.0 mL) with «-butyllithium (3.43 mL, 8.58 mmol, 2.5 M in 
hexanes) at -  78 °C followed by stirring for 30 min). After addition, the mixture was 
stirred for 1 0  min and then quenched by addition to saturated aqueous ammonium 
chloride (20 mL). Then the aqueous layer was extracted with ether (3 x 20 mL) and 
the organic layers were dried over M gS04, filtered and evaporated to give 130 (0.93 
g, 50%) as a red oil; [<x]D = + 75.8 (c 0.06 in CHCfi); IR vmax (cm'1) 3485 (C 0 2H), 
3369 (OH), 2212 (alkyne group), 1683 (C O ); H NMR (300 MHz, CDC13) 5H 8.00 
(1H, bs, COOH), 4.66 (1H, dd, J=  7.0 and 4.0, CHOH), 3.03 (1H, dd, J=  16.6, 4.0, 
CHHCOOH), 2.81 (1H, dd, J  = 16.6 and 7.0, CH//COOH), 2.42 (2H, t, J  = 7.0,
CH2C=C), 1.60-1.38 (4H, m, CH2CH2), 0.91 (3H, t, J  = 7.0, CH3); 13C NMR (75 
MHz, CDCI3) 5C 186.8 (C O ) , 175.8 (COOH), 101.7 (COCO ), 83.0 (CO CO ), 74.5 
(CHOH), 38.2 (CH2COOH), 29.6 (CH2), 21.9 (CH2), 18.9 (CH2), 13.4 (CH3); LRMS 
m/z (%)+CI 199 (M+, 75 %), 181 (71), 155 (100), 137 (70), 109 (70), 99 (20), 85 
(30), 69 (20); HRMS calcd for C 10H 14O4 (M+H) 199.0970, found 199.0961.
((S)-5-Butyl-3-oxo-2,3-dihydrofuran-2-yI) acetic acid (129). To a stirred solution 
of 3-hydroxy-4-oxodec-5-ynoic acid (0.20 g, 1.01 mmol) in acetone (20 mL, HPLC 
grade) at 20 °C was added acidified mercury sulfate solution (0.45 mL, 0.1 M 
obtained by dissolving yellow mercury11 oxide in aqueous 2.5% H2 S04). The mixture 
was stirred for 30 min then neutralized by the addition of powdered sodium hydrogen 
carbonate. The mixture was stirred for a further 1.5 h, filtered and the filtrate 
evaporated. The residue was dissolved in ether (15 mL) and the solution was washed 
with water (25 mL). The aqueous layer was extracted with ether ( 2x15  mL), and the 
combined extracts were washed with saturated aqueous sodium hydrogen carbonate 
(30 mL) then brine (30 mL), and dried over Na2 S04, filtered and evaporated. The 
residue was purified by flash column chromatography (30:70 ethyl acetate:
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petroleum ether) to give 129 (0.16 g, 80%) as a yellow oil; [a]D= + 25.0 (c 0.03 in 
MeOH); IR Vmax (cm-1) 3546 (OH), 1673 (C=0), 1648 (C=C); H NMR (300 MHz, 
CDClj) 5h 9.70 (1H, bs, COOH), 5.51 (1H, s, CH=C), 4.82 (1H, dd ,./ = 9 . 0  and 3.4, 
OCH), 3.04 (1H, d d ,./ = 17.0 and 3.4, C//HCOOH), 2.63 (1H, d d ,J  = 17.0 and 9.0, 
CHtfCOOH), 2.51 (2H, t, J = 1.5, CH2C=C), 1.61 (2H, m, CH2), 1.40 (2H, m, CH2),
0.93 (3H, t, J  = 7.0, CHj); '3C NMR (75 MHz, CDClj) 5C 203.4 (C=0), 195.1 
(O C H ), 174.4 (COOH), 103.2 (C=CH), 81.4 (OCH), 35.7 (CH2C 0 2H), 30.5 (CH2),
28.0 (CH2), 22.2 (CH2), 13.6 (CH3); LRMS m/z (%)+CI 199 (M+, 100 %), 181 (40), 
153 (40), 127 (20), 99 (10), 85 (50), 69 (10), 58 (60); HRMS calcd for Ci0H |4O4 
(M+H) 199.0970, found 199.0959.
Ethyl (£)-3-(methoxymethylcarbamoyl)-acrylate (136). Isobutyl chloroformate 
(0.95 g, 6.94 mmol) was added to a solution of but-2-enedioic acid monoethyl ester 
(1.0 g, 6.94 mmol) and 4-methylmorpholine (1.40 g, 13.9 mmol) in dichloromethane 
(50 mL) at 0 °C. After stirring for 20 min, N, Odimethylhydroxylamine 
hydrochloride (0.70 g, 6.94 mmol) was added and the resulting solution was stirred 
at 0 °C for 20 min, then at 20 °C for 2 h. The mixture was partitioned between water 
(50 mL) and dichloromethane (2 x 50 mL) and the combined organic layers were 
dried (MgSCL), filtered and evaporated to give 136 (1.10 g, 85%) as a light red oil; 
H NMR (300 MHz, CDC13) 5H 7.70 (1H, d, J=  15.5, CH=CHCO), 6.90 (1H, d, J  = 
15.5, C H C //C O ), 4.26 (2H, q, J  = 7.0, OCH2), 3.73 (3H, s, OCH3), 3.27 (3H, s, 
NCH3), 1.31 (3H, t, J  = 7.0, CH3); °C  NMR (75 MHz, CDC13) 8 C 165.6 (C=0),
164.7 (C=0), 132.5 (CH=C7/CO), 131.6 (CH=CHCO), 62.2 (OCH3), 61.2 (OCH2),
32.4 (NCH3), 14.1 (CH3). The spectroscopic data are identical to those reported in 
the literature.65
Ethyl (£)-4-oxodec-2-en-5-ynoate (137). A solution of hex-l-yne (1.45 g, 17.6 
mmol) in dry tetrahydrofuran (25 mL) was treated dropwise at -78 °C with a solution 
of «-butyllithium in hexanes (4.8 mL, 12.0 mmol, 2.5 M). The mixture was stirred at 
-78 °C for 30 min. This mixture was then added to a solution of ethyl (E)-3- 
(methoxymethylcarbamoyl)-acrylate (1.50 g, 8.02 mmol) in dry tetrahydrofuran (100 
mL). The mixture was stirred at -78 °C for 1 h, and then poured into saturated 
aqueous ammonium carbonate (30 mL). The layers were separated and the aqueous
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layer was extracted with ether (3 x 30 mL). The combined organic extracts were 
dried (MgS0 4 ), filtered and evaporated. The residue was purified by column 
chromatography (5:95 ethyl acetate: petroleum ether) to give 137 (0.60 g, 39%) as an
orange oil; ER vmax(cm'1) 2227 (alkyne group), 1691 (C=0), 1643 (C=C); ]H NMR 
(300 MHz, CDC13) 5h 6.92 (2H, m, CH=CH), 4.25 (2H, m, CH20), 2.44 (2H, t, J  =
7.0, CH2), 1.61 (2H, m, CH2), 1.44 (2H, m, CH2), 1.36 (3H, t, J  = 7.0, CH3), 0.94 
(3H, t, J=  7.0, CH3); 13C NMR (75 MHz, CDC13) 5C 177.3 (C=0), 156.1 (EtO O O ),
141.0 (CH=C/7CO), 135.2 (C7/=CHCO), 97.2 (O CCO ), 79.1 (C=CCO), 61.6 
(OCH2), 29.7 (CH2), 22.0 (CH2), 19.0 (CH3), 18.8 (CH2), 13.5 (CH3); LRMS m/z 
(%)+CI 209 (M+H, 15 %), 196 (40), 166 (22), 146 (10), 135 (20), 109 (100), 91 (10), 
79 (25), 65 (10), 53 (15); HRMS calcd for Ci2Hi6 0 3 209.1178 (M+H), found 
209.1174.
Ethyl-4-hydroxybut-2-enoate (138).66 But-2-enedioic acid monoethyl ester (3.0 g,
20.8 mmol) was dissolved in anhydrous THF (90 mL) at 0 °C under an atmosphere 
of nitrogen, the mixture was treated with (CH3)2 S.BH3 (17.7 mL, 35.4 mmol, 2.0 M 
in THF). After 2 h, water (12 mL) was carefully added, followed by K2C 0 3 (2.4 g). 
The reaction mixture was extracted with ether (3 x 60 mL). The residue obtained 
after evaporation o f the dried organic layers provided 138 (2.1 g, 69%) as a pale 
yellow oil, which was used in the next step without further purifications.
Ethyl-4-oxobut-2-enoate (139).67 Ethyl-4-hydroxybut-2-enoate (0.40 g, 3.1 mmol) 
was reacted as for 108a to give a residue that was purified by flash column 
chromatography (10:90, ethyl acetate: hexanes) to give 139 (0.20 g, 51%) as a pale 
yellow oil; *H NMR (300 MHz, CDC13) 5H 9.74 (1H, d , J =  7.0 Hz, CHO), 6.92 (1H, 
dd, / =  7.0 and 16.0 Hz, CH=C/fC=0), 6.73 (1H, d, J =  16.0 Hz, CH= CHCO), 4.23 
(2H, q, J  = 7.0 Hz, OCH2), 1.28 (3H, t, J  = 7.0 Hz, CH3); BC NMR (75 MHz, 
CDC13) 6 c 192.5 (0= 0), 164.8 (EtO O O ), 140.3 (CH=C//CO), 139.4 (C//=CHCO),
61.7 (OCH2), 14.0 (CH3).
Ethyl-4-oxobut-2-enoate (139).51,68 A saturated solution of solvent red 19 in (2.15 
mg, 4.3 mL, 0.05%,) ethanol was added to a solution of ethyl sorbate (6.0 g, 42.9 
mmol) in ethanol (182 mL) in a 250 mL round-bottomed flask. The resultant
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mixture was submitted to ozonization for 2  h, then reduction with dimethyl sulfide 
(6.43 mL) over 24 h at 20 °C. The solvent was evaporated to give 139 (5.3 g, 96%) 
as a pale yellow oil. The spectroscopic data was identical to that of 139 obtained 
from the previous method.
Ethyl-4-hydroxydec-2-en-5-ynoate (141). A solution of hex-l-yne (0.86 g, 10.5 
mmol) in dry tetrahydrofuran (25 mL) was treated dropwise at - 78 °C with a 
solution of tf-butyllithium in hexanes (3.70 mL, 14.0 mmol, 2.5 M). The mixture 
was stirred at - 78 °C for 30 min, the mixture was added dropwise to a solution of 
ethyl-4-oxobut-2-enoate (1.0 g, 11.7 mmol) in tetrahydrofuran (20 mL). The mixture 
was stirred at - 78 °C for 1 h and then poured into saturated aqueous ammonium 
chloride (30 mL). The layers were separated and the aqueous layer was extracted 
with ether (3 x 30 mL). The combined organic extracts were dried (MgSCL), filtered 
and evaporated. The residue was purified by column chromatography (30:70 ethyl 
acetate: petroleum ether) to give 141 (5.0 g, 6 8 %) as an orange oil; IR vmax (cm'1) 
3395 (OH), 2212 (alkyne group), 1621 (C=C); H NMR (300 MHz, CDC13) 5H 6.89 
(1H, dd, J  = 4.0 and 11.0 Hz, C7/=CHCOH), 6.12 (1H, dd, J  = 2.0 and 15.0 Hz 
CH=C//COH), 5.00 (1H, s, CHOH), 4.20 (2H, q, J  = 7.0 Hz, OCH2), 3.73 (2H, m, 
CH2), 2.23 (2H, m, CH2), 1.84 (2H, m, CH2), 1.29 (3H, t , J=  7.0 Hz, CH3), 0.90 (3H,
t, J  = 7.0 Hz, CH3); 13C NMR (75 MHz, CDC13) 5C 166.2 (C=0), 145.7 
(CH=CtfCOH), 121.5 (C//=CHCOH), 88.3, (OCCOH), 77.5 (C=CCOH), 68.0 
(CHOH), 61.6 (CH2), 25.6 (CH2), 22.0 (CH2), 18.4 (CH2), 14.2 (CH3), 13.6 (CH3); 
LRMS m/z (%)+CI 209 (100), 181 (40), 135 (30), 109 (75), 71 (38); HRMS calcd 
for Ci2H 180 3 210.1256, found 210.1261.|
Ethyl (£)-4-oxodec-2-en-5-ynoate (137). Ethyl-4-hydroxydec-2-en-5-ynoate (1.0 
g, 4.8 mmol) was reacted as for 108a to give a residue which was purified by column 
chromatography (5:95 ethyl acetate: petroleum ether) to give 137 (0.65 g, 65%) as an 
orange oil. The spectroscopic data were identical to that of 137 given above.
Ethyl (25,3S)-2,3-dihydroxy-4-oxodec-5-ynoate (142). To a stirred solution of 
modified ADmix-p (7.0 g, containing an additional 14.0 mg of potassium osmate) in 
1:1 tert-butyl alcohol-water (38 mL) was added sodium hydrogen carbonate (0.97 g,
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11.5 mmol) and methanesulfonamide (0.37 g, 3.85 mmol) at 0 °C. A solution of 
ethyl (£)-4-oxodec-2-en-5-ynoate (0.80 g, 3.85 mmol) in toluene (1 mL) was added 
and the mixture was stirred until the reaction was complete as determined by TLC (~ 
24 h). Ethyl acetate (20 mL) was added followed by sodium metabisulfite (5.8 g) 
and the stirred solution was allowed to warm to 20 °C. The separated aqueous layer 
was extracted with ethyl acetate (2 x 20 mL) and the combined organic layers were 
washed with aqueous sodium hydroxide (35 mL, 1 M), dried (Na2 SC>4 ), filtered and 
evaporated. Flash column chromatography of the residue (30:70 ethyl acetate: 
petroleum ether) gave 142 (0.64 g, 60%) as an orange oil; [a]D = + 56.7 (c 0.02,
CHC13); IR vma, ( c m ') 3390 (OH), 2210 (alkyne group), 1692 (C=0); H NMR (300 
MHz, CDC13) SH 4.80 (1H, s, CHOH), 4.59 (1H, s, CHOH), 4.35 (2H, q ,./ = 7.0 Hz, 
CH20), 2.46 (2H, t, J  = 7.0 Hz, CH2C=C), 1.59 (2H, m, CH2), 1.46 (2H, m, CH2), 
1.35 (3H, t, J  = 7.0 Hz, CH3), 0.93 (3H, t, J  = 7.0 Hz, CH,); A  NMR (75 MHz, 
CDCI3) 8 c 184.7 (0= 0), 171.5 (EtOC=0), 101.9 (C=CCO), 85.2 (C=CCO), 79.5 
(CHOH), 71.4 (CHOH), 62.6 (OCH2), 29.5 (CH2), 22.0 (CH2), 19.0 (CH2), 14.2 
(CH3), 13.5 (CH3); LRMS m/z (%)+CI 243 (M+H, 8  %), 215 (50), 197 (20), 179 
(15), 169 (20), 161 (5); HRMS calcd for C,2Hi80 5 243.1232 (M+H), found 
243.1244.
3-((5)-5-Butyl-3-oxo-2,3-dihydro-furan-2-yl)-3S'-hydroxy-propionic acid ethyl 
ester (143). To a stirred solution of ethyl 2,3-dihydroxy-4-oxodec-5-ynoate (0.60 g,
2.5 mmol) in acetone (60 mL, HPLC grade) at 20 °C was added acidified mercury 
oxide solution (0.45 mL, 0.1 M HgO in 2.5 % H2 SO4). The mixture was stirred for 
30 min then neutralized by the addition of powdered sodium hydrogen carbonate. 
The mixture was stirred for a further 1.5 h, filtered and the filtrate evaporated. The 
residue was dissolved in ether (15 mL) and the solution was washed with water (25 
mL). The aqueous layer was extracted with ether ( 2 x 1 5  mL), and the combined 
organic extracts were washed with saturated aqueous sodium hydrogen carbonate (30 
mL) then brine (30 mL), and dried over NaiSCL, filtered and evaporated. The 
residue was purified by flash column chromatography on silica gel (30:70 ethyl 
acetate: petroleum ether) to give 143 (0.37 g, 62%) as a yellow powder; [(x] d  = ~
133.3 (c 0.03, CHCI3 ); IR vmax (cm*1) 3387 (OH), 1689 (C=0), 1643 (C=C); H NMR 
(300 MHz, CDCI3) 5h 5.48 (1H, s, CH=C\ 4.78 (1H, d, J  = 5.6, CHOH), 4.73 (1H,
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d, J  = 5.6, CHOH), 4.31 (2H, q, J  = 7.0 Hz, OCH2), 2.51 (2H, t, J  = 7.0 Hz, CH2),
1.60 (4H, m, CH2), 1.36 (3H, t, J  = 7.0 Hz, CH3), 0.93 (3H, t, J  = 7.0 Hz, CH3); 13C 
NMR (75 MHz, CDC13) 6C 201.1 (C=0), 195.7 (C=CO), 171.7 (C 02Et), 104..4 
(C//=C), 85.8 (OCH), 69.5 (OCH), 62.7 (OCH2), 30.4 (CH2), 28.1 (CH2), 22.2 
(CH2), 14.1 (CH3), 13.7 (CH3); LRMS mlz (%)+CI 242 (M+H, 5 %), 200 (7), 169 
(100), 149 (60), 113 (10), 97 (30), 69 (15); HRMS calcd for Ci2Hi80 5 242.1154 
(M+H), found 242.1157.
Attempted synthesis of 3-((5)-5-Butyl-3-oxo-2,3-dihydro-furan-2-yl)-propionic 
acid ethyl ester, (a) Thiocarbonyldiimidazole (0.10 g, 1.25 mmol) was added 
quickly to a stirred solution of furanone 152 (0.10 g, 0.41 mmol) in tetrahydrofuran 
(4 mL). The reaction mixture was stirred at 65 °C for 12 h, in the dark, and then the 
solution was evaporated. The resulting residue was dissolved in 5:1 ethyl acetate: 
dichloromethane (10 mL), washed successively with aqueous hydrochloric acid (2.5 
mL), saturated aqueous sodium hydrogen carbonate (4 mL) and brine (4 mL), and 
dried over M gS04, filtered then evaporation gave the thiol (80 mg, 57 %) as a pale 
yellow oil.
(b) To a stirred solution of tributyltin hydride (0.25 g, 0.85 mmol) and 
azobisisobutyronitrile, AIBN, (7.0 mg, 4.26 x 10"5 mol) in toluene (5 mL) at 75 °C 
was added dropwise a solution of thiol (0.10 g, 0.28 mmol) in toluene (1 mL). The 
solution was then stirred at 75 °C for 90 min and then evaporated to give an oil, 
which was shown to be a mixture of components by TLC and so it was not treated 
further.
(i?)-2-((5)-l-Hydroxy-propyl)-2-methyl-5-phenylfuran-3-one (llOh). To a stirred 
solution of 4,5-dihydroxy-4-methyl-l-phenylhept-l-yn-3-one (75 mg, 0.32 mmol) in 
tetrahydrofuran (2 mL) was added PdCl2 powder (1.7 mg, 6.46 x 10'3 mmol) at 20 °C 
and stirring was continued for 24 h. The reaction was quenched by the addition of pH 
7 phosphate buffer (2 mL), and extracted with ethyl acetate ( 3 x 3  mL). The 
combined organic extracts were washed with brine (3 mL), dried (Na2S 04), filtered 
and evaporated. The residue was purified by flash column chromatography (30:70
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ethyl acetate: petroleum ether) to give llOh (62 mg, 0.27 mmol) as an orange oil. 
Spectroscopic data were identical with those described above.
Enantiomeric excess of 11 Oh was determined by HPLC analysis using a 
Chiralcel OJ column (50:50 ethanol: w-hexane, X=210 nM), the major enantiomer 
eluting after 5.32 min and the minor enantiomer after 6.84 min.
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Chapter 3
Towards the Synthesis of (-)-Pestalotin using Sharpless Asymmetric
Dihydroxylation
3.1. Introduction
(-)-Pestalotin 85 is a gibberellin synergist which was first isolated from the culture
filtrate of the phytopathogenic fungus Pestaltia cryptomeriaecola by Kimuro and co-
1 2workers ’ it has also been obtained from an unidentified Penicillium species by 
Ellestad and co-workers. 3 Pestalotin has a 5,6-dihydro-4-methoxy-2//-pyran-2-one 
skeleton with one hydroxy group on the side-chain. The absolute configuration of 
the (-)-enantiomer was identified as 6S, IS  (Figure 3.1).
OH
85
Figure 3.1: The structure of (-)-pestalotin.
The presence of two contiguous asymmetric centres in (-)-pestalotin 85 has made it 
an attractive synthetic target. To date, more than ten total syntheses of 85 have been 
reported, this includes the synthesis of (rac)-pestalotin4,5 as well as its optically 
active forms, 6 ' 16 in these syntheses the asymmetric centres were usually prepared in a 
stepwise manner resulting in poor diastereoselectivity.
OMe
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3.2 Several Syntheses of (6S,lS)-(-)-Pestalotin Reported in the Literature
Scheme 3.1 illustrates the total synthesis of 85 carried out by Hagiwara and co­
workers, 16 which applied a Lewis acid-mediated aldol addition of the bis- 
trimethylsilyl enol ether 146 with 2-benzyloxyhexanal 147 to generate the syn 1,2- 
glycol derivative 148 in high vyn-diastereoselectivity (Table 3.1). The syn- 
diastereoselectivity was established by an intramolecular chelation of the metal 
cation with the carbonyl group of 147 and the neighbouring alkoxy group forming a 
conformationally rigid system thus allowing stereofacial control in the nucleophilic 
addition of the enolate 146.
OM e
146
"OMe'OM e +
(a )-(b )
‘OM e'OM e
O C H 2Ph
syn 150 anti 151
'OM e
OH
rac 85
'OM e
OH
85
31 %  overall yield
Scheme 3.1. Reagents and conditions', (a) NaOH(aq), THF, 20 °C, 30 min, then HC1; 
(b) Me2 S 0 4, K2C 0 3, acetone, 20 °C, 45 h, 72% over two steps; (c) H2, 5% Pd/C, 
EtOAc, 20 °C, 46 h, 65%.
The requisite (S)-(-)-2-benzyloxyhexanal 147, was prepared in five steps staring from 
(,S,).(-).2-aminohexanoic acid (Z-norleucine, 97% optically pure) (S)-152 (Scheme 
3.2). (S)-(-)-2-Aminohexanoic acid 152 was initially treated with sodium nitrate in
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dilute sulphuric acid to give (S')-(-)-2-hydroxyhexanoic acid. After esterification 
with diazomethane, methyl (S)-(-)-2-hydroxyhexanoate 153 was protected as the 
corresponding benzyl ether using benzyl bromide and silver oxide as the base, these 
conditions were necessary in order to avoid epimerisation at C-2. 17 The resulting 
(5)-(-)-2-benzyloxyhexanoate was reduced with lithium aluminium hydride (LiAlH4) 
to (1S)-(-)-2-benzyloxyhexanol 154 and this was subsequently oxidised following 
Swem’s method to give the required (5)-(-)-2-benzyloxyhexanal 147. High-pressure 
liquid chromatography (HPLC) analysis of the intermediate compounds indicated 
that no epimerisation of the 2-benzyloxy group of compound 147 occurred during the 
reactions described in Scheme 3.2.
O C H 2Ph
(S)-147
Scheme 3.2. Reagents and conditions', (a) NaNCh, H2 SO4 , H2O, 20 °C, 23 h, 71%; 
(b) CH2N 2 , Et2 0 , quantitative yield; (c) Ag2 0 , PhC ^B r, Et2 0 , 35 °C, 30 min; (d) 
LiAlH4, Et2 0 , 0  °C, 30 min, 74% over two steps; (e) (COCl)2 , Me2 SO, Et3N, CH2CI2 , 
- 60 °C, 1 h, 44%.
The results of the aldol reaction of Z>A-trimethylsilyl enol ether 146 with (S)-(-)-2- 
benzyloxyhexanal 147 are summarized in Table 3.1. The highest diastereofacial 
selectivity (98%) was achieved when the enol ether 146 was added at - 8 6  °C to a 
solution of (S)-(-)-2-benzyloxyhexanal 147 and TiCl4 (Table 3.1, entry 1). Also 
since no selectivity was observed when TiCl4 was added to the mixture of 146 and 
147 (Table 3.1, entry 6 ), it is the initial complexation of the benzyloxyaldehyde 
moiety of 147 with TiCl4 that is responsible for the high s>7?-diastereoselectivity 
observed (Scheme 3.3).
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TMSO OTMS
Scheme 3.3: Chelation model leading to the syn diastereoisomer.
Table 3.1: Diastereoselective aldol addition to give the syn glycol derivative 148.
Entry Lewis acid Products ratio 
syn 148 :anti 149
Yield (%)
1 TiCl4 99:1 6 6
2 SnCl4 89:11 56
3 BF3 .OEE 71:29 79
4 EtAlCl2 53:47 42
5 ZnCl2 86:14 37
6 TiCl4 54:46 80
When zinc chloride was used Table (3.1; entry 5), the trimethylsilyl ether of the aldol 
product, 156, along with the pyranone 157, a Danishefsky-type hetero Diels-Alder 
reaction product, were isolated in 37% and 9% yield, respectively (Scheme 3.4).
OMe
TMSO O O
OCH2Ph OCH2Ph
Syn- and anti-156 Syn- and anti-151
Scheme 3.4: Zinc chloride-mediated aldol condensation reaction.
The lactonization of an inseparable mixture of 148 and 149 followed by methylation 
with dimethyl sulphate gave the lactonic methyl ethers 150 and 151 (Scheme 3.1). 
Deprotection of the benzyl group furnished (-)-pestalotin 85 in a 31% overall yield.
Zhang and co-workers applied the isoxazoline 161 in the preparation of the p,y- 
dihydroxy keto ester rac-148, a key precursor of raopestalotin (Scheme 3.5) . 13
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Cycloaddition of acetohydroximoyl chloride 166 with allyl alcohol 167 provides rac- 
168 as a 1:1 mixture of syn- and anti-isomers. Swem oxidation followed by addition 
of excess of L-selectride provided rac- 158 as a 99:1 mixture of syn- and ^//-isomers. 
Rac-160 was benzylated, and this was followed by deprotonation of the isoxazoline 
160, carboxylation and treatment of the resulting acid with diazomethane to give rac­
i a l  in 70% yield. Reduction of rac-161 with Raney Ni and hydrogen in aqueous 
methanol followed by brief exposure of the crude product to aqueous hydrochloric 
acid provided the keto ester rac-148 which was converted into rac-pestalotin using 
the method described by Hagiwara and co-workers (Scheme 3.1), where the rac- 148 
was lactonized under basic conditions, and the lactone was O-methylated and 
debenzylated to give racemic pestalotin (rac-85) in 56% overall yield.
N—O
(rac) - 161 <->®n (rac)-148
Scheme 3.5. Reagents and conditions: (a) Et3N, Cdrk>, 25 °C, 16 h; (b) (COCl)2 , 
Me2 SO, Et3N, THF, -78 °C, 40 min; (c) I-Selectride, THF, -78 °C, 6  h, then NaOH 
and 30% H20 2(aq), 25 °C, 2 h; (d) NaH, BnBr, NBu4, THF, 25 °C, 6  h; (e) Lithium 
tetramethylpiperidide (LTMP), C 0 2, THF, -90 °C, 4 h; (f) CH2N2, Et20 , 25 °C, 1 h; 
(g) Raney Ni, H2, MeOH-H20  15:1, 25 °C, 20 min; (h) 10% HC1, 25 °C, 15 min.
Scheme 3.6 describes the required modification to prepare enantiomerically pure 160 
which was then applied in the total synthesis of (-)-pestalotin. 15 The cycloaddition of 
158 and the acrylate derivative of Oppolzer’s camphor sultam 162 gave the 
isoxazoline 163 and its diastereoisomer (not shown) in a ratio of 94:6. The auxiliary 
was cleaved by reduction with Z.-selectride to generate optically pure alcohol 164 
(71%). Swem oxidation of 164, followed by addition of butylmagnesium bromide 
provided a mixture of 160, but enriched in the incorrect isomer for the pestalotin 
synthesis (syn/anti, 15:85). This mixture was subjected to Swem oxidation followed 
by L-selectride reduction to provide syn-160 as a single diastereoisomer which was
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isolated in 82% yield. (-)-Pestalotin 85 was then prepared using the same steps as for 
the racemic synthesis, outlined in Scheme 3.5.
,O H
Cl
1 5 8
(a)
90%
N -O .  II Xc
1 6 2  S ° 2  1 6 3  
(e )-(d ) 160-5VW  / 1 6 0 - and (eM 0
(b)
71%
1 6 0  -5V7J
76% 15:85 82%
1 6 4
Scheme 3.6. Xc refers to Oppolzer’s auxiliary. Reagents and conditions: (a) Et3N, 
C6H6 , 25 °C, 12 h; (b) Z-Selectride, THF, -78 °C, 8  h, then NaOH and 30% H20 2(aq), 
25 °C, 2 h; (c) (COCl)2, Me2 SO, Et3N, THF, -78 °C, 40 min; (d) C4H9MgCl, THF, 
-78 °C, 4 h; (e) (COCl)2, Me2 SO, Et3N, CH2C12, -78 °C, 40 min; (f) I-Selectride, 
THF, -78 °C, 6  h, then NaOH and 30% H20 2 (aq), 25 °C, 2 h.
The Sharpless asymmetric dihydroxylation (AD) reaction permits the highly 
stereoselective establishment of two adjacent stereogenic centres and thus has 
become an important reaction in natural product synthesis, including that of (-)- 
pestalotin (Scheme 3.7) . 13
Scheme 3.7. Reagents and conditions: (a) CC14, PPh3 , 25 °C, 48 h; (b) methyl 
propiolate, DBU, Cul, phenothiazine, NH2 0H.H 20 , HMPA/THF, 60 °C, 2 h; (c) 
ADmix-ct, CH3 S 0 2NH2, 0 °C, 4 h; (d) MeONa, MeOH, 0 °C, 24 h.
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Wang and Shen described the synthesis of (-)-pestalotin and its enantiomer in four 
steps using commercially available 2-hepten-l-ol 165 as the starting material 
(Scheme 3.7) . 13 The allylic alcohol 165 was converted to the chloride 166 using the 
triphenyl phosphine-carbon tetrachloride system. Reaction of 166 with methyl 
propiolate in the presence of Cul and DBU in a mixed solvent system (THF/ HMPA) 
gave the alkylated product 167 in a 65% yield. The enyne 167 was then treated with 
ADmix-a in the presence of methanesulfonamide to furnish the diol 168. Treatment 
of 168 with NaOMe-MeOH followed by acidification afforded the lactonized 
Michael adduct (-)-pestalotin 85. Its enantiomeric excess was shown to be 90% by 
analysis of the lH NMR data of the corresponding (R)-MTPA ester. The overall 
yield from 165 was 53% . 13 Similarly, dihydroxylation of 167 with ADmix-p instead 
of ADmix-a followed by Michael addition and lactonization afforded (+)-pestalotin 
85 which was shown to be 95% ee by the same method mentioned above.
3.3 Results and Discussion
The mercury(II)-catalysed rearrangement of epoxy alkynols of type 63 into the 2,3- 
dihydropyran-4-one system 65 has been the focus of previous research by our group, 
this rearrangement may occur via a P-hydroxy alkynone intermediate such 64 
(Scheme 3.8).
Epoxidation R-
Scheme 3.8: Stereospecific rearrangement of epoxy alkynols to 2,3-dihydro-4H- 
pyran-4-ones.
A main limitation to the above methodology is that the synthesis of 3-unsubstituted 
pyranone systems (i.e. R 1 = H) cannot be directly attained as the initial hydride shift 
does not occur. A possible solution for this may be the use of substrates analogous to 
the proposed intermediate 64 (such as 170) and as the ynone portion is still present, 
the mercury-catalysed cyclisation was predicted to occur. In this section it was 
proposed to use a mercury(II)-catalysed cyclisation of a P-hydroxy alkynone
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intermediate 170 as the key step towards the synthesis of (-)-pestalotin 85 (Scheme
3.9).
ADmix-a
169
OMe
HgO/ H2S04 
R t ...............................R
(l) Acid 
(li) Me2SQ4
OH 85OH 171
Scheme 3.9: The proposed route for the preparation of (-)-pestalotin 85, (where R = 
C4H9, Rj = OEt).
The cyclisation of 170 into the dihydropyranone 171 was expected to be very rapid, 
and may not require the presence of the Hg(II) catalyst due to the presence of the 
electron-donating (ethoxy) group attached to the alkyne unit; such reactions were 
previously observed with alkynyl epoxy alcohols, discussed in section 1 .2 .8 .
The synthesis of the gibberellin synergist (-)-pestalotin 85 was to be attempted using 
the dihydropyran-4-one 171 by acid induced lactonisation followed by methylation 
of the 4-hydroxy group (Scheme 3.9).
3.3.1 Attempted Preparation of the p,y-Unsaturated Alkynone 169
The synthesis of alkynone 169 was attempted using two different methods (Scheme
3.10), route A involved the alkynylation of the corresponding p,y-unsaturated 
aldehyde 172 followed by oxidation, the second synthetic route attempted was the 
alkynylation of the corresponding A-methoxy-A-methyl amide 173, a Weinreb 
amide.
Route B OEtMe
169173
Route A
0
172
Scheme 3.10: Proposed syntheses of alkynone 169.
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The preparation of the aldehyde 172 was carried out by lithium aluminium hydride 
(LiAlH4) reduction of the corresponding carboxylic acid 174 to give the alcohol 175, 
followed by oxidation (Scheme 3.11). Different oxidation conditions were 
investigated to convert 175 into the aldehyde 172; the Collins’ oxidation protocol 
using CrC>3 and pyridine resulted in considerable isomerisation to the conjugated 
aldehyde. Swem oxidation ((COCl) 2  and Me2SO, CH2C12, -  60 °C) also led to 
significant isomerisation to the conjugated aldehyde. Furthermore, DIBAL reduction 
of the corresponding ester (CH2C12, - 160 °C) resulted in the formation of the alcohol 
175 as the main product. Due to difficulty encountered in the synthesis of 172 the 
synthesis of the ynone 169 using the Weinreb amide18 was attempted.
Scheme 3.11. (R = C4H9 ,). Reagents and conditions: (a) Malonic acid, piperidine, 
xylene, 140 °C, 12 h; (b) LiAlFL*, THF, reflux, 1 h; (c) C1O 3 , pyridine, CH2C12, 20 
°C, 35 min.
3.3.1.1 Preparation o f Weinreb amides
Weinreb amides are versatile building blocks in organic synthesis. 19 Their 
preparation can be accomplished by coupling carboxylic acids and NtO- 
dimethylhydroxylamines. The majority of the methods reported use peptide coupling 
agents such as chloroformates, 20 BOP , 21 DCC , 22 and others23 or phosphonic 
derivatives.2 4 ' 26 These reagents are expensive in some cases and the removal of their 
excess (and/or the removal of by-products) from the reaction mixture may be 
difficult. Additional purification of the reaction product is often required. The use 
of acid chloride , 27 ester and lactone derivatives as intermediates towards the Weinreb 
amide synthesis has also been popular.
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Barstow28 and Einhom26 described the synthesis of Weinreb amides using the 
phosphonium salt 177 for activation of the acid (Scheme 3.12); the salt was 
generated in situ by the addition of triphenyphosphine to carbon tetrabromide.
o
nnu CBr4 + 7 RCO->H, pvridine Ji +
PPh3 --------------- 1----------- ►  Ph3PBrCBr3    ».  R ^ V p R h , ,  CBr3
177 '  H B r 178
R .N H R , II
 --------- £ — ►  R ^ f s T  1 +  PhsP^O  +  HCBr3 NI
R 2
179
Scheme 3.12: Preparation of TV-Methoxy-Wmethylamides using phosphonium salt 
186.
The A^O-dimethylhydroxylamine was conveniently used as its hydrochloride salt, an 
important advantage as the preparation of the free base is tedious. This procedure 
allowed rapid access of A-methoxyamides in good yields; however, the main 
disadvantage was the formation of the triphenylphosphine oxide by-product which 
complicated the purification of the final product.
A highly practical method for the preparation of A-methoxyamides is via the mixed 
anhydride 181, prepared in situ by the addition of isobutylchloroformate to the 
corresponding acid in the presence of a base {e.g. A-methylmorpholine, NMM) and 
A.O-dimethylhydroxylamine. This method resulted in the rapid formation of the A- 
methoxyamide as the sole product and in excellent yields (Scheme 3.13).
o
.A.R 'O H  
ISO
‘BuOCOCl
NMM 11ftS / S j
181
NHMeOMe.HCl
NMM
RA NA M e  +  HO-
179 Me
+ CCA
Scheme 3.13: The preparation of Weinreb amides via the mixed anhydride
methodology.
The carboxylic acid anhydrides have two carbonyl groups, either of which can 
theoretically participate in an aminolysis reaction to give an amide. Among the
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factors that influence which of the two carbonyls undergo aminolysis are the relative 
electrophilicity of the carbonyl group and the steric hindrance of the activating 
group. Thus the carbonyl group with the lowest electron density and least steric 
hindrance will be the one to undergo nucleophilic attack. Complete regioselectivity 
was observed when isobutyl chloroformate was used to activate the carboxylic acid. 
Isobutyl chloroformate is also very stable to storage, in contrast to chloroformates 
derived from secondary alcohols. This method provides rapid reaction rates at a low 
temperature, high yields and the product can be recovered pure without further 
purification.
The alkyl chloroformate method has been widely used for peptide synthesis, as it 
eliminates the need to use expensive coupling reagents, 29,30 the mixed anhydrides 
constitute some of the most highly activated amino acid derivatives and so they are 
extremely efficient for peptide bond formation.
3.3.1.2 Alkynylation o f Weinreb amides
In 1981, Nahm and Weinreb reported an effective and versatile method for the
conversion of Wmethoxy-Wmethylamides into ketones by reaction with
18organolithium and Grignard species in tetrahydrofuran. It is believed that this 
conversion proceeded through a very stable metal-chelated intermediate 182 
(Scheme 3.14); the inertness of 182 prevents premature release of the ketone 
functionality and thus avoids products from secondary addition of the nucleophile.
Scheme 3.14: Alkynylation of Weinreb amides to give ketones.
The conversion of the carboxylic acid 174 into Weinreb amide 173 was successfully 
carried out which provided an alternative substrate for the alkynylation reaction to 
give enynone 185,31,32 (Scheme 3.15). The A-methoxy-A-methylamide 173 was 
prepared from the acid chloride by employing a slight excess of the commercially
R Ri
183
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available N, O-dimethylhydroxylamine hydrochloride in the presence of pyridine. It 
was also prepared from the mixed anhydride of the carboxylic acid . 33,34 Weinreb 
amides have a similar stability to tertiary amides and thus require no special handling 
or storage.
Scheme 3.15: (a) R = C4H9 or (b) CH3 , Rj = C3H7 . Reagents and conditions: (a) 
SOCl2, CH2CI2 , 60 °C, 4 h; (b) MeNHOMe.HCl, CH2C12, 20 °C, 3 h; (c) pent-l-ynyl- 
lithium, THF, 20 °C, 3 h.
The intermediate 185 was prepared by the addition of lithium acetylide generated in 
situ by the addition of «-butyllithium to the terminal alkyne in anhydrous 
tetrahydrofuran. However, rapid isomerisation of 185 took place to form a mixture 
of the conjugated alkynone and 185 in a 1:2 ratio.
3.3.2 Attempted Preparation of Dihydroxy Alkynone 170
Owing to the difficulty encountered in the synthesis of the deconjugated enynone 
169, alternative synthetic routes to the diol 170 were investigated. Scheme 3.17 
outlines the proposed route for the synthesis of 170, where the alkynylation of the 
protected lactone 189 followed by the deprotection of the hydroxyl group was 
proposed to give 170. The asymmetric dihydroxylation of ester 186 under Sharpless’ 
conditions (Scheme 3.16)35 is known to cause direct cyclisation to the lactone 187. 
The synthesis of racemic lactone 187a was achieved by the dihydroxylation of ester 
186 using potassium osmate and Wmethylmorpholine N-oxide (NMO) followed by 
treatment with p-toluenesulfonic acid. 36 This gave the lactone intermediate in a 69% 
yield (Scheme 3.17).37 Unfortunately the attempted alkynylation38-40 of the
trimethylsilyl-protected lactone intermediate 189 resulted in dehydration to give the 
furanone by-product 190 as the sole product, this may be due to the highly acidic 
nature of the a-protons.
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OEt (a)
65%
186
U
A
f  R 
187
Scheme 3.16: (R -  C4H9). Reagents and conditions', (a) ADmix-a, M eS02NH2, 
tBuOH:H2 O (l:l) ,0 ° C , 40 h.
Scheme 3.17: (R = C4 H9 , P = TMS). Reagents and conditions', (a) H2SO4 (cat.), 
EtOH, reflux, 3 h; (b) K20 s 0 2(0H )4, NMO, acetone-H2 0 , 20 °C, 24 h; (c) /?-TsOH 
(cat.), benzene, 50 °C, 90 min; (d) TMSC1, NEt3, Et20 , 20 °C, 1 h; (e) (i) 
ethoxyethynyl-lithium, THF, - 78 °C, (ii) HC1, MeOH, 20 °C.
The synthesis o f 170 by dihydroxylation of the corresponding Weinreb amide 
followed by alkynylation of the protected Weinreb amide was investigated. The 
protected dihydroxy ynone 193 was prepared by the asymmetric dihydroxylation of 
the Weinreb amide 173 followed by alkynylation of the TMS protected diol 192 
(Scheme 3.18).41 The moderate yield of the alkynylation step may be attributed to 
partial deprotection of the labile TMS group of 192 under the basic conditions.
Asymmetric dihydroxylation of the Weinreb amide 173 was carried out using the 
procedure reported by Sharpless and co-workers.42 The reagent used for this 
procedure was modified ADmix-a, which contained a higher percentage of the 
osmium catalyst (1 mol%) and the chiral ligand (5 mol%) than those commonly 
used. This was essential to overcome the sluggish reactivity of the Weinreb amide 
substrate.
113
Chapter 3
The synthesis of racemic diol rac-191 was achieved using potassium osmate and N- 
methylmorpholine A-oxide (NMO) according to the Upjohn procedure. 43
TM SO ., TM SO .,''O TM S ’OTM S
Scheme 3.18: R = C4H 9 . Reagents and conditions: (a) K2 0 s0 2 (0 H)4 , (DHQ)2- 
PHAL, K3Fe(CN)6, K2C 0 3, M eS0 2NH2, 'BuO H -^O , 0 °C, 12 h; (b) TMSC1, NEt3, 
Et0 2 , 20 °C, 12 h; (c) ethoxyethynyl-lithium, THF, - 78 °C, 3 h.
The deprotection of the TMS group was unsuccessful using either 
tetrabutylammonium fluoride (TBAF) in tetrahydrofuran or hydrochloric acid in 
methanol, a mixture of products was observed by NMR probably owing to the 
instability of 193 under these conditions; consequently different protecting groups 
were investigated, which will be discussed in the following section.
3.3.2.1 Preparation of Dihydropyranones via Weinreb amides
A model system was used to investigate the possibility of applying the mercury(II)- 
catalysed cyclisation on a protected p-hydroxy alkynone to give the dihydropyranone 
intermediate. The procedure described in Scheme 3.20 was applied for the synthesis 
of Weinreb amide 196 from the TBS-protected ester 195,44 alkynylation of the 
Weinreb amide followed by the mercury(II)-catalysed cyclisation furnished the 
dihydropyran-4-one product 198 in a 75% yield (Scheme 3.19). In order to optimise 
the yield of the cyclisation step it was necessary to increase the reaction time to 6  h 
from the usual 30 min, to allow the removal of the TBS protecting group.
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Scheme 3.19: Reagents and conditions', (a) TBSC1, imidazole, CH2CI2 , 20 °C, 3 h; 
(b) NHMeOMe.HCl, Et2 0 , - 20 °C, ThMgCl, 20 min; (c) pent-l-ynyl-lithium, THF, 
0 °C, 2 h; (d) HgO/ H2 S 0 4, acetone, 20 °C, 6  h.
The direct conversion of esters into the A-methoxy-vV-methylamides is usually 
achieved using aluminium-based reagents.45 Recently, the use of Grignard reagents 
to effect this reaction was reported by Grabawski and co-workers46 (Scheme 3.20). 
‘PrMgBr was the preferred base as it gave higher yields of the amide; this method 
was general and could also be used for enolisable as well as hindered esters.
RMgX
Me(MeO)NH.HCl -------  »► Me(MeO)NMgX
199 200
g  __________ ^  X M g O v .N (O M e )M e  -R iO M g X ^  u
rS lR , R ^ O R 1 R ^ N "
201 179 Me
Scheme 3.20: The use of Grignard reagents to convert esters into Weinreb amides.
Acetonide protection was selected for the attempted synthesis of the natural product 
as this was expected to be more acid-labile and therefore more readily cleaved under 
the cyclisation conditions (Schemes 3.21-23).
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. O^Me
1* ___W
HO''/ '/ J / ' ,OH 70%
R 191
(c)
59% HO-
,O M e  
N (b)
34% V ^x,.o
R 204
Scheme 3.21. (R = C4H9). Reagents and conditions: (a) 2,2-dimethoxypropane, 
acetone, /?-TsOH (cat.), 20 °C, 2 h; (b) pent-l-ynyl-lithium, THF, 0 °C, 2 h; (c) 
Dowex-50, MeOH, 20°C, 48 h.
In the case of the w-propyl substituted intermediate 204 deprotection of the acetonide 
group using Dowex-5047 resulted in the formation of the diol intermediate 205 
(Scheme 3.21). However, in the case of the ethoxy-substituted compound 206, 
which was needed for the synthesis of 85, a competing cyclisation reaction occurred 
which resulted in the formation of the unwanted furan product 207 (Scheme 3.22). 
In view of this, the acetonide 206 was treated with the acidic mercury(II) solution, 
and this affected the one-pot cyclisation to the dihydropyran-4-one product 171 in a 
75% yield (Scheme 3.23).
OEt
203
OEt67%
206
H (f  207
Scheme 3.22: (R = C4H9). Reagents and conditions: (a) ethoxyethynyl-lithium, 
THF, - 78 °C, 3 h; (b) Dowex-50, MeOH, 20°C, 48 h.
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y 'O
206
"OEt
(a)
73%
OH rac-\l\
Scheme 3.23: (R = C4H9). Reagents and conditions', (a) HgO/ H2 SO4 , acetone, 20 
°C, 30 min.
Scheme 3.24 describes the synthesis of the dihydropyranone 171 which could be 
converted to (-)-pestalotin by acid-mediated lactonisation followed by methylation at 
the 4-hydroxyl position.
O^Me
V (a)
85% HO.,,
R 173
,OMe
(b)
70% ° Y ^ o  
R 203
.OMe
*1 (c)
67%
y ,
(d)
73%
(e)
206 OH H I OH 208
OH
(-)-pestalotin 85
Scheme 3.24: Synthesis of dihydropyranone 171 and its proposed use for the 
synthesis of (-)-pestalotin. Reagents and conditions: (a) K2 Os0 2 (OH)4, (DHQ)2- 
PHAL, K3Fe(CN)6, K2C 0 3, M eS0 2NH2, 'BuOH-H20 , 0 °C, 12 h; (b) 2,2- 
dimethoxypropane, acetone, p-TsOH (cat ), 20 °C, 2 h; (c) ethoxyethynyl-lithium, 
THF, - 78 “C, 3 h; (d) HgO/ H2S 04, acetone, 20 °C, 30 min; (e) HC1, 20 °C, 4 h; (f) 
M eS04.
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3.3.3 Attempted Synthesis o f p-Ketolactone by Base-Catalysed Cyclisation
Scheme 3.25 shows the attempted synthesis of the lactone 2 1 0  using base-catalysed 
cyclisation; the lactone 210 may be used to synthesise 85 by O-methylation followed 
by deprotection of the acetate group. Base-catalysed cyclisations of this type using 
the Evans aldol product were reported recently, see Scheme 3.26.48,49 However, in 
the case of a-unsubstituted Weinreb amide 209 an elimination reaction took place, 
which resulted in the formation of the conjugated amide 2 1 1 .
■OMe
HO, 'OH
Rac- 191
.OMe
AcO,
'OAc
209 AcO 210
.OMe
AcO.
211
Scheme 3.25: (R = C4H9 ). Reagents and conditions: (a) AC2O, pyridine, 20 °C, 90 
min; (b) KHMDS, THF, - 78 °C, 15 min.
Vanderwal and co-workers48 reported that the treatment of imide 212 with 4.0 equiv 
of potassium hexamethyldisilazide (KHMDS) at - 78 °C led to the rapid expulsion of 
the oxazolidinone auxiliary and generated the desired p-keto lactone 213 (Scheme 
3.26).
Me'
Me' Me'
kOAc
Me1
213
Scheme 3.26: Claisen-like Cyclisation of Imide Acetate 212. Reagents and 
conditions: KHMDS (4.0 equiv), THF, - 78 °C.
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3.4 Conclusions
In this chapter the Sharpless asymmetric dihydroxylation reaction was used in 
conjunction with the mercury(II) catalysed cyclisation procedure to synthesize the
2,3-dihydropyran-4//-one 171, which may be modified to give the natural product 
(-)-pestalotin.
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Experimental
(£)-Oct-3-enoic acid (174).50 Hexanal (10.0 g, 83 mmol) was slowly added to a 
mixture of malonic acid (26.0 g, 0.25 mol) and piperidine (6 . 8  mg, 0.083 mmol) in 
xylene (100 mL) which was heated at reflux. A Dean-Stark apparatus equipped with 
a gas-trap was used to observe the evolution of carbon dioxide during the reaction. 
When no more water was separated and CO2 ceased to evolve (12 h) the mixture was 
allowed to cool to room temperature, then washed with water and the xylene 
evaporated. The residue was distilled under reduced pressure to give 174 (11.4 g, 
96%) as a colourless liquid, b. p. 150-153 °C / 18 mmHg (lit b.p.{33} 92 °C / l .4 
mmHg); *H NMR (300 MHz, CDCI3) 5 5.50 (2H, m, CH-CH), 3.00 (2H, d, J  = 6 .1 
Hz, CH2C=O), 1.98 (2H, q, J  = 6.3 Hz, CH2C=C\ 1.25 (4H, m, 2CH2), 0.82 (3H, t, J  
= 6.9 Hz, CH3); 13C NMR (75 MHz, CDCI3) 5 177.6 (C0 2H), 134.5 
(C//=CHCC=0), 119.7 (C H =C //C C O ), 36.8 (CH2C=O), 31.1 (CH2C=C), 30.0 
(CH2), 21.2 (CH2), 12.9 (CH3).
(£)-Oct-3-en-l-ol (175).50,51 A solution of (£’)-oct-3-enoic acid (2.0 g, 14.1 mmol) 
in anhydrous tetrahydrofuran (30 mL) was added slowly to a solution of lithium 
aluminium hydride in anhydrous tetrahydrofuran (14.1 mL, 14.1 mmol, 1.0 M). The 
reaction was heated under reflux for lh  and then cooled to 20 °C. Water was slowly 
added to the cooled mixture to destroy the excess of lithium aluminium hydride 
(CAUTION). The ethereal layer was washed with dilute hydrochloric acid (20 mL, 
0.2 M), and saturated aqueous sodium hydrogen carbonate (20 mL), and the organic 
layer was dried (MgS0 4 ), filtered and evaporated. Distillation of the residue at 
reduced pressure gave 175 (1.0 g, 55%) as a colourless oil, b. p. 55-60 °C / 9 mm 
Hg; ]H NMR (300 MHz, CDCI3) 6  5.50 (1H, m, C H C H ), 5.30 (1H, m, C H C H ), 
3.55 (2H, t, J =  6.4 Hz, CH2OH), 2.20 (2H, q, 6.4 Hz, CH2CH2OH), 1.96 (2H, q, 
J  = 7.0 Hz, CH2C=C), 1.20 (4H, m, CH2), 0.82 (3H, t, J  = 7.0 Hz, CH3); ,3C NMR 
(75 MHz, CDC13) 8  134.7 (C7/=CHCCOH), 126.1 (CH=C//CCOH), 62.5 (CftOH),
36.4 (CH2COH), 32.7 (CH2C=C), 32.0 (CH2), 22.6 (CH2), 14.3 (CH3).
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(£)-Oct-3-enal {111)*1 Chromium trioxide (6.7 g, 67 mmol) was added to pyridine 
(10.5 g, 0.13 mol) in dichloromethane (200 mL) at 20 °C. After stirring for 15 min, 
(£)-3-octenol (1.0 g, 7.8 mmol) was added and stirring was continued for 20 min. 
The mixture was diluted with ether (50 mL), washed with aqueous sodium hydroxide 
(4 x 200 mL, 1M) then with dilute hydrochloric acid (2 x 80 mL, 2M), saturated 
aqueous sodium hydrogen carbonate (2 x 40 mL), and lastly brine (40 mL). The 
solution was dried over M gS04, filtered and evaporated (bath temperature 20° C). 
The residue was purified by column chromatography (1:5 acetone: petroleum ether) 
to give 172 (0.63 g, 64%) as a yellow oil; *H NMR (300 MHz, CDCfi) 5 9.59 (1H, s, 
CHO), 5.50 (2H, m, C H C H ), 3.03 (2H, d, J  = 5.7 Hz, CH2C C ) ,  2.01 (2H, q, J  =
6.5 Hz, C //2C=C), 1.26 (4H, m, CH2), 0.83 (3H, q, J  = 6.4 Hz, CH3); 13C NMR (75 
MHz, CDC13) 6  200.7 (CHO), 137.4 (C//CHCCHO), 119.4 (CHC//CCHO), 47.7 
(CH2CHO), 32.7 (C //2C C ) ,  31.7 (CH2), 22.5 (CH2), 14.3 (CH3).
(£)-Oct-3-enoyl chloride (184a). To a solution of (A)-oct-3-enoic acid (2.0 g, 14.1 
mmol) in dichloromethane (100 mL) cooled to 0 °C under an atmosphere of nitrogen, 
thionyl chloride (3.2 g, 4.0 mL, 33.6 mmol) was added dropwise with stirring. The 
mixture was then heated under reflux at 60 °C. Progress of the reaction was 
monitored by TLC; after the reaction was complete the solvent and excess thionyl 
chloride were evaporated to give 184a (1.64 g, 73%) as a brown oil which was used 
directly in the next step; IR vmax(cm'1) 1801 (COC1).
Oct-3-enoic acid TV-methoxy-TV-methylamide (173a).42 To a stirred solution of 
(fs)-oct-3-enoyl chloride (2.0 g, 12.5 mmol) in dichloromethane (100 mL) at 0 °C 
under an atmosphere of nitrogen, was added TV, O-dimethylhydroxylamine 
hydrochloride (2.14 g, 22 mmol) and pyridine (3.48 g, 3.4 mL, 44 mmol). The 
mixture was warmed to 20 °C and stirred for a further 3 h. Hydrochloric acid (20 
mL, 2 M) was added, and the aqueous layer extracted with dichloromethane (2 x 60 
mL). The combined organic layers were washed with saturated aqueous sodium 
hydrogen carbonate (2 x 60 mL) followed by brine (60 mL). The solution was dried 
(M gS04), filtered and evaporated. Purification of the residue by column 
chromatography (2:1 petroleum ether: ether) gave 173a (2.24 g, 97%) as a pale 
yellow oil; lH NMR (300 MHz, CDC13) 5 5.76 (2H, m, CH=CH), 3.90 (CH3, s,
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OCH3), 3.39 (5H, s, NCH3, CH2C=0), 2.24 (2 H, m, CH2C=C), 1.53 (4H, m, CH2), 
1.09 (3H, t, J  = 6.7 Hz, CH3); 13C NMR (75 MHz, CDC13) 8  148.3 (C=0), 134.8 
(C H O //C C O ), 122.6 (C7/=CHCCO), 61.6 (OMe), 36.5 (CH2C O ), 32.7 
(CH2C O ), 31.8 (CH2), 22.6 (CH2), 14.3 (CH3).
Attempted preparation of tridec-8-en-4-yn-6-one (185). To a solution of pent-1- 
yne (0.49 g, 7.1 mmol) in tetrahydrofuran (10 mL) at -78 °C was added n- 
butyllithium (2.0 mL, 5.0 mmol, 2.5 M solution in hexanes) dropwise over 10 min. 
After 30 min of stirring, a solution of oct-3-enoic acid /V-methoxy-A-methylamide 
(0.60 g, 3.2 mmol) in tetrahydrofuran (10 mL) was added dropwise. After 2 h the 
mixture was quenched by the addition of saturated aqueous ammonium chloride ( 1 0  
mL). The aqueous layer was extracted with ether ( 3 x 1 0  mL), then dried (MgS0 4 ), 
filtered and evaporated. Column chromatography (5:95 ethyl acetate: petroleum 
ether) gave a 2:1 mixture the deconjugated 185 and the conjugated alkynone (0.30 g, 
48%); 'H NMR (300 MHz, CDCI3) 8  7.08 (1H, m, conjugated-CH= CHC=0), 6.34 
(1H, d, J  = 15.9 Hz, conjugated-CH=CHC=0), 5.60 (2H, m, deconjugated- 
CH=CHCC=0), 2.81 (2 H, d ,J = 4 .9  Hz, CH2C=0), 2.39 (2H, m, CH2), 2.07 (2H, m, 
CH2), 1.63 (4H, m, CH2), 1.35 (3H, m, CH3), 1.07 (2H, m, CH2), 0.92 (3H, t, J=  6.7 
Hz, CH3); 13C NMR (75 MHz, CDC13) 8  172.0 (C=0), 154.2 (conjugated- 
CH=CHC=0), 137.1 (dQconjugated-CH=CHCC^O), 130.7 (conjugated-
CH=C7/C=0), 122.9 (deconjugated-CH=CHCC=0), 84.9 (O C C = 0), 71.5
0>CC=O ), 40.8 (CH2C=0), 32.6 (CH2C=C), 31.7 (CH2), 22.9 (CH2), 22.6 (CH2),
21.7 (CH2), 14.3 (CH3), 13.9 (CH3).
(£)-Pent-3-enoic acid (174b).53 To a solution of 3-pentenenitrile (15.0 g, 18 mL, 
185 mmol) in dichloromethane (75 mL) at 0 °C were added the following, 30% w/v 
aqueous hydrogen peroxide (30.6 g, 27 mL, 0.90 mol), tetrabutylammonium iodide 
(0.66 g, 1.8 mmol) and 20% w/v aqueous sodium hydroxide (21.6 g, 0.54 mol). The 
mixture was allowed to warm to 20 °C with vigorous stirring. When the reaction 
was complete (TLC monitoring) the aqueous layer was separated and extracted with 
dichloromethane (3 x 30 mL). The aqueous layer was then acidified with dilute 
hydrochloric acid (3.0 M), extracted with dichloromethane (5 x 30 mL) and the 
combined organic layers were dried (MgS04), filtered and evaporated to give 174b
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(9.25 g, 50%) as a clear yellow oil; ]H NMR (300 MHz, CDC13) 5 5.48 (2H, m, 
C H C H ), 2.98 (2H, d, J  = 5.6 Hz, CH2C=0), 1.64 (3H, d, J  = 5.9 Hz, CH3); 13C 
NMR (75 MHz, CDC13) 5 178.6 (C 0 2H), 130.4 (CH=C//C=0), 122.4
(C //C H C O ), 38.0 (CH2CO) 18.2 (CH3).
(£}--Pent-3-enoyl chloride (184b).53 To a stirred solution of (ZT)-pent-3-enoic acid 
(1.0 g, 10 mmol) in dichloromethane (50 mL) cooled to 0 °C under an atmosphere of 
nitrogen, was added thionyl chloride (3.2 g, 2 mL, 27 mmol) dropwise. The mixture 
was then heated under reflux at 60 °C. Progress of the reaction was monitored by 
TLC, after the reaction was complete the solvent and the excess thionyl chloride 
were evaporated to give 184b (1.0 g, 85%) as a dark brown oil, which was used 
directly in the next step; IR Vmax (cm'1) 1800 (COC1).
Pent-3-enoic acid TV-methoxy-TV-methylamide (173b). To a solution of (£)-pent-3- 
enoyl chloride (1.0 g, 8.5 mmol) in dichloromethane (50 mL) was added N,0- 
dimethylhydroxylamine hydrochloride (1.07 g, 11 mmol) and pyridine (1.74 g, 1.7 
mL, 22 mmol) with stirring at 0 °C. The mixture was then stirred at 20 °C and 
progress of the reaction was monitored by TLC. On completion, aqueous 
hydrochloric acid (10 mL, 2 M) was added, and the aqueous layer was extracted with 
dichloromethane (2 x 30 mL). The combined organic layers were washed with 
saturated aqueous sodium hydrogen carbonate (2 x 30 mL) followed by brine (30 
mL). The solution was dried (MgSCL), filtered and evaporated, purification by flash 
column chromatography (1:1 ether: petroleum ether) gave 173b (0.86 g, 71%) as a 
pale yellow oil; IR vmax(crn'1) 1666 (C O ); ]H NMR (300 MHz, CDC13) 6  5.56 (2H, 
m, C H C H ), 3.62 (3H, s, OCH3), 3.10 (5H, d, J  = 6.1 Hz, NCH3, CH2C=0), 1.60 
(3H, d, J  = 6.7 Hz, CH3); 13C NMR (75 MHz, CDC13) 8  169.3 (C O ), 129.2 
(C //C H C O ), 123.9 (C H C //C O ), 61.6 (OCH3), 36.4 (CH2C O ), 32.7 (NCH3), 18.2 
(CH3); LRMS m/z (%)+EI 144 (M+H, 35%), 80 (100), 56 (35), 32 (10); HRMS 
calcd for C7Hi30 2N 144.1024 (M+H), found 143.0946.
(/s)-Oct-3-enoic acid ethyl ester (186).54 A solution of (£)-oct-3-enoic acid (l.Og,
7.05 mmol) and concentrated sulfuric acid (1 drop) in ethanol (10 mL) was heated 
under reflux for 3 h, after cooling to 0 °C, the mixture was treated with saturated
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aqueous sodium hydrogen carbonate (6.0 mL) and extracted with ether (3 x 10 mL). 
The combined organic extracts were washed with brine (2 x 10 mL), then dried 
(MgSCL), filtered and evaporated. Chromatography of the residue (2:98 ethyl
acetate: petroleum ether) gave 186 (0.94 g, 78%) as a colourless oil; NMR (300 
MHz, CDCI3) 5 5.52 (2H, m, C H C H ), 4.15 (2H, q, J=  7.1 Hz, CH20), 3.01 (2H, d, 
J  = 4.5, CH2 C O ) ,  2.04 (2H, q, J  = 7.0, CH2C=C), 1.30 (4H, m, CH2), 1.25 (3H, t, J  
= 7.1 Hz, CH3), 0.88 (3H, t, J =  7.2 Hz, CH3); 13C NMR (75 MHz, CDC13) 5 172.2 
(C=0), 134.8 (C//=CHCO), 121.5 (C H C //C O ), 60.5 (CHzO), 38.2 (CH2C=0), 32.1 
(CH2C=C), 31.3 (CH2), 22.1 (CH2), 14.2 (CH3), 13.9 (CH3).
(5',5)-5-Butyl-4-hydroxydihydrofuran-2-one (187).55 To a stirred suspension of 
ADmix-a (12.0 g) and methanesulfonamide (0.84 g, 8.82 mmol) in a 1:1 mixture of 
tert-butyl alcohol/ water (85 mL) was added (£)-oct-3-enoic acid ethyl ester (1.50 g, 
8.82 mmol). The mixture was stirred at 0 °C for 40 h, then quenched by the addition 
of ethyl acetate (45 mL) and sodium sulfite (12.9 g). After removal from the 
cryostat, the mixture was stirred for a further 30 min at 20 °C, extracted with ethyl 
acetate (3 x 30 mL) and the combined organic layers were washed with aqueous 
potassium hydroxide (2 x 30 mL, 2M) followed by brine (2 x 30 mL). The organic 
layer was dried (Na2 S0 4 ), filtered and evaporated. Purification of the residue by 
flash column chromatography (4:6 ethyl acetate: petroleum ether) gave 187 (0.91 g,
65%) as a pale yellow oil; *H NMR (300 MHz, CDC13) 5 4.46 (1H, m, CHOU), 4.35 
(1H, m, CHOU), 2.80 (1H, dd, J =  17.5 and 5.4 Hz, CH2C=O), 2.56 (1H, d ,J =  17.5 
Hz, CH2C O ) , 1.84 (2H, m, CH2COU), 1.40 (4H, m, CH2), 0.92 (3H, t , J  = 6 . 8  Hz,
CH3); 13C NMR (75 MHz, CDC13) 8  176.1 (C=0), 85.1 (OCH), 69.0 (CHOU), 39.5 
(CH2C=O), 27.9 (CH2), 27.7 (CH2), 22.5 (CH2), 13.9 (CH3).
3,4-Dihydroxyoctanoic acid ethyl ester (188). To a solution of N- 
methylmorpholine /V-oxide (10.7 g, 79.4 mmol) in water (5.8 mL) was added, in 
succession, potassium osmate dihydrate (0.78 g, 2.12 mmol) and (£’)-oct-3-enoic acid 
ethyl ester (9.0 g, 52.9 mmol) dissolved in acetone (30.0 mL). The mixture was 
stirred at 20 °C and monitored by TLC until the reaction was complete (24 h). 
Saturated aqueous sodium hydrosulfite (13.5 mL) was added and the mixture stirred 
for 30 min, then it was filtered through celite and rinsed with acetone, evaporation of
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the solvent and column chromatography (4:6 ethyl acetate: petroleum ether) gave 
188 (8.5 g, 79%) as a white solid; IR vn„ (c m '')  3457 (OH), 1682 (C=0); ‘h  NMR 
(300 MHz, CDC13) 5 4.16 (2H, q , J  = 7.1 Hz, CH2O), 3.86 (1H, m, OCH), 3.42 (1H, 
m, OCH), 2.52 (2H, m, CH,C=0), 1.47 (2H, m, CH2COH), 1.33 (4H, m, CH2), 1.23 
(3H, t, J  = 7.1 Hz, CH?), 0.88 (3H, t, J  = 7.3 Hz, CH3); ' !C NMR (75 MHz, CDC13) 
5 173.0 (0= 0), 73.7 (C//OH), 70.5 (67/OH), 60.8 (CH20), 38.3 (C//2CO), 33.1 
(CH2), 27.8 (CH2), 24.0 (CH3), 22.6 (CH2), 14.1 (CH3); LRMS m/z (%)+FAB 205 
(M+H, 10%), 159 (100), 143 (20); HRMS calcd for CioH200 4 205.1440 (M+H), 
found 205.1446.
5-Butyl-4-hydroxydihydrofuran-2-one (rac-187a).55 A stirred mixture of 3,4- 
dihydroxyoctanoic acid ethyl ester (4.0 g, 19.6 mmol) and /vtoluenesulfonic acid 
(0.16 g, 0.86 mmol) in benzene (200 mL) was heated at 50 °C for 90 min. The 
mixture was cooled and neutralized by the addition of pyridine. Evaporation and 
column chromatography (4:6 ethyl acetate: petroleum ether) of the residue gave 187a 
(3.39 g, 87%) as an orange oil. The spectroscopic data were identical to those given 
for 187.
5-Butyl-4-(trimethylsiIanyloxy)-dihydrofuran-2-one (189). Triethylamine (1.84 g,
18.2 mmol) and chlorotrimethylsilane (1.90 g, 17.4 mmol) were added 
simultaneously to a stirred solution of 5-butyl-4-hydroxydihydrofuran-2-one (2.5 g,
15.8 mmol) in anhydrous ether (20 mL) at 0 °C. The solution was then stirred at 20 
°C for 12 h. Pentane (20 ml) was then added and the resulting slurry stirred for 10 
min. Filtration and evaporation gave a residue which was purified by flash column 
chromatography (1:9 ethyl acetate: petroleum ether) to give 189 (2.0 g, 90%) as a 
pale yellow oil; IR VmaX (cm'1) 1732 (C=0); H NMR (300 MHz, CDCI3) 5 4.39 (1H, 
m, OCH), 4.31 (1H, m, C//OTMS), 2.72 (1H, dd, J  = 17.2 and 5.2 Hz, CH2C=0), 
2.44 (1H, d, J  = 17.2 Hz, CH2C=0), 1.62 (2H, m, CH2), 1.38 (4H, m, CH2), 0.91 
(3H, t ,J = 6 .7  Hz, CH3) 0.12 (18H, s, Si(CH3)2); UC NMR (75 MHz, CDCI3) 6  175.7 
(C=0), 85.1 (OCH), 69.3 (C//OTMS), 39.8 (CH2CO), 28.2 (CH2), 27.5 (CH2), 22.6 
(CH2), 13.9 (CH3), - 0.10 (SiCH3); LRMS m/z (%)+EI 231 (M+H, 15%), 190 (40), 
159 (75), 147 (20), 116 (40), 95 (20), 73 (100), 59 (10); HRMS calcd for CnH220 3Si 
231.1416 (M+H), found 231.1414.
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Attempted preparation of l-ethoxy-6-hydroxy-5-(trimethylsilanyloxy)-dec-l-yn- 
3-one. To a stirred solution of 5-butyl-4-(trimethylsilanyloxy)-dihydrofuran-2-one 
(0.70 g, 3.04 mmol) in tetrahydrofuran (15 mL) was added a solution of lithium 
ethoxyacetylide (prepared by the addition of rc-butyllithium (2.2 mL, 5.48 mmol, 2.5 
M solution in hexanes) to a stirred solution of ethoxyacetylene (0.43 g, 0.6 mL, 6.09 
mmol, 50% solution in hexanes) in tetrahydrofuran (15 mL) at -  78 °C followed by 
stirring for 30 min). After a further 2 h the mixture was quenched by the addition of 
saturated aqueous ammonium chloride (10 mL). The aqueous layer was extracted 
with ether ( 3 x 1 0  mL), dried and evaporated. Column chromatography (10:90 ethyl 
acetate: petroleum ether) gave the by-product 190 (0.30 g, 62%) as pale yellow oil; 
H NMR (300 MHz, CDC13) 5 7.52 (1H, m, CH= CHC=0), 6.02 (1H, d, J=  15.3 Hz, 
CH=C//C=0), 4.50 (1H, m, OCH), 1.48 (2H, m, CH2), 1.32 (2H, m, CH2), 1.22 (2H, 
m, CH2), 0.98 (3H, t, J  = 7.5 Hz, CH3); 13C NMR (75 MHz, CDC13) 6 167.2 (C=0),
147.1 (CH=CH C O ), 121.1 (C H O //C O ), 80.4 (OCH), 33.7 (CH2), 26.3 (CH2),
22.3 (CH2), 13.7 (CH3).
3,4-Dihydroxyoctanoic acid JV-methoxy-iV-methylamide (rac-191).42 To a
solution of 7V-methylmorpholine 7V-oxide (0.55 g, 4.0 mmol) in water (0.30 mL) was 
added, in succession, potassium osmate dihydrate (0.04 g, 0.11 mmol) and (E)-oct-3- 
enoic acid A-methoxy-A-methylamide (0.50 g, 2.7 mmol) dissolved in acetone (1.5 
mL). The solution was stirred at 20 °C and monitored by TLC until complete (24 h). 
Saturated aqueous sodium hydrosulfite (0.35 mL) was added and the mixture stirred 
for 30 min, filtered through celite and the celite rinsed with acetone. The combined
filtrates were evaporated and the residue subjected to chromatography (5:95
i
methanol: dichloromethane) to give rac-191 (0.45 g, 76%) as a brown oil; H NMR 
(300 MHz, CDC13) 5 3.84 (1H, m, CHOW), 3.63 (3H, s, OMe), 3.39 (1H, m, CHOW), 
3.13 (3H, s, NMe), 2.60 (2H, d,J =  7.6 Hz, C H ^ O ) ,  2.40 (1H, bs, OH), 1.64 (1H, 
bs, OH), 1.46 (2H, m, CH2COH), 1.28 (4H, m, CH2), 0.84 (3H, t, J = 6.9 Hz, CH3); 
13C NMR (75 MHz, CDC13) 5 174.8 (C=0), 74.3 (COH), 70.8 (COH), 61.7 (OCH3),
35.4 (CH2), 33.7 (CH2CO), 31.2 (NCH3), 28.3 (CH2), 23.1 (CH2), 14.4 (CH3).
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(3S,45)-3,4-Dihydroxyoctanoic acid ALmethoxy-Ar-methylamide (191a).42 A 
mixture of the chiral ligand (DHQ)2-PHAL (38.9 mg, 5.0 x 10'5 mol), potassium 
ferricyanide (0.99 g, 3.0 mmol), potassium carbonate (0.42 g, 3.0 mmol), potassium 
osmate (3.68 mg, 1.0 x 10'5 mol) and methanesulfonamide (95 mg, 1.0 mmol) were 
dissolved in a 1:1 mixture of water and tert-butyl alcohol (10 mL) at 0 °C. (£>Oct- 
3-enoic acid A-methoxy-A-methylamide (0.185 g, 1.0 mmol) was added in one 
portion and the mixture was stirred at 0 °C for 12 h, then quenched by the addition of 
sodium sulfite (1.5 g) followed by warming to 20 °C and stirred for a further 30 min. 
The mixture was extracted with dichloromethane ( 3 x 6  mL) and the combined 
organic layers were washed with aqueous potassium hydroxide ( 2 x 1 0  mL, 2M) and 
then dried (Na2S0 4 ), filtered and evaporated to give a mixture of the crude diol and 
the ligand. Purification by flash column chromatography (90:10 ethyl acetate: 
petroleum ether) gave 191a (0.18 g, 85%) as a pale yellow oil, the spectroscopic data 
are identical to those for the racemic compound.
3,4-Bis-(trimethylsilanyloxy)-octanoic acid A-methoxy-TV-methylamide (192).
Triethylamine (1.6 g, 15.7 mmol) and chlorotrimethylsilane (1.6 g, 15.1 mmol) were 
added simultaneously to a stirred solution of (35,45)-3,4-dihydroxyoctanoic acid N- 
methoxy-A-methylamide (1.50 g, 6.8 mmol) in dry ether (14 mL) at 0 °C. The 
solution was then stirred at 20 °C for 12 h. Pentane (14 ml) was then added and the 
resulting slurry stirred for 10 min. Filtration and evaporation gave a residue which 
was purified by flash column chromatography (1:4 ethyl acetate in hexane) to give
192 (2.0 g, 80%) as a light brown oil; IR Vmax (cm'1) 1673 (C=0); H NMR (300 
MHz, CDCfi) 8 4.22 (1H, m, OCH), 3.68 (3H, s, OMe), 3.58 (1H, m, OCH), 3.17 
(3H, s, NMe), 2.54 (2H, m, CH2CO), 1.29 (6H, m, 3CH2), 0.90 (3H, t, J=  7.1, CH3), 
0.08 (18 H, s, 2Si(C//3)3); UC NMR (75 MHz, CDC13) 8 75.0 (OCH), 71.9 (OCH),
61.2 (OCHS), 33.9 (NCH3), 30.4 (2CH2), 28.6 (CH2), 22.7 (CH2), 14.0 (CH3), 0.40 
(Si(C7/3)3); LRMS m/z (%)+Cl 363 (M+, 5%), 271 (25), 212 (25), 211 (100), 156 
(35), 137 (58), 85 (15); HRMS calcd for C,6H37N04Si2 363.2261 (M+H), found 
363.2240.
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l-Ethoxy-5,6-bis-(trimethylsilanyloxy)-dec-l-yii-3-one (193). To a solution of 
ethoxyacetylene (1.15 g, 8.20 mmol, 50% solution in hexanes) in tetrahydrofuran (20 
mL) was added «-butyllithium (2.95 mL, 7.40 mmol, 2.5 M solution in hexanes) 
dropwise over 10 min at -78 °C. After 30 min of stirring, a solution of 3,4-bis- 
trimethylsilanyloxyoctanoic acid A-methoxy-A-methy 1 amide (1.0 g, 2.73 mmol) in 
tetrahydrofuran (20 mL) was added in one portion. After 3 h the mixture was 
quenched by addition of saturated aqueous ammonium chloride (10 mL). The 
aqueous layer was extracted with ether ( 3 x 1 0  mL), dried and evaporated. Column 
chromatography (10:90 ethyl acetate: petroleum ether) gave 193 (0.67 g, 60%) as a
yellow oil; IR v™* (c m 1) 2211 (alkyne), 1696 (C=0); H NMR (300 MHz, CDC13) 
6 4.17 (3H, q, J  = 7.1 Hz, CH20  and OCH), 3.55 (1H, m, OCH), 2.63 (2H, m, 
CH2C=0), 1.27 (9H, m, 3CH2 and CH3), 0.90 (3H, t, J  7.0 Hz, CH3), 0.10 (18 H, s, 
2Si(CNs),); °C  NMR (75 MHz, CDC13) 5 202.0 (C=0), 74.6 (OCH), 71.5 (OCH),
61.2 (CH20 ), 44.4 (CH2C=0), 29.9 (CH2), 28.6 (CH2), 22.7 (CH2), 14.1 (CH3), 14.0 
(CH3), 0.2 (Si(CHs),).
Attempted preparation of l-ethoxy-5,6-dihydroxydec-l-yn-3-one (170). Tetra- 
butylammonium fluoride (1.4 mL, 4.8 mmol, 1.0 M solution in tetrahydrofuran) was 
added to a solution of l-ethoxy-5,6-bis-(trimethylsilanyloxy)-dec-l-yn-3-one (1.0 g,
2.4 mmol) in tetrahydrofuran (10 mL). The mixture was stirred at 20 °C for 2 h, then 
water (30 mL) and ethyl acetate (60 mL) were added. The separated organic layer 
was washed with brine (30 mL) and the combined aqueous layers were extracted 
with ethyl acetate (3 x 40 mL). The organic layers were dried (MgSCL), filtered and 
evaporated to give a mixture of products as shown by !H NMR.
3-(tert-Butyldimethylsilanyloxy)-butyric acid ethyl ester (195).56 Imidazole (2.06 
g, 30.2 mmol) and ter/-butyldimethylsilyl chloride (2.74 g, 18.2 mmol) were added 
consecutively to a stirred solution of the 3-hydroxybutyric acid ethyl ester (2.0 g,
15.2 mmol) in dry dichloromethane (120 mL) at 20 °C. After 3 h, water (60 mL) 
was added and the aqueous layer was extracted with dichloromethane (3 x 50 mL). 
The combined organic layers were washed with brine (40 mL), dried (MgSCh), 
filtered and evaporated. Purification by column chromatography (1:99, ethyl acetate:
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hexane) gave 195 (3.0 g, 80%) as a colourless oil; H NMR (300 MHz, CDCb) 
S 4.24 (1H, m, OCH), 4.09 (2H, q , J =  7.2 Hz, CH20), 2.46 (1H, dd, J  = 14.5 and 7.5 
Hz, CH2C=0), 2.35 (1H, dd, J  = 14.5, 5.4 Hz, CH2C=0), 1.23 (3H, t, J  = 7.2 Hz, 
CH3), 1.18 (3H, d, J  = 6.1 Hz, CH3), 0.84 (9H, s, (CT/3,)3CSi(CH3)2), 0.02 (6H, s,
(CH3)3CSi(CH3)2 );13C NMR (75 MHz, CDC13) 8 171.6 (C=0), 65.8 (OCH), 60.2 
(CH20), 44.9 (CH2), 25.7 fC//3;3CSi(CH3)2), 23.9 (CH3), 17.9 (CH3)3CSi(CH3)2),
14.2 (CH3), - 4.5 (CH3)3C Si<0/3; 2).
3-(te/*-Butyldimethylsilanyloxy)-jV-methoxy-./V-methylbutyramide (196).57 To a 
solution of 3-(terr-butyldimethylsilanyloxy)-butyric acid ethyl ester (0.30 g, 1.21 
mmol) and N, O-dimethylhydroxylamine hydrochloride (0.18 g, 1.88 mmol) in ether 
(2.5 mL) at - 20 °C, was added a solution of isopropylmagnesium chloride (prepared 
in situ by the slow addition of isopropyl chloride (0.28 g, 3.64 mmol) to magnesium 
turnings (0.088 g, 3.64 mmol) in ether (2.0 mL) and heated under reflux for 2 h) the 
mixture was stirred for a further 20 min and quenched by the addition of aqueous 
ammonium chloride (4.0 mL, 20 wt %). The product was extracted with ter/-butyl 
methyl ether (3 x 4.0 mL) and the organic layers were dried (MgS04), filtered and 
evaporated. Column chromatography (20:80 ethyl acetate: petroleum ether) gave
196 (0.26 g, 83%) as a pale yellow oil; H NMR (300 MHz, CDC13) 8 4.34 (1H, 
sextet, J =  6.0 Hz, OCH), 3.69 (3H, s, CH30), 3.16 (3H, s, CH3N), 2.76 (1H, dd, J  = 
14.4, 7.4 Hz, CH2CO), 2.35 (1H, dd, J  = 14.4, 6.0 Hz, CH2CO), 1.21 (3H, d , J =  7.4
Hz, CH3), 0.86 (9H, s, (CH3) 3CSi(CH3)2), 0.06 (6H, s, {CR3),CSi(CH3) 2) ! 'c  NMR 
(75 MHz, CDC13) 8 66.0 (OCH), 61.3 (CH30), 41.8 (CH3N), 25.8 (/(7 /^C S i), 24.2 
(CH2), 18.0 (CH3), - 4.7 (Si(CHsh).
2-(tert-Butyldimethylsilanyloxy)-non-5-yn-4-one (197). /?-Butyllithium (5.0 mL,
12.5 mmol, 2.5 M in hexane) was added dropwise to a solution of pent-l-yne (0.94 g 
mL, 13.8 mmol) in tetrahydrofuran (10 mL) cooled to -  78 °C under an atmosphere 
of nitrogen. Stirring was continued for 10 min at -  78 °C, then the mixture was 
treated dropwise with a solution of 3-(/ert-butyldimethylsilanyloxy)-iV-methoxy-2V- 
methylbutyramide (1.20 g, 4.61 mmol) in tetrahydrofuran (10 mL). The stirred 
mixture was allowed to warm to 0 °C and stirred for a further 2 h. The mixture was 
then poured into saturated aqueous ammonium carbonate (10 mL) and the separated
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aqueous layer was extracted with ether ( 3 x 1 0  mL). The combined organic extracts 
were dried (Na2 S0 4 ), filtered and evaporated. Flash chromatography (5:95 ethyl 
acetate: petroleum ether) gave 197 (0.70 g, 57%) as a pale yellow oil; IR vmax(cm'1)
2218 (alkyne group), 1691 (C O ); H NMR (300 MHz, CDC13) 8 4.38 (1H, m, 
CHOTBS), 2.75 (1H, dd, J = 14.8, 7.3 Hz, CH2C O ), 2.56 (1H, dd, J=  14.8, 5.5 Hz, 
CH2C O ) ,  2.33 (2H, t, J  = 7.0 Hz, CH2C=C), 1.61 (2H, sextet, J =  7.0 Hz, CH2), 
1.20 (3H, d, J =  6.1 Hz, CH3CYLO), 1.01 (3H, t, J  = 7.0 Hz, CH3CH2), 0.85 (9H, s, 
S i(C //^3), 0.04 (6H, s, 2SiCH3); °C  NMR (75 MHz, CDC13) 5 186.3 (C O ), 94.3 
(C O C O ) , 81.6 ( C O C O ) ,  65.5 (OCH), 55.4 (CH2C O ), 25.8 (SiC(CH3) 3\  24.0 
(CH2), 21.2 (CH2), 21.0 (CH3), 18.0 (SiC(CH3)3), 13.5 (CH3), - 4.5 (SiOC), - 5.0 
(SiCffj); LRMS m/z (%)+FAB 269 (M+H, 50%), 253 (10), 211 (100), 159 (87); 
HRMS calcd for Ci5H280 2Si 269.1937 (M+H), found 269.1845.
2-Methyl-6-propyl-2,3-dihydropyran-4-one (198). To a stirred solution of 2-{tert- 
butyldimethylsilanyloxy)-non-5-yn-4-one (0.30 g, 1.12 mmol) in acetone (30 mL, 
HPLC grade) at 20 °C was added acidified mercury(II) sulfate solution (0.30 mL, 0.1 
M HgO in 2.5 % H2SO4). The mixture was stirred for 6 h then neutralized by the 
addition of powdered sodium hydrogen carbonate. The mixture was stirred for a 
further 1.5 h, filtered and the filtrate evaporated. The residue was dissolved in ether 
(20 mL) and the solution we washed with water (20 mL). The aqueous layer was 
extracted with ether (3 x 20 mL), and the combined organic extracts were washed 
with saturated aqueous sodium hydrogen carbonate (30 mL), then brine (30 mL), and 
the organic layers were dried (Na2S 04), filtered and evaporated. The residue was 
purified by flash column chromatography (30:70 ethyl acetate: petroleum ether) to
give 198 (0.12 g, 75%) as a yellow oil; H NMR (300 MHz, CDC13) 8 5.30 (1H, s, 
CH=C\ 4.45 (1H, m, OCH), 2.35 (2H, d, J =  7.0 Hz, CH2CO), 2.19 (2H, t , J =  7.5 
Hz, CH2), 1.58 (2H, sextet, J  = 7.5 Hz, CH2), 1.44 (3H, d, J  = 6.4 Hz, CH3), 0.93
(3H, t, 7.5 Hz, CH3); ' +  NMR (75 MHz, CDClj) 5 193.1 (C=0), 177.6 (C=CH),
104.0 (CH=C), 75.5 (OCH), 42.7 (C H £= O), 36.7 (CH2), 20.4 (CH3), 19.7 (CH2),
13.5 (CH3).
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2-(5-Butyl-2,2-dimethyl-[l,3]dioxolan-4-yl)-/V-iiiethoxy-/V-methylacetamide 
(203). 3,4-Dihydroxyoctanoic acid A-methoxy-A-methylamide (0.20 g, 0.91 mmol) 
was dissolved in a mixture of 2,2-dimethoxypropane and acetone (1:1, 9.0 mL) and a 
catalytic amount of p-toluenesulfonic acid monohydrate (8.7 mg, 4.5 x 10'5 mol) was 
added. The mixture was stirred at 20 °C until completion (approx. 2 h). Saturated 
aqueous sodium hydrogen carbonate (10 mL) was added to the mixture which was 
then extracted with dichloromethane (3 x 10 mL). The combined organic layers 
were dried (Na2S 04), filtered and evaporated. The residue was purified by column 
chromatography (1:4 ethyl acetate: petroleum ether) to give 203 (0.16 g, 70%) as a
brown oil; IR v™* (c m 1) 1688 (C=0); H NMR (300 MHz, CDC13 5 4.29 (1H, m, 
OCH), 3.86 (4H, m, OCH, CH30), 3.34 (3H, s, NCH3), 2.99 (1H, dd, J  = 15.1, 7.6 
Hz, CH2C=0), 2.69 (1H, dd, J  = 15.1, 4.3 Hz, CH2C=0), 1.74-1.53 (12H, m, 3CH2,
2CH3), 1.05 (3H, t , J  = 6.7 Hz, CH3); 13C NMR (75 MHz, CDC13) 6 184.0 (C O ),
108.7 (C(CH3)2), 81.3 (OCH), 17A (OCH), 61.7 (OCH3), 36.2 (CH2C=0), 32.7 
(CH2), 31.2 (NCH3), 28.5 (CH2), 27.8 (CH3), 27.7 (CH3), 23.1 (CH2), 14.3 (CH3); 
LRMS m/z (%)+EI 260 (27%), 244 (10), 202 (70), 184 (30), 141 (10), 59 (8), 43
(10); HRMS calcd for Ci3H250 4N 260.1861, found 260.1860.
l-(5-Butyl-2,2-dimethyl-[l,3]dioxolan-4-yl)-hept-3-yn-2-one (204). A solution of 
pent-l-yne (0.57 mL, 5.8 mmol) in tetrahydrofuran (20 mL) was cooled to -  78 °C 
under a nitrogen atmosphere, «-butyllithium (3.4 mL, 3.86 mmol, 2.5 M in hexane) 
was added and stirring was continued for 10 min at -  78 °C. The mixture was then 
treated dropwise with a solution of 2-(5-butyl-2,2-dimethyl-[l,3]dioxolan-4-yl)-7V- 
methoxy-N-methylacetamide (1.0 g, 3.86 mmol) in tetrahydrofuran (10 mL), after 
which the mixture was allowed to warm to 0 °C and stirred for 2 h. The mixture was 
poured onto saturated ammonium carbonate (10 mL) and the separated aqueous layer 
was extracted with ether (3 x 10 mL). The combined organic extracts were dried 
(Na2S 0 4), filtered and evaporated. Flash chromatography gave 204 (0.35 g, 34%) as
an orange oil, IR Vmax (cm '1) 2212 (alkyne group), 1682 (C=0); H NMR (300 MHz, 
CDC13) 5 4.09 (1H, m, OCH), 3.62 (1H, q , J  = 7.4 Hz, OCH), 2.75 (1H, dd ,J =  15.8,
7.7 Hz, C //2C O ) ,  2.67 (1H, dd, J  = 15.8, 4.4 Hz, C H //O O ), 2.28 (2H, t, J  = 7.3 
Hz, CH2O C ), 1.54 (4H, m, CH2), 1.33 (10H, m, 2CH2 and 2CH3), 0.95 (3H, t, J  =
7.3 Hz, CH3), 0.84 (3H, t, J  = 6.7 Hz, CH3); 13C NMR (75 MHz,CDCl3) 6 185.0
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(C=0), 109.0 (CMe2), 95.9 (C=CC=0), 81.5 (C=CC=0), 81.1 (OCH), 76.7 (OCH),
49.4 (CH2C=0), 32.6 (CH2), 28.5 (CH2), 27.7 (CH3), 27.5 (CH3), 23.1 (CH2), 21.6 
(CH2), 21.3 (CH2), 14.3 (CH3), 13.8 (CH3); LRMS m/z (%)+FAB 267 (M+H, 5%), 
265 (12), 251 (25), 209 (75), 191 (100), 157 (15), 95 (50), 85 (15), 59 (25); HRMS 
calcd for C16H260 3 267.1960 (M+H), found 267.1962.
8,9-Dihydroxytridec-4-yn-6-one (205). To a solution of l-(5-butyl-2,2-dimethyl- 
[l,3]dioxolan-4-yl)-hept-3-yn-2-one (0.20 g, 0.75 mmol) in methanol (25 mL) was 
added Dowex-50 (5.0 g) and the mixture was stirred at 20 °C for 48 h. The resin was 
removed by filtration and washed with methanol. Evaporation of the combined 
filtrates gave a residue that was purified by flash column chromatography (1:1 ethyl 
acetate: petroleum ether) to give 205 (0.10 g, 59%) as an orange oil; IR vmax(cm'1) 
3417 (OH), 2214 (alkyne group), 1702 (C O ); H NMR (300 MHz, CDC13) 5 4.32 
(1H, m, CHOH), 3.89 (1H, m, CHOH), 2.35 (2H, t,J =  7.0 Hz, CH2C=C), 1.59 (4H, 
m, CH2COH, CH2CO ) ,  1.29 (6H, m, 3CH2), 0.97 (3H, t, J  = 7.3 Hz, CH3), 0.85 
(3H, t, J  = 6.9 Hz, CH3); 13C NMR (75 MHz, CDC13) 5 188.1 (C O ), 101.1 
(C O C O ) , 80.9 (COH), 78.5 (C O C O ) , 72.3 (COH), 38.0 (CH2CO ) ,  34.8 
(C//2COH), 32.0 (CH2), 25.8 (CH2), 22.9 (CH2), 21.5 (CH2), 14.3 (CH3), 13.8 (CH3); 
LRMS m/z (%)+EI 227 (M+H, 6%), 224 (40), 209 (100), 187 (20), 179 (25), 165 
(80), 149 (25); HRMS calcd for Ci3H220 3 226.1569, found 226.1559.
l-(5-Butyl-2,2-dimethyl-[l,3]dioxoIan-4-yl)-4-ethoxybut-3-yn-2-one (206). A
solution of ethoxyacetylene (1.13 mL, 5.8 mmol) in tetrahydrofuran (20 mL) was 
cooled to -  78 °C under an atmosphere of nitrogen, «-butyllithium (2.1 mL, 5.2 
mmol, 2.5 M in hexane) was added and stirring was continued for 10 min at -  78 °C. 
A solution of 2-(5-butyl-2,2-dimethyl-[l,3]dioxolan-4-yl)-/V-methoxy-A-methyl 
acetamide (0.50 g, 1.93 mmol) in tetrahydrofuran (20 mL) was then added dropwise 
and the mixture was allowed to warm to 0 °C and stirred for 3 h. The mixture was 
poured onto saturated aqueous ammonium chloride (10 mL) and the separated 
aqueous layer was extracted with ether ( 3 x 1 0  mL). The combined organic extracts 
were dried (Na2SC>4 ), filtered and evaporated. Flash chromatography (2:8 ethyl 
acetate: petroleum ether) gave 206 (0.35 g, 67%) as an orange oil; IR Vmax (cm*1) 
2222 (alkyne group), 1710 (C=0); H NMR (300 MHz, CDC13) 6 4.11 (2H, q, J  =
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7.0 Hz, CH20 ), 3.91 (1H, m, OCH), 3.57 (1H, m, OCH), 2.66 (2H, m, CH2C=0),
1.49 (2H, m, CH2), 1.31 (13H, m, 2CH2 and 3CH3), 0.86 (3H, t, J =  6.1 Hz, CH3); 
I3C NMR (75 MHz, CDC13) 5 200.9 (C=0), 109.0 (CMe2), 91.0 (C O C O ) , 81.3 
(CO C =O ), 81.2 (OCH), 76.8 (OCH), 61.7 (CH20), 46.5 (CH2C O ), 32.5 (CH2),
28.5 (CH2), 27.7 (CH3), 27.5 (CH3), 23.1 (CH2), 14.5 (CH3), 14.2 (CH3); LRMS m/z 
(%)+FAB 307 (20), 287 (18), 271 (10), 257 (5), 239 (8), 229 (30), 211 (60), 183 
(12), 154 (100); HRMS calcd for C 15H240 4 268.1909, found 268.1895.
Attempted preparation of l-ethoxy-5,6-dihydroxydec-l-yn-3-one (170). To a
solution of 1 -(5-butyl-2,2-dimethyl-[ 1,3]dioxolan-4-yl)-4-ethoxybut-3-yn-2-one 
(0.30 g, 1.11 mmol) in methanol (25 mL) was added Dowex-50 (3.0 g) and the 
mixture was stirred at 20 °C for 48 h. The resin was then removed by filtration and 
washed with methanol. Evaporation of the combined filtrates gave a residue that was 
purified by flash column chromatography (10:90 diethyl ether: petroleum ether) to 
give the by-product 2-butyl-5-ethoxyethynylfuran 207 (0.15 g, 70%) as an orange 
oil; H NMR (300 MHz, CDC13) 5 6.02 (1H, d, J  =3.0 Hz, CZ/O), 5.83 (1H, d, J  
=3.0 Hz, CH=C), 4.12 (2H, q, J  = 7.1 Hz, CH2O), 2.51 (2H, t,J =  7.3 Hz, CH2), 1.50 
(2H, m, CH2), 1.28 (2H, m, CH2), 1.19 (3H, t, J =  7.1 Hz, CH3), 0.85 (3H, t,J =  7.3 
Hz, CH3); 13C NMR (75 MHz, CDC13) 8 157.0 (CH2C O H ), 146.2 (C=CCOH),
108.7 (CH=CC=C), 105.8 (CH=CCU2), 82.5 (C O O ), 61.4 (CH20 ), 31.7 (CH2), 30.5 
(CH2), 28.1 (CH2), 22.6 (C O O ), 14.5 (CH3), 14.1 (CH3).
6-Ethoxy-2-(l-hydroxy-pentyl)-2,3-dihydropyran-4-one (rac-171). To a stirred 
solution of 1 -(5-butyl-2,2-dimethyl-[ 1,3]dioxolan-4-yl)-4-ethoxybut-3-yn-2-one 
(0.30 g, 1.12 mmol) in acetone (30 mL, HPLC grade) at 20 °C was added acidified 
mercury(II) sulfate solution (0.30 mL, 0.1 M HgO in 2.5 % H2S 04). The mixture 
was stirred for 30 min then neutralized by the addition of powdered sodium hydrogen 
carbonate. The mixture was stirred for a further 1.5 h, and then worked up as for 
198. The residue was purified by flash column chromatography on silica gel (3:7 
ethyl acetate: petroleum ether) to give rac-171 (0.19 g, 73%) as a yellow oil; IR vmax 
(cm'1) 3482 (OH), 1695 (C O ); H NMR (300 MHz, CDC13) 8 4.56 (1H, s, CH=C), 
3.79 (3H, m, CH20 , OCH), 3.44 (1H, m, CHOH), 2.32 (1H, dd, J  = 14.4, 7.7 Hz, 
C //H C O ), 2.25 (1H, dd, J  = 14.4, 4.5 Hz, C H //C O ), 1.14 (9H, m, CH3, 3CH2),
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0.65 (3H, t, J =  6.8 Hz, CH3); " c  NMR (75 MHz, CDC13) 8 193.7 (C=0), 169.0 
(C=CH), 108.4 (CH=C), 81.3 (OCH), 78.3 (CHOH), 64.2 (CH2O), 32.7 (CH2CO), 
28.8 (CH2), 27.7 (CH2), 23.1 (CH2), 14.6 (CH3), 14.2 (CH3); LRMS m/z (%)+CI 229 
(M+H, 60%), 211 (90), 183 (80), 157 (70), 141 (100), 123 (50); HRMS calcd for 
Ci2H20O4 229.1440 (M+H), found 229.1437.
2-Acetoxy-l-[(methoxy-methyl-carbamoyI)-methyl]-hexyl acetate (209). To a
stirred solution of 3,4-dihydroxyoctanoic acid A^methoxy-A^-methylamide (0.20 g, 
0.91 mmol) in pyridine (2.0 mL, 24.8 mmol) at 0 °C was added acetic anhydride (2.0 
mL, 1.82 mmol). After stirring for 90 min, the solvents were evaporated and the 
residue was purified by column chromatography (3:7 ethyl acetate: petroleum ether) 
to give 209 (0.26 g, 93%) as a colourless oil; IR vmax (cm'1) 1693 (C=0), 1652
(C=0); *H NMR (300 MHz, CDC13) 5 5.43 (1H, m, OCH), 5.09 (1H, m, OCH), 3.66 
(3H, s, CH30 ), 3.14 (3H, s, CH3N), 2.65 (2H, d, J =  5.9 Hz, CH2C=0), 2.07 (3H, s, 
CH3C O ) , 2.05 (3H, s, CH3C=0), 1.56 (2H, q, J=  7.4 Hz, CH2), 1.27 (4H, m, CH2),
0.86 (3H, t, J  = 6.7 Hz, CH3); 13C NMR (75 MHz, CDC13) 5 170.6 (C=0), 170.1 
(C=0), 73.7 (OCH), 70.2 (OCH), 61.2 (CH30), 33.6 (CH2C=O), 32.2 (CH3N), 30.3 
(CH2), 27.4 (CH2), 22.4 (CH2), 21.0 (CH3C=0), 20.9 (CH3C=0), 13.9 (CH3); LRMS 
m/z (%)+EI 304 (M+H, 100%), 244 (100), 215 (20), 202 (100), 184 (70), 173 (85), 
141 (90), 132 (100), 123 (83), 113 (35), 99 (100), 81 (90), 69 (42); HRMS calcd for 
Ci4H250 6N 303.1682, found 303.1685.
Attempted synthesis of l-(4,6-dioxotetrahydropyran-2-yl)-pentyl acetate (210).
2-Acetoxy-l-[(methoxy-methyl-carbamoyl)-methyl]-hexyl acetate (0.20 g, 0.66 
mmol) was dissolved in tetrahydrofuran (6.0 mL) and cooled to -  78 °C. KHMDS 
(1.32 mL, 1.32 mmol, 1.0 M in tetrahydrofuran) was added over 5 min, and after a 
further 10 min the mixture was quenched by the rapid addition of aqueous 
hydrochloric acid (6.0 mL, 0.5 M). The resulting mixture was extracted with ethyl 
acetate (3 x 10 mL). The combined organic extracts were dried (MgS04), filtered 
and evaporated to give after column chromatography (7:3 ethyl acetate: petroleum
ether) the amide by-product 211 (0.10 g, 62%) as a colourless oil; 'h  NMR (300 
MHz, CDC13) 8 6.84 (1H, dd, J =  15.5, 6.1 Hz, CH=CHC=0), 6.55 (1H, d, 7 = 15.5 
Hz, CH=C//C=0), 5.40 (1H, q, J =  6.1 Hz, OCH), 3.69 (3H, s, OCH3), 3.24 (3H, s,
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NCH3), 2.08 (3H, s, COCH3), 1.62 (2H, m, CH2), 1.32 (4H, m, CH2), 0.88 (3H, t , J  = 
6.6 Hz, CH3); °C  NMR (75 MHz, CDC13) 8 171.2 (CH30 C = 0 ), 162.4 (0=0), 147.9 
(C//=CHC=0), 120.5 (CH=C//C=0), 78.1 (OCH), 52.8 (CH30), 34.0 (CH3N), 33.6 
(CH2), 27.5 (CH2), 23.9 (CH2), 18.2 (CO2CH3\  14.3 (CH3).
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Towards the Total Synthesis of NK10958P
4.1 Introduction
Natural products possessing immunosuppressant activity have received a great deal 
of attention since the introduction of cyclosporin A (CsA)1 214 and FK-5062 215, 
which are used for the treatment of autoimmune diseases, especially those associated 
with organ transplantation.3 Recently Kawada and co-workers reported the isolation 
of the novel immunosuppressant agent 84 (PA-48153C)4 from the fermentation 
broths of Streptomyces prunicolor PA-48153C and found it to possess potent 
immunosuppressant activity similar to that exhibited by 214 and 215. Interestingly, 
PA-48153C 84 was found to have a different mode of action to CsA 214 and FK-506 
215; PA-48153C was found to inhibit the responses of both T and B lymphocytes to 
mitogens,5 while CsA and FK-506 affect only T-cell activation.6 Kobayashi and co­
workers have also reported the isolation of a plant-growth regulator, given the name 
pironetin, from Streptomyces sp. NK10958P whose structure has proven to be 
identical with that of 84 (Figure 4 .1).7
Me
^ .-Y 'tr V rM e O 1
Cyclosporin A 214
ORkMeMeO,
rOH
OH
R = H, NK10958P 83 
R = Me, Pironetin 84Me
kOMe
Me Me
FK-506 215
Figure 4.1: The structures of CsA, FK-506 and pironetin.
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A major limitation to pironetin as a therapeutic agent is its high cytotoxicity; 
however, recently certain structurally-modified derivatives of pironetin have shown 
promise.8 Moreover, these relatively simple structures exhibit potency comparable 
to that shown by CsA. Another recent report in the literature suggests efficacy of 
certain derivatives of 84 in assays against uterine and ovarian tumours, in addition to 
activity as inhibitors of tubulin polymerisation and thus the cell cycle.6,9
4.2 Syntheses o f Pironetin Reported in the Literature
Interesting biological activity and a simple structure makes 84 and its demethylated 
analogue 83 attractive synthetic targets. In 1995, the first total synthesis of 84 was 
reported by Kawada and co-workers,10 which utilized a carbohydrate approach to the
2-pyranone ring. Since then more than four total syntheses of 84 have been reported, 
6,11-13 those generally involve over 20 steps with complex starting material.
Gurjar and co-workers disclosed two syntheses of 84 (Scheme 4.1),11 in which the 
stereochemistry was set via combinations of stereoselective epoxide-ring openings 
and Evans aldol reactions (Scheme 4.2).
M e M e Me Me
'CHO
O M e OH O. O M e OH
2 1 6
( R o u te  A )
(Route B)
M e
M e
Me
•OH
O BnOH
2 1 9218220
A
Bit 2 1 7
M e
2 2 1  OH
OEt
Scheme 4.1: Retrosynthetic strategy for pironetin.
The synthesis of 84 was initially attempted using route A in which the Stork-Ueno 
radical cyclisation was a key step; however, this route was abandoned due to the 
unsatisfactory yields of some steps. The second route investigated used Sharpless’s 
asymmetric epoxidation reaction and the Evans asymmetric aldol methodology to
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establish the stereogenic centres; this resulted in the successful total synthesis of 84 
(Scheme 4.2).
C H O
.CO2M6
Scheme 4.2. Reagents and conditions', (a) (i) IBX, DMSO, 20 °C, 30 min., (ii) 
Ph3P=CHC02Et, C6H6, 20 "C, 3 h, (iii) DIBAL-H, CH2C12, -20 °C, 30 min.; (b) 
TBHP, TTIP, (-)-DIPT, CH2C12, -20 "C, 20 h; (c) (i) Me2LiCu, Et20 , -78 °C, 8 h, (ii) 
TBS-C1, Im, CH2C12, 20 ”C, 3 h, (iii) KH, Mel, Et20 , 20 °C, 30 min, (iv) Bu^NF, 
THF, 20 ”C, 2 h; (d) (i) IBX, DMSO, 20 "C, 30 min., (ii) Ph3P=CHC02Et, C6H6, 20 
”C, 3 h, (iii) DIBAL-H, CH2C12, -20 °C, 45 min.; (e) TBHP, TTIP, (+)-DIPT, 
CH2C12, -20 °C, 18 h; (f) Red-Al, THF, 0 °C, 4 h; (g) (i) Piv.Cl, Py, CH2C12, 20 °C, 1 
h, (ii) TBS-OTf, 2,6-Iutidine, CH2C12, 0 °C, 5 min., (iii) DIBAL-H, CH2C12, -20 °C, 
20 min., (iv) IBX, DMSO, 20 °C, 30 min.; (h) (.S’)-A'-butanoyloxazolidmone, 
Bu2BOTf, CH2C12, -78 °C, 6 h; (i) (i) TBS-OTf, 2,6-lutidine, CH2C12, 0 °C, 10 min., 
(ii) LiBFLt, MeOH-THF, 0-20 °C, 4 h; G) (i) IBX, DMSO, 20 °C, 30 min., (ii) 
(CCl3CH20 ) 2P=CHC02Me, NaH, DMF, -40 ”C, 6 h; (k) 1% HC1, EtOH, 20 ”C, 12 h.
The stereocentres present in the side-chain of 84 were established mainly from the 
Sharpless asymmetric epoxidation product, the Evans aldol addition of aldehyde 216
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with (5)-iV-butanoyloxazolidinone in the presence of dibutylborontriflate gave 227 
with high diastereoselectivity as confirmed by the high resolution ]H NMR spectrum 
of the aldol product. Oxidation of the terminal alcohol 228 (IBX, DMSO, 20 °C) 
followed by cis-olifination with modified Homer-Wadsworth-Emmons reaction 
((CCl3CH20)2P0CHC02Me, NaH, DMF, - 40 °C) gave 229 as a sole product. 
Finally compound 231 was treated with 1% aqueous hydrochloric acid in ethanol at 
20 °C for 12 h to give pironetin 84. Kitahara14 and Chida15 have also reported 
syntheses of 84 in which nucleophilic additions to epoxides play prominent strategic 
roles.
Scheme 4.3 outlines the synthetic route described by Keck and co-workers towards 
the synthesis of pironetin 84, which applies the recently developed lactone 
annulation procedure to install the lactone moiety by reaction of the lithium enolate 
of methyl acetate with p-acetoxy aldehyde 230 (Scheme 4.6).12
PM BO  O TM S O O C H 3
231 Me 232
Scheme 4.3: Retrosynthesis of 84.
The synthesis of the p-acetoxy aldehyde 230 was achieved by the Lewis acid 
promoted Mukaiyama aldol reaction of the silyl enol ether 231 and the aldehyde 232, 
the preparation o f these two intermediates is outlined in Schemes 4.4 and 4.5. The 
addition reaction of 231 and 232 using BF3.Et20  as Lewis acid proceeded to give 241 
as a single diastereomer, which underwent samarium diiodide reduction to give the 
desired diol 242 in good diastereoselectivity (4.6:1). Acylation of the diol, followed 
by removal of the PMB protecting group, gave the desired primary alcohol, which 
was oxidised to the corresponding aldehyde 230. Lactone annulation was effected by 
the reaction of 230 with the lithium enolate of methyl acetate to give the desired 
lactone product 241. Finally, removal of the acetate protecting group by acid- 
catalysed methanolysis gave (-)-pironetin (Scheme 4.6).
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OH M e 2 3 3
(a)
M e
M e O
(b) PM BO X
OH M e
M e
2 3 4
kA M e
23 5
(d) p m b o ^ ^ t m s (c)X = CH2 -----► x = o
2 3 1
Scheme 4.4: Synthesis o f the Enol Ether 231. Reagents and conditions: (a) LDA, 
LiCl, EtI, 93%; (b) (i) LiNH2:BH3, (ii) KH, PMBBr; (c) 0 s 0 4, N aI05, 52% from 
241; (d) (TMS)2NLi, TMSC1.
BnO O BnO  O C H 3  BrBnO  O C H 3
Me M e Me M e 
2 3 8
HO O C H 3 O O C H 3
M e MeMe Me Me Me
BnO O C H 3
Scheme 4.5: Synthesis o f Aldehyde 232. Reagents and conditions', (a) (i) 
CH3CH=€HCH2SnBu3, TiCl4, 89%, (ii) KH, Mel, 92%; (b) (i) 9-BBN, H20 2, 92%,
(ii) TPAP, NMO, (iii) CBr4, PPh3, 68% over two steps; (c) BuLi, Mel, 99%; (d) 
Li/NH3, 84%; (e) TPAP, NMO.
PM BO  O T M S 0  O C H 3
kA
2 3 1
M e M e
(a)
PM BO  O OH O C H 3
2 4 1  Me Me
(b)
PM B O  OH OH O C H 3 O O A c O A c O C H 3
(d)
M e M e Me Me
O A c O C H 3
Me Me
2 4 3
Scheme 4.6: Total synthesis of pironetin 84. Reagents and conditions', (a)
BF3.Et20 , 86%; (b) Sml2, THF, MeOH, 91%; (c) (i) DDQ, 92%, (ii) Ac20 , 97%, (iii) 
TPAP, NMO; (d) CH=C(OLi)-OMe, 74%; (e) MeOH, 3 N HCl, 65 °C, 8 h, 86%.
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A recent report by Dias and co-workers described the shortest synthetic route to 84 to 
date, consisting of 18 steps and involving three syn aldol reactions to establish the six 
stereogenic centres (Scheme 4.7). The final steps in this synthesis involved the 
Homer-Wadsworth-Emmons reaction of the aldehyde 244 using the stabilizing 
reagent ((o-cresol)2P(0)CH2C02Et) under Ando’s conditions to give the 
corresponding a,p-unsaturated ester (Z:E >95:5).16 Lactonisation of the a,p- 
unsaturated ester was achieved by treatment with 1% aqueous hydrochloric acid in 
ethanol, this furnished the desired product in 11% overall yield from 247.
Me O Me
Et Homer
Emmons Acetylide 
coupling
Evans' aldol
O T s O M e O R  O PM B
H C =C L i +
M e Me 2 4 6
Evans'
aldol
O O r\ r\ d
Scheme 4.7: Retrosynthetic analysis of pironetin described by Dias and co-workers.
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4.3 Results and Discussions
In this chapter the attempted synthesis of NK10958P 83 using chiral boron-mediated 
cross-aldol coupling of fragments 249 and 250 will be described (Scheme 4.8). As 
part of this effort two proposed syntheses of the lactonic aldehyde 250 were 
investigated, the first incorporating a mercury(II) catalysed step to achieve the 
cyclisation to the dihydropyranone ring (Scheme 4.9). The second method 
investigated used Keck’s annulation procedure, 17 i.e. the aldol addition of the lithium 
enolate of methyl acetate to a p-acetoxy aldehyde intermediate 264 (Scheme 4.22).
Scheme 4.8: Retrosynthetic analysis of NK10958P
4.3.1 Proposed Synthesis o f the a,/I-Unsaturated Lactone 250 using a Mercury(II)- 
Catalysed Cyclisation
As outlined in Scheme 4.9, the cyclisation of alkynic epoxy alcohol 253 in the 
presence of a mercury(II) catalyst was expected to furnish the dihydropyranone 254, 
a key intermediate for the synthesis of 250.
Scheme 4.9: Proposed method for the synthesis of 250. Reagents and conditions: (a) 
(i) UAIH4 , THF, 20 °C, (ii) TBHP, TTIP, (-)-DET, CH2C12, -20 °C; (b) (i) S 0 3-2Py,
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DMSO, NEt3, 20 °C, (ii) ethoxyacetylene, «-BuLi, THF, - 78 °C; (c) HgO, H2S 04, 
acetone, 20 °C.
4.3.1.1 Wittig- Wadsworth-Emmons reaction
The Wittig-Wadsworth-Emmons reaction is an important reaction in organic 
synthesis (Scheme 4.10). A strong base (e.g. /i-butyllithium or sodium hydride) is 
used to generate the ylide that attacks the carbonyl compound. The reaction is 
believed to occur via an oxaphosphetane intermediate and is driven by the strength of 
the P-0 bond that is formed in the phosphine oxide.
n
R3P—|—R2 
Ri
Base +  r 2
R 3P — ( -  
R i
Ylide
R^P=<
R4COR3 R3(j>—f ~ R 2 
O x  R 3
r4
Oxaphosphetane
R i  R3
MRo R<
Scheme 4.10: Mechanism of the Wittig reaction.
Generally, an unstabilized ylide affords predominantly the Z-isomer, while an ylide 
bearing a stabilising group such as an ester affords mainly or exclusively the E- 
isomer, being more thermodynamically stable on account of steric constraints in the 
Z-isomer.
Phosphonate esters such as 255 also react readily with bases to form ylides (Scheme 
4.11). Such ylides will also attack aldehydes and ketones to give a,p-unsaturated 
acids and esters, a process known as the Wadsworth-Emmons reaction. These 
phosphonate esters can be prepared by the Arbuzov reaction. One of the advantages 
of this method is that the phosphate byproduct is water-soluble which simplifies the 
isolation of the product. Owing to stabilization of the ylide, (£>isomers frequently 
predominate.
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(EtO )3P +  BrCH2C 0 2Et
11 — R jR 2C O
(E tO )2P— C H C 0 2Et
C ^ Lc2h5 Br
(E tO )2 ^ -C H 2C 0 2Et
C H C 0 2Et
A  + 8R i R2 (E tO b P -O N a
256
O Base
(EtO )2 P— C H 2C 0 2 Et 1
Phosphonate ester 255
Scheme 4.11: The Arbuzov and Wadsworth-Emmons reactions.
Treating the anion derived from ester phosphonate 258 with the aldehyde 263 under 
Wadsworth-Emmons conditions afforded 251 (Scheme 4.12); a 1:1 mixture of the 
E/Z isomers was initially obtained, but the crude product was heated under reflux in 
diphenyl disulfide for 10 h which resulted in the formation of the (£)-isomer 251 as 
the sole product.18'20 LiAlFfi reduction in anhydrous ether gave 25921 and then 
Sharpless asymmetric epoxidation gave the epoxide 252. Scheme 4.13 describes the 
preparation of aldehyde 263. However, since the LiAH-fi reduction and epoxidation 
reactions gave poor yields and also given the large number of steps involved in this 
proposed route, a shorter route to the a,p-unsaturated lactone 250 was investigated, 
this is discussed in the next section.
O E t  
Br 257
(c)
(a)
84% EtO-
EtO'
OEt
- P - ^  258
56%
(d)
259
46%
OBn
(b)
70%
252
OBn
OBn
Scheme 4.12. Reagents and conditions: (a) P(OEt)3 , 160 °C, 5 h; (b) (i) NaH, THF, 
0 °C, 263, 1.5 h, (ii) Ph2S2, THF, 65 °C, 10 h; (c) LiAlFfi, THF, 20 °C, 20 h; (d) 
TBHP, TTIP, (-)-DET, CH2C12, -20 °C, 6 h.
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Scheme 4.13: Reagents and conditions: (a) PhCHO, /?-TsOH, toluene, 90 °C, 2.5 h; 
(b) A1C13, LiAlH4 , ether, 0 °C, 1 h; (c) NaH, BnBr, THF:DMF, 20 °C, 51 h; (d) SO3- 
pyridine, NEt3, DMSO: CH2C12, 0 °C, 12 h.
4.3.2 Proposed Synthesis o f  the a,p-lnsatu rated Lactone 250 using Evans 
Asymmetric A ldol M ethodology
The key step of this route is the Keck annulation procedure, involving the aldol 
addition of the p-acetoxy aldehyde 264 to the lithium enolate of methyl acetate. The 
aldehyde 250 could be obtained by the deprotection of the TBS protecting group 
followed by oxidation (Scheme 4.14).
Scheme 4.14: Proposed synthesis of the lactonic aldehyde fragment of NK10958P 
using Evans aldol methodology.
4.3.2.1 Evans Asymmetric Aldol Reaction: Introduction
Deprotonation of the keto derivative 266 under kinetic control affords the (Z)- and 
the (^-enolates (Scheme 4.15). Each isomer then reacts with the electrophile (re- or 
5 7-face attack) to give two different enantiomers. In general, the enolate geometry 
plays an important role in determining the stereochemical outcome of the aldol 
reaction which proceeds via a cyclic transition state. The (Z)-enolate reacts with an 
aldehyde to produce the 1,2-syn products, whereas the 1,:2-anti products arise from 
the (£)-enolate.
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Scheme 4.15: Preparation of (Z)- and (£)-enolates from keto derivatives.
The reaction is believed to occur via a six-membered cyclic, Zimmerman-Traxler 
transition state22 in which the alkyl group of the aldehyde derivative adopts a pseudo- 
equatorial position. Furthermore, within 1,2-syn or 1,:2-anti aldol products, 
enantioselection can be obtained by means of a chiral auxiliary or a chiral ligand- 
based enolate.
Derived from (S)-valine, Evans’ 2-oxazolidinone 269 (Scheme 4.16) is an important 
auxiliary for asymmetric C-C and C-X (X = O, N, Br, F, etc.) bond formation. The 
Evans’ aldol reaction involves the application of chiral enolates such as 270 to 
achieve highly diastereoselective and enantioselective C-C bond formation; high 
levels of erythro diastereoface selection lead to the s>w-aldol product 271, the 
favoured transition state 272 projects the small hydrogen (as opposed to the 
isopropyl) towards the sterically demanding centre of the transition state. The Evans 
auxiliary is readily cleaved from the aldol addition product and recycled without any 
racemization o f the aldol product.
\-J
2 6 9  '
2 7 1 ,  Evans s y n ^ -
nBu2BOTf
‘Pr2NEt
Me
Bus ^Bu
v^ - i A o  \_ /
2 7 0  '
Bu
'/■SsjSu
M e ' 1
2 7 2  (favoured)
OH O O
RjCHO
R , I  Bu
A t / ' buH—
Me
2 7 3  (unfavoured)
* «'ArAAft A  ■'< 1 ^Me
2 7 4 ,  non-Evans syn
Scheme 4.16: The proposed mechanism for the Evans asymmetric aldol reaction.
The 7V-butanoyl oxazolidinone 279 was prepared in 85% yield by reacting 278 with 
butyroyl chloride (1.0 equiv, - 78 °C) (Scheme 4.17).23 Selective enolisation of 279
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with di-rt-butylboronyl trifluoromethanesulfonate to form the (Z)-enolate, followed 
by condensation with aldehyde 276 resulted after oxidative work-up in the 
diastereomeric aldol adduct 265. However, the aldol addition reaction using this 
method gave a poor yield (35%) of the aldol 265 along with unreacted 7V-butynyl 
oxazolidinone 279 (65%).24 25
o
--------—------► TBSO^^^^OH--  22----- ► TBSO'^x / ^H
260 89% 275 80% 276
I nh2 0 0 M
(c> cr^NH (d)
--------------------  M y  — ^
f f i  ‘* ' 7 0  r - s i /277 278 Ph7 279 Ph'
96%
Ph
Scheme 4.17: Reagents and conditions: (a) TBSC1, imidazole, THF, 20 °C, 14 h; (b) 
S 03-pyridine, NEt3, DMSO, 0 °C, 30 min; (c) K2C 0 3, CO(OEt)2, 135 °C, 2 h; (d) n- 
BuLi, CH3(CH2)2COCl, THF, - 78 °C, 1 h.
Scheme 4.18 describes the aldol addition reaction reported by Crimmins and co­
workers,26 where the enolization of 4-benzyl-3-propionyloxazolidin-2-one 280 with 
titanium tetrachloride (1.1 equiv) and (-)-sparteine (2.5 equiv) followed by the 
addition of the appropriate aldehyde (1.1 equiv) at 0 °C produced the Evans syn 
adduct, 283 as the major diastereomer in high yield (84-98%) with excellent 
diastereocontrol (Table 4.1).
Ln
/Tk
° n ? n -H ° ?\ oh o o
M V S ,  T ic u  t  M A  R C H O ^
\— I  (-)-sparteine } ----  ^ Me  ^ Me -— ^
B r f  B r f  I
280 281 28J 283
Scheme 4.18: Titanium tetrachloride-mediated aldol addition to 280.
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Table 4.1\ Titanium tetrachloride-mediated aldol addition of 280.
Entry Temperature Aldehyde
(RCHO)
Yield (%) 283:282
1 0°C Et 84 99:1
2 0°C MeCH=CH 89 97:3
3 0 °C Me2CH 89 98:2
4 0 °C t- Bu 87 97:3
5 -78 °C Me2CH 98 98:2
It was observed by Crimmins that the use of 1.05 equiv of titanium tetrachloride, 1.0 
equiv of (-)-sparteine, and 1.0 equiv of A-methyl-2-pyrrolidinone (NMP) resulted in 
similar reactivity and diastereocontrol as those observed with 2.5 equiv of (-)- 
sparteine.26
jV-Acyloxazolidinones produce Evans syn aldol adducts when their chlorotitanium 
enolates are formed in the presence of 2.0 equiv of (-)-sparteine (or (-)- 
sparteine/NMP, 1.0 equiv of each). In these instances the non-chelated transition 
state 284 is operative possibly due to coordination of the second equivalent of the 
amine to the metal centre, thus preventing coordination of the imide carbonyl to the 
metal. The same factors that govern the boron enolate transition states would then be 
operative resulting in the Evans syn product. It was observed by the same group that 
the non-Evans syn adducts were obtained simply by the use of 1 equiv of (-)- 
sparteine and 1 equiv o f titanium tetrachloride; this was attributed to the formation of 
a highly ordered chelated transition state 285 (Scheme 4.19), a model proposed
27-29previously by Nagao and Fujita.
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Scheme 4.19: Asymmetric aldol addition using titanium tetrachloride and (-)-
sparteine for the enolisation of A-acyloxazolidinones.
The above procedure was successfully applied for the synthesis of the aldol product 
265 (Scheme 4.20); this procedure was operationally simple as the reagents were 
used as purchased and no oxidative workup was necessary. The conversion of the 
chiral imide 265 to an A-methoxy-A^-methylamide, such as 286, through the use of 
aluminium amides (prepared in situ by the reaction of N, O-dimethylhydroxylamine 
hydrochloride and trimethyl aluminium, CH2CI2 , - 15 to 0 °C) was developed by 
Evans and co-workers.30,31 The iV-methoxy-A^-methylamide is stable and readily 
converted into its corresponding ketone (using Grignard reagents) or the aldehyde 
(by DIBAL reduction).32
Scheme 4.20: Reagents and conditions: (a) TiCU, (-)-sparteine, 276, CH2CI2, - 78-20 
°C, 2 h; (b) NHMeOMe, AlMe3, CH2C12, 20 °C, 24 h; (c) Ac20 , NEt3, DMAP, 
CH2CI2 , 20 °C, 4 h; (d) DIBA1-H, THF, - 78 °C, 30 min.
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The transamidation reaction is favoured by the presence of either an a-heteroatom 
substituent or a (3-alcohol functionality (aldol products). Acceleration of the 
transamination in the latter case is probably due to the formation of a chelated 
intermediate (Scheme 4.21), which only activates the exocyclic carbonyl group 
towards nucleophilic attack.
MeONHR.HCl
Me-,A1
Scheme 4.21: Evans transamination reaction.
Owing to the poor yield o f the DIBAL reduction of 287 arising from incomplete 
conversion, an alternative route to aldehyde 264 was sought, involving Red-Al 
reduction to cleave the auxiliary and generate the aldehyde functionality, followed by 
protection of the (3-hydroxyl group as the acetate. Owing to the instability of the 
aldehyde 264, towards P-elimination and decomposition, the crude material was used 
directly in the annulation step without further purification. Scheme 4.22 describes 
the proposed route to the a,P-unsaturated lactone 250. The protected lactone 291 
was synthesized in good yields using Keck’s lactone annulation procedure (Scheme 
4.23).17 Removal of the TBS group33 of lactone 291 was achieved using dilute 
hydrochloric acid in methanol; however, various attempts at oxidation to aldehyde 
250 were unsuccessful,34,35 the following conditions; SCVpyridine, PCC and Swem 
oxidation gave a crude mixture of products as determined by ]H NMR.
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Scheme 4.22: Reagents and conditions: (a) Red-Al, THF, - 55 °C, 1 h; (b) AC2O, 
NEt3, DMAP, CH2CI2 , 20 °C, 4 h; (c) LDA, CH3OAc, THF, - 78 °C, 15 min; (d) HC1 
(1.0 M), MeOH, 20 °C, 24 h; (e) S 0 3-pyridine, NEt3, DMSO, 0 °C, 30 min.
The Keck annulation reaction is believed to occur by an aldol addition involving the 
p-acetoxy aldehyde and the lithium enolate of methyl acetate (generated in situ by 
reaction of lithium diisopropyl amide and methyl acetate). Subsequent acyl 
migration, lactonisation and p-elimination generate the lactone product.
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Scheme 4.23: Preparation of a,p-unsaturated lactones.
4.3.3 Synthesis o f the Acyclic Ketone Fragment 249
The enantioselective a-propargylation of acyclic ketones was reported by Enders and 
co-workers to proceed in high enantioselectivity (94-99% ee).36 Initially, the acyclic 
ketones were converted into their corresponding “SAMP-hydrazones” (A)-293 by 
reaction with the enantiomerically pure hydrazine (S)-l-amino-2- 
methoxymethylpyrrolidine (SAMP), readily available from (S)-proline. Metallation 
(lithium diisopropylamide in ether at 0 °C) gave the chiral azaenolate (S)-294, then
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alkylation with alkyl iodide furnished the hydrazone 295. The treatment of 295 with 
an excess o f methyl iodide at 60 °C led to a mixture of the methiodides 297 and 298. 
Hydrazone cleavage via acidic workup of methiodides 297 in a two-phase system (3- 
4 N HC1/ ft-pentane, 60 min) or by ozonolysis led to the a-substituted, 
enantiomerically enriched acyclic ketones 299 (Scheme 4.24).
• l L o  ________________________ ^  J e ® S  ^  j ,  - o c h 3
Rr "v| 3 R i / i 0CH3 Ri '^j^
R2 R2 R2
(S )-293  (5 )-2 9 4  295
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t/ (a) r  H3n4 ^
R O C H 3 II P O C H 3 II O C H 3
R ,"  ^  R , - ^ * R3
R2 296  r2 297  R2 298
O
” 3 *  rA ^
299  R2
Scheme 4.24. Reagents and conditions', (a) Excess Mel, 60 °C; (b) 6.0 M HC1, n- 
pentane.
The preparation of the Acyclic Ketone Fragment 249 was achieved using the ((S)-1- 
Amino-2-(methoxymethyl)pyrrolidine) (SAMP) hydrazone 302, as outlined in 
Scheme 4.25. Cleavage o f the SAMP hydrazone was achieved by the addition of 
methyl iodide followed by the acid hydrolysis procedure to furnish the enantiopure 
ketone in 54% yield. The high enantioselectivity was confirmed by the high 
resolution *H NMR of the coupled product 302.
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Scheme 4.25: Reagents and conditions: (a) SAMP, 60 °C, 20 h; (b) (i) LDA, 0 °C, 4 
h, (ii) crotyl bromide, 20 °C, 4 h; (c) (i) Mel, 60 °C, 20 h, (ii) HC1 (4.0 M), n- 
pentane, 20 °C, 30 min.
4.4 Conclusions
The conversion of the lactonic alcohol 292 into the corresponding aldehyde 250 was 
a key step in this sequence; use of milder conditions for this reaction, such as Dess- 
Martin periodate procedure may give the lactonic aldehyde 250. The crossed-aldol 
reaction using (-)-diisopinocampheylboron triflate of the aldehyde 250 and ketone 
249,37 followed by stereoselective reduction of the ketone functionality using
38tetramethylammonium triacetoxyborohydride (Me4NHB(OAc)3 ) is expected to 
generate the final product NK10958P. This proposed route towards NK10958P 
could be extended to achieve the synthesis of the methylated derivative pironetin 84.
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Experimental
2-(Diethoxyphosphoryl)butyric acid ethyl ester (258)39 A mixture of ethyl-2 - 
bromobutyrate (10.0 g, 51.3 mmol) and triethyl phosphite (10.6 g, 64.0 mmol) was 
heated at 160 °C. After 1 h, a further portion of triethyl phosphite (10.6 g, 64.0 mmol) 
was added and the heating continued for 4 h. The excess triethyl phosphite was 
distilled under reduced pressure to give 258 (10.8 g, 84%) as an orange oil which was
used in the next step without further purification; *H NMR (300 MHz, CDC13) 5 4.12 
(6 H, m, CH20 ), 2.78 (1H, dq, J  = 10.5, 4.4 Hz, CHP), 1.90 (2H, m, CH2CH3), 1.27 
(9H, m, CH3), 0.94 (3H, t, J  = 7.3 Hz, CH3);13C NMR (75 MHz, CDC13) 6  169.2 
(C=0), 62.6 (CH20 ), 62.5 (CH 20 ), 61.3 (CH2 0), 48.4 (C//C), 20.7 (CH2), 16.3 (CH3),
14.1 (CH3), 13.0 (CH3), 12.8 (CH3).
5-BenzyIoxy-2-ethylpent-2-enoic acid ethyl ester (251).19 A solution of 2- 
(diethoxyphosphoryl)butyric acid ethyl ester (2.3 g, 9.15 mmol) in dry 
tetrahydrofuran (25 mL) was added to a stirred suspension of sodium hydride (0.37 
g, 9.15 mmol, 60 % dispersion in oil) in dry tetrahydrofuran (5 mL) at 0 °C. After 
being stirred at 20 °C for 30 min, a solution of 3-(benzyloxy)propionaldehyde (1.2 g, 
7.32 mmol) in dry tetrahydrofuran (25 mmol) was added dropwise at 0  °C and the 
mixture was stirred for 1 h. The resulting solution was poured onto ice-cooled water 
(10 mL) and then extracted with ether ( 3 x 1 0  mL). The extracts were washed with 
brine (10 mL), dried (M gS04), filtered and evaporated to give a 1:1 mixture of (E)- 
ester and (Z)-ester (1.7 g, 6.5 mmol) as a colourless oil. A solution of the crude 
product in anhydrous tetrahydrofuran (80 mL) was heated at reflux in the presence of 
diphenyl disulfide (0.42 g, 1.94 mmol) to give solely the (^-isom er 251 (1.61 g,
70%) as a pale yellow oil; H NMR (300 MHz, CDC13) 6  7.33 (5H, m, Ph), 6.74 
(1H, t, J =  7.0 Hz, CH=C\ 4.53 (2H, s, OCHtfh), 4.21 (2H, q, J =  7.1 Hz, OCH2), 
3.56 (2H, t, J =  7.0, CH2OBn), 2.50 (2H, q, J =  7.0 Hz, CH2CH=), 2.32 (2H, q, J  =
7.5 Hz, C7/2 -C=CH), 1.30 (3H, t, J  = 7.1 Hz, CH3), 1.01 (3H, t, J  = 7.5 Hz, 
CH2CH3y, n C NMR (75 MHz, CDCI3 ) 8  167.6 (C=0), 138.2 (ywo-phenyl), 137.7 
(phenyl), 135.8 (C=CH), 128.4 ( O CH), 127.6 (phenyl), 73.0 (OCftPh), 68.9 
(CH2OBn), 60.3 (CH20), 29.1 (C/fcCH=C), 2 0 . 2  (C.H2C=CH), 14.3 (C7/iCH20), 
13.8 (CH2 CH}).
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2-Ethyl-5-phenoxypent-2-en-l-ol (259).40 A solution of 5-benzyloxy-2-ethylpent-
2-enoic acid ethyl ester (1.50 g, 5.65 mmol) in dry tetrahydrofuran (4 mL) was added 
slowly to a suspension of lithium aluminium hydride (0 . 1 0  g, 1 . 6 6  mmol) in ether 
(1.5 mL), at such a rate as to cause gentle reflux. The reaction mixture was stirred at 
20 °C; at reaction completion (20 h) the mixture was cooled to 0  °C and quenched by 
the slow addition of water (3 mL) (CAUTION), then poured into a mixture of 10% 
aqueous sulfuric acid (3 mL) and crushed ice. The aqueous phase was filtered and 
extracted with ether ( 3 x 6  mL) and the solid filtrate was washed with ether (3 x 12 
mL). The combined organic layers were washed with saturated aqueous sodium 
hydrogen carbonate (2 x 60 mL) and brine (2 x 12 mL) and then dried (MgS0 4 ), 
filtered and evaporated. Column chromatography (10:90 ethyl acetate: petroleum
ether) gave 259 (0.70 g, 56%) as a colourless oil; *H NMR (300 MHz, CDCI3) 6  7.30 
(5H, m, Ph), 5.41 (1H, t, J  = 7.1 Hz, CH=C), 4.52 (2H, s, OC//2Ph), 4.04 (2H, s, 
CH2OU), 3.49 (2H, t , J =  7.0 Hz, CH2OBn), 2.38 (2H, q, J =  7.0, C //2CH=C), 2.11
(2H, q, J  — 7.6 Hz, C //2CH3), 1.00 (3H, t, J =  7.6 Hz, CH2CH3); °C  NMR (75 MHz, 
CDCI3) 5 148.2 (i/wo-phenyl), 142.7 (C=CH), 129.3 (meta-phenyl), 121.5 (CH=C\
120.9 (para-phenyl), 119.1 (ortho-phenyl), 72.3 ( 0 0 / 2Ph), 70.5 (CH2OH), 68.1 
(CH2OBn), 28.0 (CH2), 20.3 (CH2), 11.5 (CH3).
[2-Ethyl-3-(2-phenoxyethyl)oxiranyl] methanol (252).40 Crushed 3A molecular 
sieves (0.34 g) were added into a flame-dried 50-mL flask cooled under nitrogen. 
Dichloromethane (17 mL) was added and the flask cooled to -  20 °C. 2-Ethyl-5- 
phenoxypent-2-en-1 -ol (0.65 g, 2.94 mmol), (-)-diethyl tartrate (73 mg, 3.53 mmol), 
and titanium tetra-isopropoxide (84 mg, 0.29 mmol) were added sequentially, and the 
mixture was stirred at -  20 °C for 15 min, followed by the slow addition of tar/-butyl 
hydroperoxide (1.96 mL, 5.88 mmol, 3.0 M in dichloromethane). After the reaction 
was complete ( 6  h) as indicated by TLC, water (2 mL) was added and the mixture 
stirred for 60 min while allowing it to warm to 20 °C. Hydrolysis of the tartrate was 
affected by the addition of 30% aqueous sodium hydroxide saturated with sodium 
chloride and stirring vigorously. The mixture was filtered through a pad of celite and 
the aqueous layer was extracted with dichloromethane (3 x 50 mL). Evaporation of 
the volatile solvents gave a residue which was purified by flash column 
chromatography (20:80 ethyl acetate: hexane), to give 252 (0.30 g, 46%) as a pale
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yellow oil; H NMR (300 MHz, CDC13) 8 7.33 (5H, m, Ph), 4.53 (2H, s, OC//2Ph), 
3.74 (1H, dd, J  = 12.2 and 7.4 Hz, CH//OH), 3.62 (3H, t, J  = 5.7 Hz, OCH and 
CH2OBn), 3.18 (1H, dd, J  = 12.2 and 4.8 Hz, C//HOH), 1.96 (1H, m, CHHCH20), 
1.79 (2H, m, CH2CH3), 1.50 (1H, m, CH//CH20), 1.01 (3H, t, J=  7.0 Hz, CH2CH3);
C NMR (75 MHz, CDC13) 8 138.2 (//wo-phenyl), 128.6 (phenyl), 127.7 (phenyl),
73.2 (OC/fcPh), 67.6 (CH20), 63.9 (CCHO), 63.0 (CH2OBn), 58.1 (CCT/O), 28.7 
(C//2CHO), 21.8 (CHs), 9.2 (CH2).
2-PhenyI-l,3-dioxane (261).41 A solution of 1,3-propanediol (3.8 g, 50 mmol) in 
toluene (13 mL) was treated with benzaldehyde (5.3 g, 50 mmol) and a catalytic 
amount of/?-toluenesulfonic acid (15 mg, 7.9 x 10~5 mol). The solution was stirred at 
reflux under a Dean-Stark trap until the theoretical amount of water (~ 0.9 mL) had 
separated (2.5 h). The mixture was cooled to 20 °C, washed with aqueous sodium 
hydroxide ( 2 x 1 0  mL, 1 M), dried (M gS04), filtered and evaporated to give 261 (7.9 
g, 96%), as a white solid; H NMR (300 MHz, CDC13) 8 7.47 (2H, m, phenyl), 7.34 
(3H, m, phenyl), 5.51 (1H, s, CtfPh), 4.27 (2H, dd, 12.2, 5.0 Hz, CH20), 4.00 (2H, 
t, J  = 12.2 Hz, CH2O), 2.23 and 1.47 (2H, m, CH2); 13C NMR (75 MHz, CDCI3) 
8 137.5 {ipso-phenyl), 128.8 (phenyl), 127.7 (phenyl), 106.9 (OCH), 65.1 (CH20),
33.5 (CH2).
3-(Benzyloxy)propan-l-ol (262).42 Anhydrous aluminium chloride (7.3 g, 55 mmol) 
was added dropwise to dry ether (23 mL) and the solution was cooled to 0 °C with 
stirring. Lithium aluminium hydride (0.55 g, 14.5 mmol) was slowly added and 
stirring continued for 30 min, after which a solution of 2-phenyl-1,3-dioxane (4.5 g,
27.5 mmol) in ether (9 mL) was added and the mixture stirred for a further 30 min at 0 
°C. 10% aqueous sulfuric acid (45 mL) was added dropwise over 30 min with stirring 
(CAUTION). The aqueous layer was extracted with ether (3 x 10 mL) and the 
combined organic layers were dried (M gS04), filtered and evaporated to give 262
(3.85 g, 84%) as a colourless oil; H NMR (300 MHz, CDCI3) 8 7.53 (5H, m, Ph), 
4.73 (2H, s, OC/frPh), 3.99 (2H, t, J  = 5.6 Hz, CH20), 3.87 (2H, t, J  = 5.6 Hz, 
CH20 ), 2.17 (1H, bs, COH), 2.05 (2H, quintet, J =  5.6 Hz, CH2CH2); UC NMR (75
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MHz, CDCI3 ) 8  138.5 (//?so-phenyl), 128.7 (phenyl), 128.1 (phenyl), 127.9 (phenyl), 
73.7 (OCff2Ph), 69.7 (CH2OBn), 62.3 (CH2OH), 32.6 (CH2).
3-(Benzyloxy)propan-l-ol (262).43 To a solution of sodium hydride (2.5 g, 62.5 
mmol, 60 % in oil), in a mixture of tetrahydrofuran (27 mL) and dimethylformamide 
(17.5 mL) stirred at 0 °C was added dropwise a solution of propane- 1,3-diol (4.25 g, 
56 mmol) in tetrahydrofuran (13 mL). After stirring at 20 °C for 3 h, benzyl bromide 
(6.65 mL, 56 mmol) was introduced dropwise. After 48 h the mixture was quenched 
by the addition of water (30 mL) and the aqueous layer was extracted with ethyl 
acetate (3 x 30 mL). The organic layers were washed with brine (30 mL), dried 
(MgSCL), filtered and the organic solvents evaporated. The residue was purified by 
column chromatography (2:8 ethyl acetate: petroleum ether) to give 262 (4.9 g, 55%) 
as a colourless oil, with spectroscopic data identical to those given earlier for 262.
3-(Benzyloxy)propionaldehyde (263).44 To a solution of alcohol 262 (2.0 g, 12 
mmol) in 1:4 dimethyl sulfoxide: dichloromethane (120 mL) at 0 °C was added 
triethylamine (4.9 g, 48.2 mmol) and SCb-pyridine (3.83 g, 24.1 mmol) and the 
resulting solution was stirred at 0 °C for 12 h. The mixture was diluted with ethyl 
acetate (150 mL) and washed with water (2 x 80 mL), then saturated aqueous 
ammonium chloride (2x 80 mL) and brine (80 mL). The combined organic layers 
were dried (MgS0 4 ), filtered and evaporated, purification by column chromatography 
gave 263 (1.72 g, 87%) as a colourless oil; H NMR (300 MHz, CDCI3) 8  9.83 (1H, t, 
J  = 1.8 Hz, C H O \ 7.32 (5H, s, Ph), 4.57 (2H, s, PhC//20), 3.81 (2H, t, J  = 6.0 Hz, 
CH20), 2.68 (2H, dt, J  = 6.0 and 1.8 Hz, CH2CHO); 13C NMR (75 MHz, CDC13) 
8  201.0 (C H O ), 137.9 (/pso-phenyl), 128.4 (phenyl), 127.8 (phenyl) 127.7 (phenyl),
73.3 (PhC//20 ), 63.9 (CH20 ), 43.9 (CH2CHO).
3-(terf-Butyldimethylsilanyloxy)-propan-l-ol (275).44 Imidazole (2.68 g, 39.4 
mmol) and tert-butyldimethylsilyl chloride (5.94 g, 39.4 mmol) were added 
consecutively to a stirred solution of the propane-1,3-diol (15.0 g, 0.197 mol) in dry 
tetrahydrofuran (90 mL) at 0 °C and the resulting cloudy mixture was stirred at 20 °C 
for 14 h. The mixture was then washed with water (5 x 35 mL) and the organic layer 
was dried (M gS04), filtered and evaporated. Purification of the residue by flash
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column chromatography (20:80 ethyl acetate: hexane) gave 275 (6.64 g, 89%) as a 
colourless oil; H NMR (300 MHz, CDC13) 6 H 3.73 (4H, m, CH20), 2.58 (1H, bs,
OH), 1.70 (2H, m, CH2), 0.82 (9H, s, (C/Z^CSi), 0.01 (6 H, s, (C //3 )2 Si); ” c  NMR 
(75 MHz, CDC13) 8 c 62.8 (OCH2), 62.3 (OCH2), 34.3 (CH2), 25.7 (C7/3/,CSi(CH 3h),
18.2 (CH3)3CSi(CH3)2), -5.5 (CH3 )3CSi(C//3; 2).
3-(/£rt-Butyldimethylsilanyloxy)-propionaldehyde (276).44 To a stirred solution of 
alcohol 265 (2.50 g, 13.2 mmol) in dimethylsulfoxide (10 mL) at 0 °C was added 
triethylamine (8.85 g, 87.4 mmol) followed by the slow addition of a solution of 
S 03-pyridine (6.30 g, 39.5 mmol) in dimethylsulfoxide (20 mL). The resulting 
mixture was stirred at 0 °C for 30 min, then added to ice and neutralized with 
hydrochloric acid (1M). The mixture was extracted with ether (3 x 30 mL) and the 
combined organic layers were washed with brine (2 x 20 mL), dried (MgSCL), 
filtered and evaporated, purification by column chromatography (15:85 ethyl acetate:
petroleum ether) gave 276 (2.0 g, 80%) as an orange oil; *H NMR (300 MHz, 
CDCfi) 5h 9.80 (1H, t, J =  2.1 Hz, CHO), 3.98 (2H, t, 7 =  6.0 Hz, OCH2), 2.58 (2H, 
dt, 7  = 2 . 1  and 6 . 0  Hz, CHjCHO), 0 . 8 8  (9H, s, (C7fy3CSi(CH3)2), 0.06 (6 H, s, 
(CH3)3C S i(C /^ 2); 13C NMR (75 MHz, CDCI3) 6 C 201.9 (CHO), 57.4 (CH2 0), 46.6 
(CH2CO), 25.8 ((C //i)3CSi(CH3)2), 18.2 (CH3)3CSi(CH3)2), -3.6 (CH3)3CSi(CH3) 2).
2-Amino-3-phenylpropan-l-ol (111 )45 A 1L 3-necked flask was fitted with a 
magnetic stirrer, a reflux condenser and an addition funnel. The flask was charged 
with sodium borohydrate (8.20 g, 216 mmol) and anhydrous tetrahydrofuran (240 
mL) and L-phenylalanine (15.0 g, 91 mmol). The mixture was cooled to 0 °C and a 
solution of iodine (22.8 g, 91 mmol) in anhydrous tetrahydrofuran (60 mL) was 
added dropwise over 30 min. The mixture was heated at reflux for 18 h, it was then 
cooled to 25 °C and methanol (20 mL) was added slowly, stirring for a further 30 
min followed by solvent evaporation gave a white paste. The residue was dissolved 
in aqueous potassium hydroxide (180 mL, 20%) and stirred for 4 h at 25 °C. The 
aqueous layer was extracted with dichloromethane (3 x 100 mL) and the combined 
organic layers were dried (M gS04), filtered and evaporated. Recrystallisation from 
toluene gave 277 (15.0 g, 92%) as a white solid; H NMR (300 MHz, CDCI3) 5 7.22 
(5H, m, Ph), 3.63 (1H, dd, 7  = 10.5 and 3.9 Hz, OC//H), 3.38 (1H, dd, 7 =  10.5 and
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7.1 Hz, OCH//), 3.13 (1H, m, CHNH2), 2.78 (1H, dd, J =  13.4 and 5.3 Hz, C//HPh), 
2.54 (1H, dd, J  = 13.4 and 8.4 Hz, CHtfPh); 13C NMR (75 MHz, CDCI3 ) 5C 139.2 
(//?so-phenyl), 128.4 (phenyl), 126.1 (phenyl), 72.2 (C //2OH), 57.0 (C//NH2), 39.5 
(CH2Ph).
(4S)-4-(PhenyImethyl)-2-oxazolidinone (278)46 A dry 500 mL 3-necked round- 
bottomed flask equipped with a thermometer and an 18-in Vigreux column with a 
distillation head was charged with alcohol 277 (2.0 g, 13.2 mmol), potassium 
carbonate (0.18 g, 1.32 mmol) and diethyl carbonate (3.2 g, 26.8 mmol). The 
mixture was carefully heated to 135-140 °C, and ethanol was allowed to distil as it 
was formed. After 2 h, the light brown slurry was cooled to 20 °C, diluted with 
dichloromethane (10 mL) and filtered to remove most of the remaining potassium 
carbonate. The mixture was washed with aqueous sodium hydrogen carbonate (2 x 
10 mL, 1 M). The organic layer was dried (MgS0 4 ), filtered and evaporated to give 
a pale yellow crystalline solid. Recrystallization (ethyl acetate/ petroleum ether) 
gave 278 (2.24 g, 96%) as a colourless solid; *H NMR (300 MHz, CDCI3 ) 8h 7.33 
(3H, m, phenyl), 7.19 (2H, m, phenyl), 4.97 (1H, bs, NH), 4.49 (1H, t, J  = 6.1 Hz, 
C//HO), 4.16 (1H, t, J =  6.1 Hz, CH//O), 4.10 (1H, m, CHN), 2.88 (2H, m, CH2Ph); 
13C NMR (75 MHz, CDC13) 5C 159.2 (C O ) , 136.0 (i/wo-phenyl), 129.0 (phenyl),
127.3 (phenyl), 69.6 (CH20 ), 53.8 (C//N), 41.5 (C,H2Ph).
4-Benzyl-3-butyryloxazolidin-2-one (279).47 To a stirred solution of (4S)-4- 
(phenylmethyl)-2-oxazolidinone (1.0 g, 5.65 mmol) in dry tetrahydrofuran (28 mL) 
at -  78 °C under an atmosphere o f nitrogen, was added w-butyllithium (2.5 mL, 5.65 
mmol, 1.6 M solution in hexanes), after stirring for 15 min, the solution was treated 
with butyryl chloride (0.60 g, 5.65 mmol) and then stirred for a further 1 h at -  78 °C. 
The mixture was warmed up to 20 °C, then poured into a mixture of ethyl acetate (27 
mL) and saturated aqueous ammonium chloride (11 mL). The separated organic 
layer was washed successively with saturated aqueous ammonium chloride (11 mL), 
saturated aqueous sodium hydrogen carbonate (27 mL) and brine (27 mL). The 
organic layer was dried (M gS04), filtered and evaporated to give 279 (1.2 g, 86%) as
a brown oil; IR v ^ c n f 1) 1782 (C=0), 1700 (N 0=0); H NMR (300 MHz, CDC13) 
5h 7.29 (3H, m, phenyl), 7.22 (2H, m, phenyl), 4.67 (1H, m, CHN), 4.15 (2H, m,
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OCH2), 3.29 (1H, dd, J  = 10.2 and 2.4 Hz, C//HPh), 2.92 (2H, m, CH2C O ) , 2.76 
(1H, dd, J  = 10.2 and 7.2 Hz, CHtfPh), 1.73 (2H, sextet, J=  5.7 Hz, CH2), 1.01 (3H, 
t, J  = 5.7 Hz, CH3); 13C NMR (75 MHz, CDC13) 5C 173.2 (C O ), 153.5 (NC=0),
135.3 (//?5o-phenyl), 129.4 (phenyl), 129.0 (phenyl), 127.3 (phenyl), 66.2 (CH20),
55.1 (CH2N), 37.9 {CH2Ph), 37.4 (CH2), 17.7 (CH2), 13.7 (CH3); LRMS m/z (%)+CI 
248 (M+, 50 %), 206 (20), 179 (10), 178 (100), 156 (5); HRMS calcd for C14H170 3N 
248.12812 (M+H), found 248.12885.
4-BenzyI-3-[5-(te/t-butyldimethylsilanyloxy)-2-ethyl-3-hydroxypentanoyI]- 
oxazolidin-2-one (265). To a solution of 4-benzyl-3-butyryloxazolidin-2-one (3.50 
g, 14.1 mmol) in anhydrous dichloromethane (120 mL) at 0 °C was added titanium 
tetrachloride (14.8 mL, 14.8 mmol, 1.0 M in dichloromethane). After stirring for 5 
min (-)-sparteine (3.31 g, 14.1 mmol) was added dropwise and the mixture was 
stirred at 0 °C for 20 min, it was then cooled to -78 °C, and 1-methyl-2-pyrrolidinone 
(1.40 g, 14.1 mmol) was added. After stirring for 10 min 3 -(tert- 
butyldimethylsilanyloxy)-propionaldehyde (2.9 g, 15.3 mmol) was added dropwise. 
The mixture was stirred for 1 h at -78 °C, then gradually warmed to 0 °C, and stirred 
for 1 h. The reaction was warmed to 20 °C and quenched with half-saturated 
aqueous ammonium chloride (17.5 mL). The aqueous layer was extracted with 
dichloromethane (2 x 15 mL) and the combined organic layers were washed with 
brine (20 mL), dried (M gS04), filtered and the solvents evaporated. Purification by 
column chromatography (20:80 ethyl acetate: petroleum ether) gave 265 (5.0g, 81%) 
as a pale yellow oil; [a]o = + 50.3 (c 1.28, CHC13); IR vmax (cm 1) 3469 (OH), 1780 
(C O ), 1692 (NC=0); H NMR (300 MHz, CDC13) 8H 7.30 (3H, m, phenyl), 7.23 
(2H, m, phenyl), 4.71 (1H, m, CHN), 4.12 (3H, m, CH20 , CHOH), 3.85 (2H, m, 
C//2OTBS), 3.34 (1H, dd, 7 =  13.3 and3.1 Hz, CHHPh), 2.71 (1H, dd, J=  13.3, 10.1 
Hz, CH//Ph), 1.71 (5H, m, CHC=O, 2CH2), 0.98 (3H, t , J = 7 . 5  Hz, CH3), 0.88 (9H,
s, (0 /^ C S i(C H 3)2), 0.06 (6H, s, ( C H ^ C S if C ^ ) ;  °C  NMR (75 MHz, CDC13) Sc
175.2 (C O ) , 153.4 (N C O ), 135.4 (//750-phenyl), 129.4 (phenyl), 128.9 (phenyl),
127.3 (phenyl), 71.9 (CHOH), 65.9 (CH20), 62.3 (CH20 ), 55.6 (CHN), 49.5 
(C //C O ), 38.1 (CH2Ph), 35.8 (CH2COH), 25.9 (CH3) 3CSi(CH3)2), 20.9 (CH2), 18.2 
(CH3)3CSi(CH3)2), 11.6 (CH3); LRMS m/z (%)+CI 436 (M+, 85 %), 418 (75), 388
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(100), 330 (40), 304 (55), 259 (40), 248 (60), 218 (25), 206 (70); HRMS calcd for 
C2 3H37 0 5NSi 436.2514 (M+H), found: 436.2520.
5-(te/t-Butyldimethylsilanyloxy)-2-ethyl-3-hydroxypentanoic acid iV-methoxy-A- 
methyl-amide (286). To a suspension of N, O-dimethylhydroxylamine 
hydrochloride (0.50 g, 5.06 mmol) in anhydrous dichloromethane (10 mL) at 0 °C 
was added trimethylaluminium (2.5 mL, 5.06 mmol, 2.0 M in toluene) over 5 min 
(CAUTION: vigorous gas evolution). The solution was warmed to 20 °C and stirred 
for 30 min; it was then cooled to - 15°C and a solution of 4-benzyl-3-[5-(tert- 
butyldimethylsilanyloxy)-2-ethyl-3-hydroxypentanoyl]-oxazolidin-2-one ( 1 . 1 0  g,
2.53 mol) in dichloromethane (7.0 mL) was added. After stirring at 0 °C for 30 min, 
the mixture was cooled to -  10 °C and allowed to warm to 20 °C overnight. An 
aqueous solution o f tartaric acid (13.5 mL, 1 M) was added via a cannula and the 
resulting mixture was vigorously stirred for 1 h. The aqueous layer was extracted 
with dichloromethane ( 3 x 5  mL) and the combined organic layers were washed with 
brine (20 mL), dried (MgSCL), filtered and evaporated. Purification by flash column 
chromatography (30:70 ethyl acetate: petroleum ether) gave 286 (0.51 g, 62%) as an
orange oil; [o]D = + 5.7 (c 1.03, CHCI3); IR v ^ f c m '1) 3342 (OH), 1755 (C=0); H 
NMR (300 MHz, CDCI3) SH 3.83 (3H, m, CH20  and CHOH), 3.77 (3H, s, OCH3), 
3.17 (3H, s, NCH3), 1.71 (2H, m, CH2CH), 1.61 (1H, m, C//CH2), 130 (2H, m, 
CH2), 0.87 (12 H, s, (TT/jjjCSiiCH,), and CH3), 0.04 (6 H, s, (CHjhCSifC/f,^); ‘3C 
NMR (75 MHz, CDCI3) 5C 176.5 (C=0), 72.4 (CHOH), 62.4 (CH20), 61.4 (OCH3),
47.6 (NCH3), 36.3 (CT/jCHOH), 25.8 (fCT/^CShCH jh), 2 0.9 (CH2), 18.1 
((CH3)3CSi(CH3)2), 12.0 (CH3); LRMS m/z (%)+CI 320 (M+, 45 %), 304 (20), 259 
(30), 188 (30), 178 (100), 117 (15), 102 (50), 89 (30); HRMS calcd for Ci5H330 4NSi 
320.2252 (M+H), found 320.2255.
Acetic acid l-|2-(n'rt-l)ulyldimethylsilanvloxy)-ethyl]-2-(:V-niethoxy-,V-mc(hvl- 
carbamoyl)-butyl ester (287). To a stirred solution of 5 -(tert- 
butyldimethylsilanyloxy)-2-ethyl-3-hydroxypentanoic acid .V-methoxy-A'-methyl- 
amide (0.15 g, 0.47 mmol), in dichloromethane (1.2 mL) at 20 °C was added acetic 
anhydride (72 mg, 0.70 mmol), triethylamine (80 mg, 0.72 mmol) and a catalytic 
amount of DMAP (0.57 mg). The mixture was stirred for 4 h and then diluted with
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ether (7.5 mL), the mixture was then washed with brine ( 2 x 5  mL) and the organic 
layer was dried (MgSCL), filtered and evaporated. Purification by column 
chromatography (15:85 ethyl acetate: petroleum ether) gave 287 (0.15 g, 8 8 %) as a
yellow oil; [ct]D = + 46.2 (c 0.87, CHC13); IR vmax (cm '1) 1748 (C=0); 'h  NMR (300 
MHz, CDCI3) SH 3.63 (3H, s, OCH3), 3.57 (2H, m, CH20), 3.45 (1H, q, J  = 5.3 Hz, 
OCH), 3.17 (3H, s, NCH3), 2.02 (3H, s, CH3C=0), 1.82 (4H, m, CH2), 1.48 (1H, m, 
CHCH2), 0.86 (12 H, s, (CH3) 3CSi(CH3)2, and CH3), 0.04 (6 H, s, (CH3)3CSifC7/j)2);
,3C NMR (75 MHz, CDCI3) 5c 170.6 (C=0), 166.4 (CH3C=0), 65.8 (OCH), 61.4 
(CH3O), 59.4 (CH20 ), 45.2 (CH3N), 33.9 (CH2), 25.9 (CH}) }CSi(CH3)2), 22.1 (CH),
21.3 (CH2), 21.1 (CHjC=0), 18.2(CH3)3CSi(CH3)2), 1 2 . 1  (CH3); LRMS m/z (%)+CI 
362 (M+, 35 %), 346 (15), 304 (15), 302 (20), 242 (20), 241 (30), 230 (35), 178 
(100), 170 (15); HRMS calcd for C 17H 350 5NSi 362.2357 (M+H), found 362.2364.
Acetic acid l-[2-(tert-butyldimethylsilanyIoxy)-ethyl]-2-formylbutyl ester (264).
To a solution o f acetic acid l-[2-(te/t-butyldimethylsilanyloxy)-ethyl]-2-(A- 
methoxy-7V-methyl-carbamoyl)-butyl ester (0.50 g, 1.38 mmol) in anhydrous 
tetrahydrofuran (12 mL) at -  78 °C was added DIBALH (1.4 mL, 1.38 mmol, 1.0 M 
solution in toluene). After stirring for 30 min, the solution was added to a 1:1 
mixture of diethyl ether: 1M aqueous hydrochloric acid (20 mL). This mixture was 
allowed to warm to 20 °C, and the separated organic layer was washed with brine (15 
mL) and dried (MgSCL). Filtration and evaporation gave 264 (0.2 g, 48%) as a 
colourless oil that was used without further purifications.
5-(te/t-Butyldimethylsilanyloxy)-2-ethyl-3-hydroxypentanal (290). To a 100 mL
flame-dried flask charged with anhydrous tetrahydrofuran (15 mL) was added 
sodium £A(2-methoxyethoxy) aluminium hydride (Red-Al) (0.40 mL, 1.27 mmol). 
The mixture was cooled to — 78 °C and a solution of the ester 265 (0.50 g, 1.15 
mmol) in tetrahydrofuran (10 mL) was added slowly. After 15 min the solution was 
warmed to -  55 °C and stirred for 1 h. The reaction was quenched at that 
temperature by the addition of ethyl acetate (1.9 mL) followed by methanol (0.5 
mL). The mixture was poured into a solution of hydrochloric acid (6 . 6  mL, 1.4 mL) 
and ether (14 mL) at -20 °C, stirred for 15 min and the organic layer decanted from 
the frozen aqueous layer. The organic layers were dried (K2C 0 3), filtered and
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evaporated to give 290 (0.42 g), that was used immediately without further 
purification.
Acetic acid l-[2-(tert-butyldimethylsilanyloxy)-ethyl]-2-formylbutyl ester (264).
To a solution of 5-(terr-butyldimethylsilanyloxy)-2-ethyl-3-hydroxypentanal (0.40 g,
1.54 mmol) in dichloromethane (5 mL) at 20 °C was added acetic anhydride (0.23 g, 
2.31 mmol), triethylamine (0.25 g, 2.46 mmol) and a catalytic amount of DMAP (19 
mg). The mixture was stirred for 4 h, then diluted with ether (15 mL), washed with 
brine (12 mL) and the organic layers were dried (M gS04), filtered and evaporated to 
give 264 (0.30 g, 86%) that was used without further purification.
6-[2-(te/t-Butyldimethylsilanyloxy)-ethyl]-5-ethyl-5,6-dihydropyran-2-one (291).
To a stirred solution of diisopropylamine (0.19 g, 1.89 mmol) in anhydrous 
tetrahydrofuran (20 mL) at 0 °C was added w-butyllithium (0.69 mL, 1.72 mmol, 2.5 
M in hexanes). After 20 min at 0 °C the solution was cooled to -  78 °C; methyl 
acetate (0.14 g, 1.89 mmol) was added and stirring was continued for 15 min. A 
solution of acetic acid l-[2-(tert-butyldimethylsilanyloxy)-ethyl]-2-formylbutyl ester 
(0.52 g, 1.72 mmol) in anhydrous tetrahydrofuran (7 mL) cooled to -  78 °C was 
transferred into the enolate solution via cannula. Stirring was continued for 15 min 
at which time TLC analysis indicated the absence of the aldehyde 264. The mixture 
was warmed to 0 °C, stirred for an additional 30 min and finally warmed to 20 °C for 
15 min. The solution was transferred via cannula into an Erlenmeyer flask 
containing a pH 7 buffer (83 mL) and dichloromethane (83 mL). The organic layer 
was separated, kept and the aqueous layer was extracted with dichloromethane (2 x 
35 mL) followed by ethyl acetate (1 x 35 mL). The combined organic layers were 
dried (MgS04), filtered through a pad of celite and evaporated. The residue was 
purified by flash column chromatography (10:90 ethyl acetate: petroleum ether) to 
give 291 (0.18 g, 84%) as a colourless oil; [u]D = + 67.8 (c 1.12, CHC13); IR Vmax (cm' 
‘) 1728 (C=0); 'h  NMR (300 MHz, CDCI3) 6H 6.98 (1H, dd, J  = 9.8, 3.8 Hz, 
C7/=CHC=0), 6.01 (1H, d, J  = 9.8 Hz, 0H=C//C=O), 4.62 (1H, dt, J  = 9.4 and 3.8 
Hz, OCH), 3.75 (2H, m, CH20 ), 2.26 (1H, m, CH), 1.93-1.64 (4H, m, 2CH2), 0.93 
(3H, t, J  = 7.5, CH3), 0.85 (9H, s, (C7/^CSi(CH3)2), 0.03 (6H, s, (CH3)3CSirC7/3; 2); 
13C NMR (75 MHz, CDC13) 8c 164.4 (C=0), 150.5 (C//=CHC=0), 120.8
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(CH=C//C=0), 76.6 (OCH), 58.8 (CH20), 38.5 (CH), 34.2 (CH2), 25.9 
( ( 0 / 5; 5CSi(CH3)2), 20.8 (CH2), 18.2 ((CH3)3CSi(CH3)2), 10.9 (CH3), -5.4 
((CH3)3CSifC //^2); LRMS m/z (%)+CI 285 (M+, 100 %), 269 (80), 227 (95), 209 
(25), 181 (20), 153 (95), 135 (60), 107 (50), 81 (20); HRMS calcd for Ci5H280 3Si 
285.1886 (M+H), found 285.1883.
5-Ethyl-6-(2-hydroxyethyI)-5,6-dihydropyran-2-one (292). To a stirred solution 
of 6-[2-(tert-butyldimethylsilanyloxy)-ethyl]-5-ethyl-5,6-dihydropyran-2-one (0.20 
g, 0.70 mmol) in methanol (17 mL) at 20 °C was added hydrochloric acid (2.8 mL,
1.0 M). After stirring for 22 h, the methanol was evaporated and the remaining 
aqueous residue was extracted with ether ( 3 x 1 0  mL). The combined organic layers 
were washed with 5% aqueous sodium carbonate (2 x 10 mL) followed by brine (10 
mL), and then dried (M gS04), filtered and evaporated. Flash column 
chromatography (1:1 ethyl acetate: petroleum ether) gave 292 (80 mg, 67%) as a pale
yellow oil; [a]D = + 52.0 (c 0.79, CHClj); IR vmax (c m 1) 3372 (OH), 1731 (C O ); ‘h  
NMR (300 MHz, CDC13) 5H 6.99 (1H, dd, J  = 9.8, 5.9 Hz, C77=CHC=0), 5.97 (1H, 
d, J=  9.8 Hz, CH=C/7C=0), 4.67(1 H, d t , ./ = 10.1 and 3.6 Hz, OCH), 3.81 (2H, m, 
CH20), 2.57 (1H, bs, OH), 2.28 (1H, m, CH), 2.00-1.47 (4H, m, CH2), 0.94 (3H, t, J
= 7.5 Hz, CH3); ' 3C NMR (75 MHz, CDCI,) 5C 164.8 (C=0), 151.0 (C7/=CHC=0),
120.5 (CH=CtfC=0), 77.8 (OCH), 58.5 (CH20 ), 38.5 (CH), 33.8 (CH2), 20.7 (CH2),
10.9 (CH3); LRMS m/z (%)+CI 170 (15), 169 (M+, 100 %), 166 (25), 27 (5); HRMS 
calcd for C9Hi40 3 169.0870 (M+H), found 169.0875.
Attempted Synthesis of (3-EthyI-6-oxo-3,6-dihydro-2Zf-pyran-2-yl)- 
acetaldehyde (250). To a solution of 5-ethyl-6-(2-hydroxyethyl)-5,6-dihydropyran- 
2-one (0.20 g, 1.18 mmol) in dimethylsulfoxide (1.0 mL) at 0 °C was added 
triethylamine (0.78 g, 7.8 mmol) and a solution of S 0 3-pyridine (0.56 g, 3.53 mmol) 
in dimethylsulfoxide (2.0 mL). The resulting solution was stirred at 0 °C for 30 min, 
poured onto ice and then neutralized with dilute hydrochloric acid. The aqueous 
solution was extracted with ether ( 3 x 1 5  mL) and the combined organic layers were 
washed with brine (2 x 10 mL), dried (M gS04) filtered and evaporated to give pale 
yellow oil that was shown by NMR to be a mixture of products.
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(l-EthylpropylideneH(S>2-methoxymethylpyrrolidin-l-yl)-amine (301) 36 A
solution of SAMP (0.50 g, 3.84 mmol) and 3-pentanone (0.34 g, 3.92 mmol) was 
heated under reflux (bath temperature at 60 °C) for 20 h. When the reaction was 
complete (determined by TLC and IR), the mixture was cooled to 20 °C and poured 
into dichloromethane and water (6:1, 21 mL). The separated organic layer was dried 
(MgSCL), filtered and evaporated to give 301 (0.60 g, 71%) suitable for prompt 
conversion into 302; *H NMR (300 MHz, CDC13) SH 3.39-3.20 (4H, m, OCH2, 
NCH2), 3.32 (3H, s, OCH3), 2.40-1.80 (9H, m, 2CH2 of ring, 2CH2 of chain, NCH),
I.05 (6H, m, CH3); °C  NMR (75 MHz, CDC13) 5C 173.7 (C=N), 75.4 (CH20), 66.0 
(CHN), 59.1 (CH30 ), 55.0 (CH2N), 28.7 (CH2), 26.6 (CH2), 23.4 (CH2), 21.9 (CH2),
II.9 (CH3), 11.0(CH3).
(£)-l-Bromobut-2-ene.48 A solution o f the but-2-en-l-ol (3.0 g, 42 mmol) in 
anhydrous ether (15 mL) was cooled to 0 °C and treated dropwise with freshly 
distilled phosphorus tribromide (2.0 mL, 7.4 mmol). The mixture was stirred for 3 h 
at 10 °C before being poured onto ice (45 g). The separated organic layer was 
washed successively with water (20 mL), saturated aqueous potassium carbonate (20 
mL) and brine (20 ml). Then the organic layer was dried (MgSCL), filtered and 
evaporated at atmospheric pressure to give (E)-1 -bromobut-2-ene (4.0 g, 70%) as a
colourless liquid, which was used immediately and without further purification; H 
NMR (300 MHz, CDC13) 5H 5.74 (2H, m, C,H=CH), 3.93 (2H, d, J  = 6.5 Hz,
CH2Bt), 1.73 (3H, d, J  = 6.0 Hz, CH3); 13C NMR (75 MHz, CDC13) 5C 131.4 
(CH3C//=CH), 127.5 (CH3CH=CH), 33.6 {CH2Br), 17.7 (CH3).
[(£)-(5)-l-Ethyl-2-methylhex-4-en-(Z)-ylidene]-((5)-2-methoxymethyIpyrrolidin- 
l-yl)-amine (302). w-Butyllithium (0.64 mL, 1.60 mmol, 2.5 M solution in hexanes) 
was added dropwise to a solution of diisopropylamine (0.16 g, 1.60 mmol) in 
anhydrous ether (5 mL) at 0 °C. After 15 min (l-ethylpropylidene)-((S>2- 
methoxymethylpyrrolidin-1 -yl)-amine (0.30 g, 1.50 mmol) was added and the 
mixture was stirred at 0 °C for 4 h. The mixture was then cooled to - 110 °C and a 
solution of crotyl bromide (0.21 g, 1.6 mmol) in anhydrous ether (2 mL) was added. 
Stirring was continued at - 110 °C for 1 h and then allowed to warm to 20 °C over 4 
h. The mixture was poured into water and ether (1:2, 30 mL) and the separated
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organic layer was washed with water ( 2 x 1 5  mL). The organic layer was dried 
(MgS04), filtered and evaporated, the residue oil was purified by column 
chromatography (50:50 diethyl ether: petroleum ether) to give 302 (0.20 g, 59%) as a
pale yellow oil; [a]D = + 16.5 (c 0.61, CHC13); IR vmM (cm 1) 1607 (C=N); 'h  NMR 
(300 MHz, CDC13) 8h 5.41 (1H, m, CH3C//=CH), 5.28 (1H, m, CH3CH=CW), 3.57 
(1H, m, NC//), 3.32 (4H, m, OCH3, NC//H), 3.16 (2H, q, J  = 8.0 Hz, OCH2), 2.96 
(1H, m, NCH/7), 2.42-1.81 (8H, m, p-ring 2CH2, N=CCH2, CH2), 1.64 (4H, m, CH,
C=CC//3), 1.09 (3H, t, J =  7.4, CH3), 1.02 (3H, d, J  = 7.1, CHCH3)\ ” c  NMR (75 
MHz, CDC13) 5c 176.0 (C=N), 129.1 (CH3CH=C7/), 126.0 (CH,(7/=CH), 76.0 
(OCH2), 65.9 (OCH3), 59.2 (CHN), 55.2 (NCH2), 37.4 (C//C=N), 34.7 (CH2), 26.8 
(CH2), 23.9 (CH2), 21.9 (CH2), 17.9 (CH3), 17.7 (CH3), 12.3 (CH3); LRMS m/z 
(%)+CI 253 (M+, 70 %), 242 (55), 210 (42), 195 (25), 151 (30), 129 (20), 116 (45), 
114 (22), 70 (15); HRMS calcd for C ,5H28ON2 253.2274 (M+H), found 253.2278.
(£)-(5)-4-Methyloct-6-en-3-one (249). SAMP hydrazone 302 (0.20 g, 0.79 mmol) 
was dissolved in methyl iodide (0.56 g, 3.97 mmol) and the solution was heated 
under reflux for 20 h. The excess methyl iodide was then removed in vacuo and the 
remaining viscous brown oil was dissolved is aqueous hydrochloric acid (5 mL, 4 M) 
and stirred for 5 min at 20 °C, w-pentane (20 mL) was then added and the mixture 
was stirred vigorously for 30 min. The organic layer was separated and washed with 
aqueous sodium hydrogen sulfite (3 mL) followed by pH 7 buffer solution (3 mL), 
and then dried over MgSCL. The solvents were filtered and evaporated and the 
remaining oil was purified by kugelrohr distillation to give 249 (60 mg, 54%) as a 
colourless liquid; H NMR (300 MHz, CDCfi) 8h 5.44 (1H, m, CH3C//=CH), 5.28 
(1H, m, CH3CH=C//), 2.56 (1H, sextet, J =  6.9 Hz, CHCH3), 2.41 (2H, q, J=  7.1 Hz, 
CH2C O ), 2.26 (1H, m, CH2C=C), 2.03 (1H, m, CH2C=C), 1.63 (3H, d, J  = 6.9 Hz, 
CHCH3\  1.03 (6H, m, 2CH3)> 13C NMR (75 MHz, CDC13) 5C 215.0 (C=0), 128.1 
(CH3CH=CH), 127.3 (CH3C//=CH), 46.2 (CH), 36.1 (CH2), 34.5 (CH2), 17.9 (CH3),
16.1 (CH3), 7.7 (CH3). Spectroscopic data were identical to those reported in the 
literature.49
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Table 1. Crystal data and structure refinement.
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
Volume
Z
Density (calculated) 
Absorption coefficient 
F(000)
Crystal 
Crystal size
Grange for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to 0= 27.48° 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [F2 > 2 o(F2)\ 
R indices (all data)
Absolute structure parameter 
Extinction coefficient 
Largest diff. peak and hole
05src0001 (EE1/UCL)
C 1 4 H j (5O3
232.27 
120(2) K 
0.71073 A  
Orthorhomb ic
P 2 i2 i2 ,
a  = 6.2521(3) A a  = 90°
b = 9.3237(17) A /?=90°
c = 20.809(4) A y = 90°
1213.0(3) A 3 
4
1.272 M g /m 3 
0.089 mm- 1  
496
Slab; colourless 
0 .34x0.15 x 0.12 mm3 
2.93 -  27.48°
- 8  < /j < 7, -11 < k <  12, -27  < /<  24 
27007
2773 [Rint = 0.0356]
99.5 %
Semi-empirical from equivalents
0.9895 and 0.9705
Ful 1-matrix least-squares on F2
2773 / 0 /  158
0.984
RJ = 0.0306, wR2 = 0.1038 
R1 = 0.0318, wR2 = 0.1059 
0.7(8)
0.037(11)
0 . 2 2 2  and -0.165 e A -3
Diffractometer: Nonius KappaCCD area detector (<p scans and (o scans to fill asymmetric unit sphere). Cell determination: DirAx 
(Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. Hooft, Nonius B.V., 
1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in Enzymology (1997) Vol. 276: 
Macromolecular Crystallography, part A, pp. 307-326, C. W. Carter, Jr. & R. M. Sweet, Eds., Academic Press). Absorption correction: 
SORTAV (R. H. Blessing, Acta Cryst. A51 (1995) 33-37; R. H. Blessing, J. Appl. Cryst. 30 (1997) 421-426). Structure solution: 
SHELXS97 (G. M. Sheldrick, Acta Cryst. (1990) A46 467-473). Structure refinement: SHELXL97 (G. M. Sheldrick (1997), University 
of Gottingen, Germany). Graphics: Cameron - A Molecular Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, Chemical 
Crystallography Laboratory, University o f Oxford, 1993).
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Table 2. Atomic coordinates [x 104], equivalent isotropic displacement parameters [A2 x 103] and site occupancy factors. 
Ueq is defined as one third of the trace of the orthogonalized If1 tensor.
Atom X y z ueq S.o.f
Cl 611(2) 2532(1) 1089(1) 17(1) 1
C2 -261(2) 4012(1) 912(1) 18(1) 1
C3 -1612(2) 4444(1) 1433(1) 2 0 ( 1 ) 1
C4 -1604(2) 3365(1) 1869(1) 18(1) 1
C5 3014(2) 2607(2) 1187(1) 23(1) 1
C6 -127(2) 1407(1) 606(1) 17(1) 1
C7 685(2) - 1 0 0 ( 1 ) 741(1) 2 2 ( 1 ) 1
C8 38(2) -1153(1) 218(1) 27(1) 1
C9 -2738(2) 3251(1) 2483(1) 18(1) 1
CIO -2255(2) 2146(1) 2913(1) 2 1 ( 1 ) 1
C ll -3385(2) 2041(1) 3487(1) 25(1) 1
C12 -4999(2) 3011(1) 3628(1) 26(1) 1
C13 -5477(2) 4115(2) 3202(1) 25(1) 1
C14 -4335(2) 4237(1) 2635(1) 2 2 ( 1 ) 1
0 1 -377(1) 2230(1) 1711(1) 18(1) 1
0 2 2 1 0 (2 ) 4647(1) 414(1) 23(1) 1
03 -2397(1) 1483(1) 609(1) 2 2 ( 1 ) 1
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Table 3. Bond lengths [A] and angles [°],
C l-O l 1.4612(14)
C1-C5 1.5178(16)
C 1 -C 6 1.5252(16)
C1-C2 1.5290(17)
C2-02 1.2285(15)
C2-C3 1.4322(17)
C3-C4 1.3555(17)
C3-H3 0.9500
C4-01 1.3474(14)
C4-C9 1.4645(17)
C5-H5A 0.9800
C5-H5B 0.9800
C5-H5C 0.9800
C6-03 1.4208(15)
C6-C7 1.5196(16)
C6 -H 6 1 . 0 0 0 0
C7-C8 1.5203(17)
01-C1-C5 107.95(10)
01-C1-C6 108.89(9)
C5-C1-C6 114.83(10)
01-C1-C2 103.72(9)
C5-C1-C2 1 1 0 . 1 0 ( 1 0 )
C6-C1-C2 110.72(9)
02-C2-C3 130.09(12)
02-C2-C1 123.56(11)
C3-C2-C1 106.34(10)
C4-C3-C2 107.20(10)
C4-C3-H3 126.4
C2-C3-H3 126.4
01-C4-C3 114.96(10)
01-C4-C9 115.57(10)
C3-C4-C9 129.47(11)
C1-C5-H5A 109.5
C1-C5-H5B 109.5
H5A-C5-H5B 109.5
C1-C5-H5C 109.5
H5A-C5-H5C 109.5
H5B-C5-H5C 109.5
03-C6-C7 112.29(10)
03-C6-C1 105.35(9)
C7-C6-C1 114.37(10)
03-C6-H6 108.2
C7-C6-H6 108.2
C1-C6-H6 108.2
C6-C7-C8 112.05(10)
C6-C7-H7A 109.2
C8-C7-H7A 109.2
C7-H7A 0.9900
C7-H7B 0.9900
C 8 -H 8 A 0.9800
C 8 -H 8 B 0.9800
C 8 -H 8 C 0.9800
C9-C14 1.3935(18)
C9-C10 1.3973(17)
C10-C11 1.3923(18)
C10-H10 0.9500
C11-C12 1.386(2)
C l l - H l l 0.9500
C12-C13 1.3897(19)
C12-H12 0.9500
C13-C14 1.3839(18)
C13-H13 0.9500
C14-H14 0.9500
03-H 3A 0.8400
C6-C7-H7B 109.2
C8-C7-H7B 109.2
H7A-C7-H7B 107.9
C7-C8-H8A 109.5
C7-C8-H8B 109.5
H 8 A -C 8 -H 8 B 109.5
C7-C8-H8C 109.5
H 8 A -C 8 -H 8 C 109.5
H 8 B -C 8 -H 8 C 109.5
C14-C9-C10 119.69(11)
C14-C9-C4 119.84(11)
C10-C9-C4 120.46(11)
C l1-C 10-C 9 119.49(12)
Cl 1-C10-H10 120.3
C9-C10-H10 120.3
C12-C11-C10 120.26(12)
C12-C11-H 11 119.9
C 10-C11-H 11 119.9
Cl1-C12-C13 120.38(12)
Cl1-C 12-H 12 119.8
C13-C12-H12 119.8
C14-C13-C12 119.54(13)
C14-C13-H13 1 2 0 . 2
C12-C13-H13 1 2 0 . 2
C13-C14-C9 120.62(12)
C13-C14-H14 119.7
C9-C14-H14 119.7
C4-01-C 1 107.77(9)
C 6-03-H 3A 109.5
Symmetry transformations used to generate equivalent atoms.
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Table 4. Anisotropic displacement parameters [A2x 1 0 3]. The anisotropic displacement 
factor exponent takes the form: -2 n 2[h2a*2Un + — + 2 h k a* b* Un ].
Atom Uu U22 t / 3 3 jjZl Un j j \ 2
Cl 16(1) 2 0 (1 ) 15(1) 0 ( 1 ) 1 ( 1 ) 0 ( 1 )
C2 18(1) 18(1) 19(1) - 1 ( 1 ) - 1 ( 1 ) 0 ( 1 )
C3 2 1 (1 ) 18(1) 2 0 ( 1 ) - 1 ( 1 ) 2 ( 1 ) 2 ( 1 )
C4 16(1) 19(1) 18(1) -3(1) - 1 ( 1 ) 0 ( 1 )
C5 17(1) 27(1) 26(1) - 1 ( 1 ) -3(1) 0 ( 1 )
C6 15(1) 2 1 (1 ) 16(1) 0 ( 1 ) 0 ( 1 ) 1 ( 1 )
C7 24(1) 2 1 (1 ) 2 1 ( 1 ) - 2 ( 1 ) - 2 ( 1 ) 4(1)
C8 31(1) 2 2 ( 1 ) 28(1) - 6 ( 1 ) - 1 ( 1 ) 2 (1 )
C9 18(1) 2 0 ( 1 ) 16(1) -3(1) - 1 ( 1 ) - 2 ( 1 )
CIO 25(1) 19(1) 19(1) - 2 ( 1 ) 0 ( 1 ) - 1 ( 1 )
C ll 35(1) 2 2 ( 1 ) 18(1) 0 ( 1 ) 0 ( 1 ) -4(1)
C12 30(1) 28(1) 19(1) -4(1) 6 ( 1 ) - 8 ( 1 )
C13 25(1) 26(1) 23(1) -5(1) 3(1) 0 ( 1 )
C14 24(1) 2 2 ( 1 ) 19(1) - 1 ( 1 ) 1 ( 1 ) 2 ( 1 )
0 1 2 0 (1 ) 18(1) 14(1) 0 ( 1 ) 1 ( 1 ) 4(1)
0 2 26(1) 2 2 (1 ) 2 2 (1 ) 3(1) 5(1) 2 (1 )
03 16(1) 26(1) 23(1) -5(1) - 2 ( 1 ) 3(1)
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F urther in format! on
£14
C13
CIO
C12 Cl 1
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